<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for self‐harm in children and adolescents - Witt, KG - 2021 | Cochrane Library</title> <meta content="Interventions for self‐harm in children and adolescents - Witt, KG - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013667.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for self‐harm in children and adolescents - Witt, KG - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013667.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013667.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for self‐harm in children and adolescents" name="citation_title"/> <meta content="Katrina G Witt" name="citation_author"/> <meta content="katrina.witt@orygen.org.au" name="citation_author_email"/> <meta content="Sarah E Hetrick" name="citation_author"/> <meta content="Gowri Rajaram" name="citation_author"/> <meta content="Philip Hazell" name="citation_author"/> <meta content="University of Sydney School of Medicine" name="citation_author_institution"/> <meta content="Tatiana L Taylor Salisbury" name="citation_author"/> <meta content="King's College London" name="citation_author_institution"/> <meta content="Ellen Townsend" name="citation_author"/> <meta content="University of Nottingham" name="citation_author_institution"/> <meta content="Keith Hawton" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD013667.pub2" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/03/07" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013667.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013667.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013667.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; Cognitive Behavioral Therapy [methods]; Confidence Intervals; Depression [therapy]; Dialectical Behavior Therapy [methods]; Family Therapy; *Mentalization; Odds Ratio; Patient Compliance; Psychosocial Intervention [*methods]; Psychotherapy [*methods]; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention [methods]; Self-Injurious Behavior [prevention &amp; control, psychology, *therapy]; Suicidal Ideation; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013667.pub2&amp;doi=10.1002/14651858.CD013667.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="qy4lqFNF";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013667\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013667\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ko","pt","ms","hr","fr","zh_HANS","zh_HANT","th","ja","fa","pl","ro"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013667.pub2",title:"Interventions for self\\u2010harm in children and adolescents",firstPublishedDate:"Mar 7, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Common Mental Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=qy4lqFNF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013667.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013667.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013667.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013667.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013667.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013667.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ro&quot;,&quot;title&quot;:&quot;Sumar&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;riskOfBias2&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Risk of Bias&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013667.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013667.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013667.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013667.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>31229 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013667.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-sec-0244"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-sec-0086"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-sec-0228"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/appendices#CD013667-sec-0249"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#riskOfBias2"> Risk of bias </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/supinfo/CD013667StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/supinfo/CD013667StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for self‐harm in children and adolescents</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information#CD013667-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Katrina G Witt</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information#CD013667-cr-0005">Sarah E Hetrick</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information#CD013667-cr-0006">Gowri Rajaram</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information#CD013667-cr-0007">Philip Hazell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information#CD013667-cr-0008">Tatiana L Taylor Salisbury</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information#CD013667-cr-0009">Ellen Townsend</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information#CD013667-cr-0010">Keith Hawton</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information/en#CD013667-sec-0255">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 07 March 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013667.pub2">https://doi.org/10.1002/14651858.CD013667.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013667-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013667-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013667-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013667-abs-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013667-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013667-abs-0004">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD013667-abs-0016">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013667-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013667-abs-0001" lang="en"> <section id="CD013667-sec-0001"> <h3 class="title" id="CD013667-sec-0001">Background</h3> <p>Self‐harm (SH; intentional self‐poisoning or self‐injury regardless of degree of suicidal intent or other types of motivation) is a growing problem in most countries, often repeated, and associated with suicide. Evidence assessing the effectiveness of interventions in the treatment of SH in children and adolescents is lacking, especially when compared with the evidence for psychosocial interventions in adults. This review therefore updates a previous Cochrane Review (last published in 2015) on the role of interventions for SH in children and adolescents. </p> </section> <section id="CD013667-sec-0002"> <h3 class="title" id="CD013667-sec-0002">Objectives</h3> <p>To assess the effects of psychosocial interventions or pharmacological agents or natural products for SH compared to comparison types of care (e.g. treatment‐as‐usual, routine psychiatric care, enhanced usual care, active comparator, placebo, alternative pharmacological treatment, or a combination of these) for children and adolescents (up to 18 years of age) who engage in SH. </p> </section> <section id="CD013667-sec-0003"> <h3 class="title" id="CD013667-sec-0003">Search methods</h3> <p>We searched the Cochrane Common Mental Disorders Specialized Register, the Cochrane Library (Central Register of Controlled Trials [CENTRAL] and Cochrane Database of Systematic Reviews [CDSR]), together with MEDLINE, Ovid Embase, and PsycINFO (to 4 July 2020). </p> </section> <section id="CD013667-sec-0004"> <h3 class="title" id="CD013667-sec-0004">Selection criteria</h3> <p>We included all randomised controlled trials (RCTs) comparing specific psychosocial interventions or pharmacological agents or natural products with treatment‐as‐usual (TAU), routine psychiatric care, enhanced usual care (EUC), active comparator, placebo, alternative pharmacological treatment, or a combination of these, in children and adolescents with a recent (within six months of trial entry) episode of SH resulting in presentation to hospital or clinical services. The primary outcome was the occurrence of a repeated episode of SH over a maximum follow‐up period of two years. Secondary outcomes included treatment adherence, depression, hopelessness, general functioning, social functioning, suicidal ideation, and suicide. </p> </section> <section id="CD013667-sec-0005"> <h3 class="title" id="CD013667-sec-0005">Data collection and analysis</h3> <p>We independently selected trials, extracted data, and appraised trial quality. For binary outcomes, we calculated odds ratios (ORs) and their 95% confidence internals (CIs). For continuous outcomes, we calculated the mean difference (MD) or standardised mean difference (SMD) and 95% CIs. The overall quality of evidence for the primary outcome (i.e. repetition of SH at post‐intervention) was appraised for each intervention using the GRADE approach. </p> </section> <section id="CD013667-sec-0006"> <h3 class="title" id="CD013667-sec-0006">Main results</h3> <p>We included data from 17 trials with a total of 2280 participants. Participants in these trials were predominately female (87.6%) with a mean age of 14.7 years (standard deviation (SD) 1.5 years). The trials included in this review investigated the effectiveness of various forms of psychosocial interventions. None of the included trials evaluated the effectiveness of pharmacological agents in this clinical population. There was a lower rate of SH repetition for DBT‐A (30%) as compared to TAU, EUC, or alternative psychotherapy (43%) on repetition of SH at post‐intervention in four trials (OR 0.46, 95% CI 0.26 to 0.82; N = 270; k = 4; high‐certainty evidence). There may be no evidence of a difference for individual cognitive behavioural therapy (CBT)‐based psychotherapy and TAU for repetition of SH at post‐intervention (OR 0.93, 95% CI 0.12 to 7.24; N = 51; k = 2; low‐certainty evidence). We are uncertain whether mentalisation based therapy for adolescents (MBT‐A) reduces repetition of SH at post‐intervention as compared to TAU (OR 0.70, 95% CI 0.06 to 8.46; N = 85; k = 2; very low‐certainty evidence). Heterogeneity for this outcome was substantial ( I² = 68%). There is probably no evidence of a difference between family therapy and either TAU or EUC on repetition of SH at post‐intervention (OR 1.00, 95% CI 0.49 to 2.07; N = 191; k = 2; moderate‐certainty evidence). However, there was no evidence of a difference for compliance enhancement approaches on repetition of SH by the six‐month follow‐up assessment, for group‐based psychotherapy at the six‐ or 12‐month follow‐up assessments, for a remote contact intervention (emergency cards) at the 12‐month assessment, or for therapeutic assessment at the 12‐ or 24‐month follow‐up assessments. </p> </section> <section id="CD013667-sec-0007"> <h3 class="title" id="CD013667-sec-0007">Authors' conclusions</h3> <p>Given the moderate or very low quality of the available evidence, and the small number of trials identified, there is only uncertain evidence regarding a number of psychosocial interventions in children and adolescents who engage in SH. Further evaluation of DBT‐A is warranted. Given the evidence for its benefit in adults who engage in SH, individual CBT‐based psychotherapy should also be further developed and evaluated in children and adolescents. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013667-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013667-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013667-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013667-abs-0020">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013667-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD013667-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD013667-abs-0018">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013667-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013667-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013667-abs-0021">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD013667-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/ro#CD013667-abs-0022">Română</a> </li> <li class="section-language"> <a class="" href="full/ru#CD013667-abs-0003">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD013667-abs-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013667-abs-0014">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013667-abs-0015">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013667-abs-0002" lang="en"> <h3>Interventions for children and adolescents who self‐harm</h3> <p>We have reviewed the international literature regarding psychosocial interventions, pharmacological (drug), and natural product (dietary supplementation) treatment trials in the field. A total of 17 trials meeting our inclusion criteria were identified. There is little evidence of beneficial effects for individual cognitive behavioural therapy (CBT)‐based psychotherapy, mentalisation‐based therapy for adolescents (MBT‐A), group‐based psychotherapy, enhanced assessment approaches, compliance enhancement approaches, family interventions, or remote contact interventions. There is some evidence of effectiveness for dialectical behaviour therapy (DBT‐A) for adolescents. However, few trials have been conducted and those that have are generally small, meaning that possible beneficial effects of some of these therapies cannot be ruled out. </p> <p><b>Why is this review important?</b> </p> <p>Self‐harm (SH), which includes intentional self‐poisoning/overdose and self‐injury, is a major problem in many countries and is strongly linked with suicide. It is therefore important that effective treatments for SH patients are developed. There has been an increase in the use of interventions for SH in children and adolescents. It is therefore important to assess the evidence for their effectiveness. </p> <p><b>Who will be interested in this review?</b> </p> <p>Hospital administrators (e.g. service providers), health policy officers and third party payers (e.g. health insurers), clinicians working with patients who engage in SH, patients themselves, and their relatives. </p> <p><b>What questions does this review aim to answer?</b> </p> <p>This review is an update of a previous Cochrane Review from 2015 which found little evidence of beneficial effects of interventions for SH in children and adolescents. This updated review aims to further evaluate the evidence for effectiveness of interventions for children and adolescents with SH with a broader range of outcomes. </p> <p><b>Which studies were included in the review?</b> </p> <p>To be included in the review, studies had to be randomised controlled trials of either psychosocial or drug treatments for children and adolescents up to 18 years of age who had recently engaged in SH. </p> <p><b>What does the evidence from the review tell us?</b> </p> <p>There have been surprisingly few investigations of treatments for SH in children and adolescents, despite the size of this problem in many countries. We found positive effects of DBT‐A on repetition of SH. There is currently no clear evidence for the effectiveness of individual CBT‐based psychotherapy, MBT‐A, group‐based psychotherapy, enhanced assessment approaches, compliance enhancement approaches, family interventions, or remote contact interventions in preventing repetition of SH. </p> <p><b>What should happen next?</b> </p> <p>We recommend further trials of DBT‐A. Given the evidence for its benefit for adults who engage in SH, individual CBT‐based psychotherapy should also be further developed and evaluated in children and adolescents. Given the extent of SH in children and adolescents, greater attention should be paid to the development and evaluation of specific therapies for this population. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013667-sec-0244" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013667-sec-0244"></div> <h3 class="title" id="CD013667-sec-0245">Implications for practice</h3> <section id="CD013667-sec-0245"> <p>Presentations of children and adolescents to clinical services following SH are common, yet there have been relatively few systematic investigations into interventions that may prevent recurrence. We found only 17 trials of psychosocial interventions in this clinical population. We found none of pharmacological treatments. </p> <p>Given the evidence for its benefit for adults who engage in SH, individual CBT‐based psychotherapy needs to be further developed and evaluated in children and adolescents. However, treatment adherence with this approach may be challenging in this age group. One small feasibility study included in this review, for example, found that few adolescents completed the acute treatment phase, and even fewer attended any of the booster sessions offered (<a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>). We also found some positive effects of DBT‐A, but methodological factors limit confidence in the generalisability of the results.  We recommend further evaluation of these approaches to assess the impact of these interventions in different samples and settings. Given the multi‐component nature of these intervention approaches, greater use of head‐to‐head trials, which allow for dismantling of the effect size(s) between one or more component(s), should be considered. </p> <p>Given the high incidence of family problems in children and adolescents who engage in SH, the lack of evidence for efficacy of family therapy approaches found in this review is both surprising and disappointing. On the strength of the evidence from three trials, including one recent larger trial, there is also little support for group‐based therapy for adolescents with a history of multiple episodes of SH. Additionally, it is notable that the authors of one of these trials reports an incident in which one participant posted confidential information about another participant on an online blog (<a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>), highlighting the potential risks associated with group‐based therapy in this clinical population </p> <p>An argument for intervention following an episode of SH is that it may improve other outcomes even if it does not reduce SH. Secondary outcomes were examined variably across the included trials. There was only limited evidence that experimental interventions might lead to better outcomes in these other domains. DBT‐A improved depression, hopelessness, and suicidal ideation in the short term. Both DBT‐A and therapeutic assessment appeared to improve treatment adherence (at least for individual therapy). Conspicuously, other treatments that might have been expected to improve depression, such as individual CBT‐based psychotherapy and MBT‐A did not perform any better than TAU.  </p> <p>Indeed, few psychosocial interventions appear to perform better than TAU. However, TAU was not well described in most clinical trials we examined. TAU also varies greatly across clinical settings (Witt 2018b). A positive step forward would be the operationalisation of TAU to inform both clinical practice and research. It is possible that TAU has an advantage over some of these specific interventions because it offers more flexibility to tailor treatment to the specific needs of the patients. </p> <p>Results of this review would also suggest that a comprehensive therapeutic assessment may increase engagement with subsequent treatment whilst, additionally, enabling the identification of psychosocial needs that should be addressed during treatment. Although this finding is based on a single cluster‐randomised trial which may overestimate the effectiveness of the intervention, this result suggests that a comprehensive therapeutic psychosocial assessment might be a useful part of a clinical intervention. This is in keeping with official guidance (<a href="./references#CD013667-bbs2-0205" title="National Institute for Health and Clinical Excellence. Self-harm: Longer-Term Management [National Institute for Health and Care Excellence clinical guideline 133]. Accessed 26 June 2020 from: www.nice.org.uk/guidance/cg133/evidence/full-guideline-pdf-184901581. London, UK: National Institute for Health and Clinical Excellence, 2011.">NICE 2011</a>). </p> </section> <h3 class="title" id="CD013667-sec-0246">Implications for research</h3> <section id="CD013667-sec-0246"> <p>Given that SH results from a complex interplay between genetic, biological, psychiatric, psychosocial, social, cultural, and other factors, the development of interventions for SH in children and adolescents could benefit from being based on detailed investigation of these factors, including those that might reduce the risk of further SH, as well as having benefits for other outcomes. Ideally, the development of new treatments should ensure their feasibility and suitability for the young people for whom they are designed; children and adolescents with experience of SH and their carers should be involved in this process. </p> <p>Additionally, trials of interventions for children and adolescents who engage in SH should include a range of outcome measures, not just SH and suicide, but also acceptability, adherence, and attitudes to treatment by young people, their caregivers, and service providers, as these may help to identify contributors to any apparent benefit or lack of impact. In particular, the inclusion of outcomes that matter to those who engage in SH is required to further inform intervention development (<a href="./references#CD013667-bbs2-0210" title="OwensC , FoxF , RedwoodS , DaviesR , FooteL , SalisburyN , et al. Measuring outcomes in trials of interventions for people who self-harm: qualitative study of service users' views. British Journal of Psychiatry Open2020;6:e22.">Owens 2020</a>). It is also important that adverse effects of treatment, both short‐ and long‐term, are carefully evaluated, such as the release of confidential information described in the <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a> trial. Use of an agreed set of outcome measures would also assist in evaluation across trials. Investigation of the mechanisms through which treatments might work is also desirable to assist with the identification of clinically relevant subgroups of patients who may benefit from certain, more intensive, forms of intervention. </p> <p>Heed should also be paid to the principles of development and evaluation of treatments as laid out in the UK Medical Research Council guidance regarding complex interventions. Additionally, from a service planning perspective, future trials should also include economic evaluations in order to determine which interventions may be most feasible to routinely implement throughout a health service (<a href="./references#CD013667-bbs2-0078" title="Bustamante-MadsenL , EddlestonM , Schultz-HansenK , KonradsenF . Quality assessment of economic evaluations of suicide and self-harm interventions. Crisis2018;39:82-95.">Bustamante‐Madsen 2018</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013667-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013667-sec-0008"></div> <div class="table" id="CD013667-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Comparison 1: Individual CBT‐based psychotherapy compared to TAU or other comparator for self‐harm in children and adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Comparison 1: Individual CBT‐based psychotherapy compared to TAU or other comparator for self‐harm in children and adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> self‐harm in children and adolescents  (up to 18 years or age)<br/><b>Intervention:</b> Individual CBT‐based psychotherapy<br/><b>Comparison:</b> TAU or other comparator </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with TAU or other comparator</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Comparison 1: Individual CBT‐based psychotherapy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Repetition of SH by post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.93<br/>(0.12 to 7.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>51<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Our confidence in the effect estimate of individual CBT‐based psychotherapy on repetition of SH at post‐intervention is limited. The true effect may be substantially different from the estimate of the effect. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>160 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>150 per 1,000<br/>(22 to 580) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded this domain by one level as we rated any of the sources of risk of bias (as described in <a href="#CD013667-sec-0064">Assessment of risk of bias in included studies</a>) at high risk for one of the studies included in the pooled estimate. </p> <p><sup>2</sup> We downgraded this domain by one level where the 95% CI for the pooled effect included the null value. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013667-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Comparison 2: DBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Comparison 2: DBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> self‐harm in children and adolescents  (up to 18 years or age)<br/><b>Intervention:</b> DBT‐A<br/><b>Comparison:</b> TAU or another comparator </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with TAU or another comparator</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Comparison 2: DBT‐A</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Repetition of SH at post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.46<br/>(0.26 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>270<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are very confident that the true effect lies close to that of the estimate of the effect estimate of DBT‐A on repetition of SH at post‐intervention. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>432 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>259 per 1,000<br/>(165 to 384) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD013667-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Comparison 3: MBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Comparison 3: MBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> self‐harm in children and adolescents  (up to 18 years or age)<br/><b>Intervention:</b> MBT‐A<br/><b>Comparison:</b> TAU or another comparator </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with TAU or another comparator</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Comparison 3: MBT‐A</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Repetition of SH at post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.70<br/>(0.06 to 8.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>85<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of MBT‐A on repetition of self‐harm by post‐intervention. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>805 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>743 per 1,000<br/>(198 to 972) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded this domain by one level as we rated any of the sources of risk of bias (as described in <a href="#CD013667-sec-0064">Assessment of risk of bias in included studies</a>) at high risk for one of the studies included in the pooled estimate. </p> <p><sup>2</sup> We downgraded this domain by one level as one of the studies included in the pooled estimate used a proxy measure (i.e. cut‐scores on the Risk Taking and Self‐Harm Inventory) to ascertain repetition of SH. It is unclear how scores on this measure may relate to actual SH behaviour. </p> <p><sup>3</sup> We downgraded this domain by one level where the 95% CI for the pooled effect included the null value. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013667-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Comparison 7: Family therapy compared to placebo for self‐harm in children and adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Comparison 7: Family therapy compared to placebo for self‐harm in children and adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> self‐harm in children and adolescents  (up to 18 years or age)<br/><b>Intervention:</b> Family therapy<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Comparison 7: Family therapy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Repetition of SH at post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.00<br/>(0.49 to 2.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>191<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are moderately confident in the effect estimate of family therapy on repetition of SH at post‐intervention. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>216 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>216 per 1,000<br/>(119 to 364) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded this domain by one level where the 95% CI for the pooled effect included the null value. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013667-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013667-sec-0009"></div> <section id="CD013667-sec-0010"> <h3 class="title" id="CD013667-sec-0010">Description of the condition</h3> <p>Self‐harm (SH), which includes all intentional acts of self‐poisoning (such as intentional drug overdoses) or self‐injury (such as self‐cutting), regardless of degree of suicidal intent or other types of motivation (<a href="./references#CD013667-bbs2-0137" title="HawtonK , HarissL , HallS , SimkinS , BaleE , BondA . Deliberate self-harm in Oxford, 1990-2000: a time of change in patient characteristics. Psychological Medicine2003;33:987-96.">Hawton 2003</a>), has been a growing problem in children and adolescents up to 18 years of age (<a href="./references#CD013667-bbs2-0143" title="HawtonK , SaundersKEA , O'ConnorR . Self-harm and suicide in adolescents. Lancet2012;379:2373-82.">Hawton 2012b</a>). Rates of SH in children and adolescents have been increasing over recent decades across a number of comparable countries, according to the number of presentations to general hospitals and primary care (<a href="./references#CD013667-bbs2-0079" title="CairnsR , KarangesEA , WongA , BrownJA , RobinsonJ , Pearson S-A, et al. Tends in self-poisoning and psychotropic drug use in people aged 5 – 19 years: a retrospective cohort study in Australia. BMJ Open2019;9:e026001. [DOI: 10.1136/bmjopen-2018-026001]">Cairns 2019</a>; <a href="./references#CD013667-bbs2-0132" title="GriffinE , McMahonE , McNicholasF , CorcoranP , PerryIJ , ArensmanE . Increasing rates of self-harm among children, adolescents and young adults: a 10-year national registry study 2007-2016. Social Psychiatry and Psychiatric Epidemiology2018;53:663-71.">Griffin 2018</a>; <a href="./references#CD013667-bbs2-0200" title="MorganC , WebbRT , CarrMJ , KontopantelisE , GreenJ , Chew-GrahamC , et al. Incidence, clinical management, and mortality risk following self harm among children and adolescents. BMJ Open2017;359:j4351.">Morgan 2017</a>). This increase may be attributable to a number of factors, including: younger age of onset of SH behaviours (<a href="./references#CD013667-bbs2-0119" title="GardnerW , PajerK , CloutierP , ZemekR , CurrieL , HatcherS , et al. Changing rates of self-harm and mental disorders by sex in youths presenting to Ontario emergency departments: repeated cross-sectional study. Canadian Journal of Psychiatry2019;64:789-97.">Gardner 2019</a>; <a href="./references#CD013667-bbs2-0132" title="GriffinE , McMahonE , McNicholasF , CorcoranP , PerryIJ , ArensmanE . Increasing rates of self-harm among children, adolescents and young adults: a 10-year national registry study 2007-2016. Social Psychiatry and Psychiatric Epidemiology2018;53:663-71.">Griffin 2018</a>; <a href="./references#CD013667-bbs2-0164" title="JungKY , KimT , HwangSY , LeeTR , YoonH , ShinTG , et al. Deliberate self-harm among young people begins to increase at the very early age: a nationwide study. Journal of Korean Medical Science2018;33:e191.">Jung 2018</a>; <a href="./references#CD013667-bbs2-0211" title="PereraJ , WandT , BeinKJ , ChalkleyD , IversR , SteinbeckKS , et al. Presentations to NSW emergency departments with self-harm, suicidal ideation, or intentional poisoning, 2010-2014. Medical Journal of Australia2018;208:348-53.">Perera 2018</a>), changes in the potential lethality of methods of SH used by children and adolescents (<a href="./references#CD013667-bbs2-0132" title="GriffinE , McMahonE , McNicholasF , CorcoranP , PerryIJ , ArensmanE . Increasing rates of self-harm among children, adolescents and young adults: a 10-year national registry study 2007-2016. Social Psychiatry and Psychiatric Epidemiology2018;53:663-71.">Griffin 2018</a>), increased risk of SH repetition in children and adolescents, relative to young adults (i.e. 20 to 24‐year‐olds; <a href="./references#CD013667-bbs2-0066" title="BennardiM , McMahonE , CorcoranP , GriffinE , ArensmanE . Risk of repeated self-harm and associated factors in children, adolescents, and young adults. BMC Psychiatry2016;16:421.">Bennardi 2016</a>), changes in clinical documentation and improved administrative coding of cases of SH in children and adolescents, resulting in a higher detection rate of young people who engage in SH (<a href="./references#CD013667-bbs2-0189" title="McGillK , HilesS , HandleyTE , PageA , LewinTJ , WhyteI , et al. Is the reported increase in young female hospital-treated intentional self-harm real or artefactual?Australian and New Zealand Journal of Psychiatry2018;53:663-72.">McGill 2018</a>). </p> <p>In contrast to suicide rates, rates of hospital‐presenting SH are higher in young females than males in most countries. The female to male ratio peaks at approximately five to six times in 12 to 14‐year‐olds, before decreasing with age (<a href="./references#CD013667-bbs2-0099" title="DigginsE , KelleyR , CottrellD , HouseA , OwensD . Age-related differences in self-harm presentations and subsequent management of adolescents and young adults at the emergency department. Journal of Affective Disorders2017;208:399-405.">Diggins 2017</a>; <a href="./references#CD013667-bbs2-0132" title="GriffinE , McMahonE , McNicholasF , CorcoranP , PerryIJ , ArensmanE . Increasing rates of self-harm among children, adolescents and young adults: a 10-year national registry study 2007-2016. Social Psychiatry and Psychiatric Epidemiology2018;53:663-71.">Griffin 2018</a>; <a href="./references#CD013667-bbs2-0191" title="McMahonEM , KeeleyH , CannonM , ArensmanE , PerryIJ , ClarkeM , et al. The iceberg model of suicide and self-harm in Irish adolescents: a population-based study. Social Psychiatry and Psychiatric Epidemiology2014;49:1929-35.">McMahon 2014</a>). While reasons for the differential prevalence of SH behaviours in young females compared to young males are complex, an earlier age of onset of psychiatric disorders in young females may represent an important factor (<a href="./references#CD013667-bbs2-0220" title="RhodesAE , BoyleMH , BridgeJA , SinyorM , LinksTS , TonmyrL , et al. Antecedents and sex/gender differences in youth suicidal behavior. World Journal of Psychiatry2014;4:120-32.">Rhodes 2014</a>). However, only about 1:28 young males, and 1:18 young females who SH ever present to hospital (<a href="./references#CD013667-bbs2-0120" title="GeulayovG , CaseyD , McDonaldKC , FosterP , PritchardK , WellsC , et al. Incidence of suicide, hospital-presenting non-fatal self-harm, and community-occurring non-fatal self-harm in adolescents in England (the Iceberg Model of Self-Harm): a retrospective study. Lancet Psychiatry2018;5:167-74.">Geulayov 2018</a>). Therefore, it is apparent that SH in children and adolescents in the community (i.e. without hospital presentation) is very common, although less is known about the treatment needs of these youth (<a href="./references#CD013667-bbs2-0143" title="HawtonK , SaundersKEA , O'ConnorR . Self-harm and suicide in adolescents. Lancet2012;379:2373-82.">Hawton 2012b</a>; <a href="./references#CD013667-bbs2-0182" title="MadgeN , HewittA , HawtonK , De WildeEJ , CorcoranP , FeketeS , et al. Deliberate self-harm within an international community sample of young people: comparative findings from the Child &amp; Adolescent Self-harm in Europe (CASE) study. Journal of Child Psychology and Psychiatry, and Allied Disciplines2008;49:667-77.">Madge 2008</a>; <a href="./references#CD013667-bbs2-0191" title="McMahonEM , KeeleyH , CannonM , ArensmanE , PerryIJ , ClarkeM , et al. The iceberg model of suicide and self-harm in Irish adolescents: a population-based study. Social Psychiatry and Psychiatric Epidemiology2014;49:1929-35.">McMahon 2014</a>). </p> <p>For those who present to hospital, the most common method of SH is self‐poisoning. Overdoses of analgesics and psychotropics, especially paracetamol or acetaminophen, are common in some countries, particularly high‐income countries (<a href="./references#CD013667-bbs2-0079" title="CairnsR , KarangesEA , WongA , BrownJA , RobinsonJ , Pearson S-A, et al. Tends in self-poisoning and psychotropic drug use in people aged 5 – 19 years: a retrospective cohort study in Australia. BMJ Open2019;9:e026001. [DOI: 10.1136/bmjopen-2018-026001]">Cairns 2019</a>; <a href="./references#CD013667-bbs2-0144" title="HawtonK , BergenH , WatersK , NessJ , CooperJ , SteegS , et al. Epidemiology and nature of self-harm in children and adolescents: findings from the Multicentre Study of Self-harm in England. European Child &amp; Adolescent Psychiatry2012;21:369-77.">Hawton 2012c</a>; <a href="./references#CD013667-bbs2-0231" title="SheenCL , DillonJF , BatemanDN , SimpsonKJ , MacDonaldTM . Paracetamol toxicity: epidemiology, prevention and costs to the health-care system. Quarterly Journal of Medicine2002;95:609-19.">Sheen 2002</a>). Self‐cutting is the next most frequent method used by those who present to hospital. However, in the community, self‐cutting and other forms of self‐injury are far more frequent than self‐poisoning (<a href="./references#CD013667-bbs2-0120" title="GeulayovG , CaseyD , McDonaldKC , FosterP , PritchardK , WellsC , et al. Incidence of suicide, hospital-presenting non-fatal self-harm, and community-occurring non-fatal self-harm in adolescents in England (the Iceberg Model of Self-Harm): a retrospective study. Lancet Psychiatry2018;5:167-74.">Geulayov 2018</a>; <a href="./references#CD013667-bbs2-0182" title="MadgeN , HewittA , HawtonK , De WildeEJ , CorcoranP , FeketeS , et al. Deliberate self-harm within an international community sample of young people: comparative findings from the Child &amp; Adolescent Self-harm in Europe (CASE) study. Journal of Child Psychology and Psychiatry, and Allied Disciplines2008;49:667-77.">Madge 2008</a>; <a href="./references#CD013667-bbs2-0202" title="MüllerA , ClaesL , BrählerE , De ZwaanM . Prevalence and correlates of self-harm in the German general population. PLOS One2016;11:e0157928.">Müller 2016</a>). </p> <p>SH is associated with increased risk of future suicide. While suicide is relatively uncommon in younger children, rates have been increasing across a number of countries in recent years, particularly among young females (<a href="./references#CD013667-bbs2-0070" title="BouldH , MarsB , MoranP , BiddleL , GunnellD . Rising suicide rates among adolescents in England and Wales. Lancet2019;394:116-7.">Bould 2019</a>; <a href="./references#CD013667-bbs2-0174" title="LahtiA , RäsänenP , RialaK , KeränenS , HakkoH . Youth suicide trends in Finland, 1969-2008. Journal of Child Psychology and Psychiatry, and Allied Disciplines2011;52:984-91.">Lahti 2011</a>; <a href="./references#CD013667-bbs2-0222" title="RohBR , JungEH , HongHJ . A comparative study of suicide rates among 10-19-year-olds in 29 OECD countries. Psychiatry Investigations2018;15:376-83.">Roh 2018</a>; <a href="./references#CD013667-bbs2-0235" title="StefanacN , HetrickS , HulbertC , SpittalMJ , WittK , RobinsonJ . Are young female suicides increasing? A comparison of sex-specific rates and characteristics of youth suicides in Australia over 2004-2014. BMC Public Health2019;19:1389.">Stefanac 2019</a>; <a href="./references#CD013667-bbs2-0233" title="SkinnerR , McFaullS . Suicide among children and adolescents in Canada: trends and sex differences, 1980-2008. Canadian Medical Association Journal2012;184:1029-34.">Skinner 2012</a>; <a href="./references#CD013667-bbs2-0239" title="SullivanEM , AnnestJL , SimonTR , LuoF , DahlbergLL . Suicide trends among persons aged 10-24 years — United States, 1994-2012. Morbidity and Mortality Weekly Report. Surveillance Summaries: MMWR2015;64:201-5.">Sullivan 2015</a>). For example, recent data from the UK showed that children and adolescents who presented to hospital on at least one occasion following an episode of SH were 30 times more likely to die by suicide within a year (<a href="./references#CD013667-bbs2-0147" title="HawtonK , BaleL , BrandF , TownsendE , NessJ , WatersK , et al. Mortality in children and adolescents following presentation to hospital after non-fatal self-harm in the Multicentre Study of Self-harm: a prospective observational cohort study. Lancet Child &amp; Adolescent Health2020;4(2):111-20. [DOI: 10.1016/S2352-4642(19)30373-6]">Hawton 2020a</a>). A history of SH, particularly with frequent repetition, is the strongest risk factor for suicide across a range of psychiatric disorders (<a href="./references#CD013667-bbs2-0265" title="ZahlDL , HawtonK . Repetition of deliberate self-harm and subsequent suicide risk: long-term follow-up study of 11 583 patients. British Journal of Psychiatry2004;185:70-5.">Zahl 2004</a>). </p> <p>SH and suicide in children and adolescents are the result of a complex interplay between genetic, biological, psychiatric, psychosocial, social, cultural, and other factors (<a href="./references#CD013667-bbs2-0143" title="HawtonK , SaundersKEA , O'ConnorR . Self-harm and suicide in adolescents. Lancet2012;379:2373-82.">Hawton 2012b</a>). Psychiatric disorders, particularly mood disorders, are associated with the largest population attributable risk for SH in children and adolescents. While personality disorders should not be diagnosed in younger children, emergent traits consistent with those in adult borderline personality disorder have also been found to be associated with a significant population attributable risk for SH in this population (<a href="./references#CD013667-bbs2-0256" title="WittK , MilnerA , SpittalMJ , HetrickS , RobinsonJ , PirkisJ , et al. Population attributable risk of factors associated with the repetition of self-harm behaviour in young people presenting to clinical services: a systematic review and meta-analysis. European Child &amp; Adolescent Psychiatry2019;28:5-18.">Witt 2019a</a>), particularly those who engage in frequent repetition of SH (<a href="./references#CD013667-bbs2-0090" title="CrowellSE , BeauchaineTP , HsiaoRC , WasilevCA , YaptangcoM , LinehanMM . Differentiating adolescent self-injury from adolescent depression: possible implications for borderline personality development. Journal of Abnormal Child Psychology2012;40:45-57.">Crowell 2012</a>). Alcohol and illicit drug misuse may also play an important role. </p> <p>Both psychological and biological factors appear to further increase vulnerability to SH. Psychological factors may include poor emotion regulation abilities, or poor emotional intelligence may also contribute to the risk of SH in this population (<a href="./references#CD013667-bbs2-0072" title="BrauschAM , WoodsSE . Emotion regulation deficits and nonsuicidal self-injury prospectively predict suicidal ideation in adolescents. Suicide &amp; Life-threatening Behavior2019;49:868-80.">Brausch 2019</a>; <a href="./references#CD013667-bbs2-0194" title="MikolajczakM , PetridesKV , HurryJ . Adolescents choosing self-harm as an emotion regulation strategy: the protective role of trait emotional intelligence. British Journal of Clinical Psychology2009;48:191-3.">Mikolajczak 2009</a>). Psychological influences on children and adolescents who engage in SH include feelings of entrapment, lack of belonging, and perceiving oneself as a burden (<a href="./references#CD013667-bbs2-0206" title="O'ConnorRC , RasmussenS , HawtonK . Distinguishing adolescents who think about self-harm from those who engage in self-harm. British Journal of Psychiatry2012;200:330-5.">O'Connor 2012</a>). Other contributors include perfectionism, low self‐esteem, social isolation, impulsivity, hopelessness, and poor parent‐child attachment (<a href="./references#CD013667-bbs2-0143" title="HawtonK , SaundersKEA , O'ConnorR . Self-harm and suicide in adolescents. Lancet2012;379:2373-82.">Hawton 2012b</a>).  </p> <p>Relationship problems are common in children and adolescents who engage in SH, especially problems with family members (<a href="./references#CD013667-bbs2-0116" title="FortuneS , CottrellD , FifeS . Family factors associated with adolescent self-harm: a review. Journal of Family Therapy2016;38:226-56.">Fortune 2016</a>). Relationship problems with partners are more common in older adolescents (i.e. 15 to 18‐year‐olds) than in younger children (i.e. 10 to 14‐year‐olds; <a href="./references#CD013667-bbs2-0144" title="HawtonK , BergenH , WatersK , NessJ , CooperJ , SteegS , et al. Epidemiology and nature of self-harm in children and adolescents: findings from the Multicentre Study of Self-harm in England. European Child &amp; Adolescent Psychiatry2012;21:369-77.">Hawton 2012c</a>). A history of emotional, physical, or sexual abuse has been associated with a significant population attributable risk of SH (<a href="./references#CD013667-bbs2-0178" title="LiuRT , ScopellitiKM , PittmanSK , ZamoraAS . Childhood maltreatment and non-suicidal self-injury: a systematic review and meta-analysis. Lancet Psychiatry2018;5:51-64.">Liu 2018</a>; <a href="./references#CD013667-bbs2-0183" title="MadgeN , HawtonK , McMahonEM , CorcoranP , De LeoD , De WildeEJ , et al. Psychological characteristics, stressful life events and deliberate self-harm: findings from the Child and Adolescent Self-harm in Europe (CASE) Study. European Child &amp; Adolescent Psychiatry2011;20:499-508.">Madge 2011</a>; <a href="./references#CD013667-bbs2-0256" title="WittK , MilnerA , SpittalMJ , HetrickS , RobinsonJ , PirkisJ , et al. Population attributable risk of factors associated with the repetition of self-harm behaviour in young people presenting to clinical services: a systematic review and meta-analysis. European Child &amp; Adolescent Psychiatry2019;28:5-18.">Witt 2019a</a>). Bullying and victimisation (<a href="./references#CD013667-bbs2-0150" title="HeerdeJA , HemphillSA . Are bullying perpetration and victimization associated with adolescent deliberate self-harm? A meta-analysis. Archives of Suicide Research2019;23:353-81.">Heerde 2019</a>), including cyber‐bullying (<a href="./references#CD013667-bbs2-0150" title="HeerdeJA , HemphillSA . Are bullying perpetration and victimization associated with adolescent deliberate self-harm? A meta-analysis. Archives of Suicide Research2019;23:353-81.">Heerde 2019</a>; <a href="./references#CD013667-bbs2-0162" title="JohnA , GlendenningAC , MarchantA , MontgomeryP , StewartA , WoodS , et al. Self-Harm, suicidal behaviours, and cyberbullying in children and young people: systematic review. Journal of Medical Internet Research2018;20:e129.">John 2018</a>), can also increase the risk of SH. Exposure to suicidal behaviour in others, either through personal contact, or through portrayals in traditional (e.g. films or television dramas) or new media (including social media), may also be an important factor as SH in children and adolescents often has a 'contagious' quality (<a href="./references#CD013667-bbs2-0148" title="HawtonK , HillNTM , GouldM , JohnA , LascellesK , RobinsonJ . Clustering of suicides in children and adolescents. Lancet Child and Adolescent Health2020;4:58-67.">Hawton 2020b</a>; <a href="./references#CD013667-bbs2-0190" title="McMahonEM , CorcoranP , KeeleyH , PerryIJ , ArensmanE . Adolescents exposed to suicidal behavior of others: prevalence of self-harm and associated psychological, lifestyle, and life event factors. Suicide &amp; Life-threatening Behavior2013;43:634-45.">McMahon 2013</a>). Biological factors include disturbances in the serotonergic and stress response systems (<a href="./references#CD013667-bbs2-0245" title="Van HeeringenK , MannJJ . The neurobiology of suicide. Lancet Psychiatry2014;1:63-72.">Van Heeringen 2014</a>). </p> </section> <section id="CD013667-sec-0011"> <h3 class="title" id="CD013667-sec-0011">Description of the intervention</h3> <p>Treatment for SH in children and adolescents may involve psychosocial interventions, pharmacological interventions, or a combination of the two approaches. </p> <section id="CD013667-sec-0012"> <h4 class="title">Psychosocial interventions</h4> <p>Psychological approaches used to treat children and adolescents who engage in SH typically involve brief individual‐ or group‐based psychological therapy. Treatment may vary in initial management, location of treatment, continuity, intensity, and frequency of contact with therapists. There is also considerable variation among countries in the availability of services to provide such interventions. Consequently, there is no standard psychosocial treatment of SH in children and adolescents. However, in high‐income countries, treatment generally consists of a combination of assessment, support, involvement of parents, family, and caregivers, and individual psychological therapies. </p> </section> <section id="CD013667-sec-0013"> <h4 class="title">Pharmacological interventions</h4> <p>Given the prevalence of psychiatric disorders in children and adolescents who engage in SH (<a href="./references#CD013667-bbs2-0145" title="HawtonK , SaundersKEA , TopiwalaA , HawC . Psychiatric disorders in patients presenting to hospital following self-harm: a systematic review. Journal of Affective Disorders2013;151:821-30.">Hawton 2013</a>), pharmacological treatments may include antidepressants, antipsychotics, and mood stabilisers (including anticonvulsants and lithium). SH also arises in the context of anxiety and general distress and thus anxiolytics (including both benzodiazepines and non‐benzodiazepine anxiolytics) may be trialled. Other pharmacological agents may also be trialled. However, treatment with pharmacological agents is generally less common than treatment with psychosocial interventions in this population, partly due to concerns about the risk of exacerbating SH (<a href="./references#CD013667-bbs2-0196" title="MillerM , SwansonSA , AzraelD , PateV , StrumerT . Antidepressant dose, age, and the risk of deliberate self-harm. JAMA Internal Medicine2014;174(6):899-909.">Miller 2014</a>). </p> </section> <section id="CD013667-sec-0014"> <h4 class="title">Combined psychosocial and pharmacological interventions</h4> <p>Treatment may also involve a combination of both psychosocial and pharmacological approaches, such as cognitive behavioural therapy combined with fluoxetine (<a href="./references#CD013667-bbs2-0122" title="GilbertAC , DeYoungLLA , BarthelemyCM , JenkinsGA , MacPhersonHA , KimKL , et al. The treatment of suicide and self-injurious behaviors in children and adolescents. Current Treatment Options in Psychiatry2020;7:39-52.">Gilbert 2020</a>). </p> </section> </section> <section id="CD013667-sec-0015"> <h3 class="title" id="CD013667-sec-0015">How the intervention might work</h3> <section id="CD013667-sec-0016"> <h4 class="title">Psychosocial interventions</h4> <p>Mood disorders, in particular, have been identified as key modifiable risk factors for children and adolescents who engage in SH (<a href="./references#CD013667-bbs2-0256" title="WittK , MilnerA , SpittalMJ , HetrickS , RobinsonJ , PirkisJ , et al. Population attributable risk of factors associated with the repetition of self-harm behaviour in young people presenting to clinical services: a systematic review and meta-analysis. European Child &amp; Adolescent Psychiatry2019;28:5-18.">Witt 2019a</a>). Psychosocial interventions may address some of the underlying psychological risk factors associated with SH. The mechanisms of action of these interventions might help children and adolescents improve their coping skills and tackle specific problems, manage psychiatric disorders, improve self‐esteem, increase a sense of social connectedness, and reduce impulsivity and harmful reactions to distressing situations. What follows, is a description of the psychosocial interventions that are typically available for children and adolescents who engage in SH. </p> <section id="CD013667-sec-0017"> <h5 class="title">Cognitive behavioural therapy‐based psychotherapy</h5> <p>Cognitive behavioural therapy (CBT)‐based psychotherapy helps people to identify and critically evaluate the ways in which they interpret and evaluate disturbing emotional experiences and events, and aims to help them change the ways in which they deal with problems (<a href="./references#CD013667-bbs2-0250" title="WestbrookD , KennerleyH , KirkJ . An Introduction to Cognitive Behaviour Therapy: Skills and Applications. London, UK: SAGE Publications, 2008.">Westbrook 2008</a>). This is achieved in three steps: first, people are helped to change the ways in which they interpret and evaluate distressing emotions; second, they learn strategies to help them change the way in which they think about the meanings and consequences of these emotions; finally, with the benefit of modified interpretation of emotions and events, they are helped to change their behaviour and develop positive functional behaviour (<a href="./references#CD013667-bbs2-0163" title="JonesC , HackerD , CormacI , MeadenA , IrvingCB . Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia. Cochrane Database of Systematic Reviews2012, Issue 4. Art. No: CD008712. [DOI: 10.1002/14651858.CD008712.pub2]">Jones 2012</a>). </p> <p>Problem‐solving therapy (PST) is an integral part of CBT, although it can be delivered as a therapy in and of itself. PST assumes that ineffective and maladaptive coping behaviours that drive SH might be overcome by helping the person to learn skills to actively, constructively, and effectively solve the problems he or she faces in their daily lives (<a href="./references#CD013667-bbs2-0204" title="NezuAM , NezuCM , D'ZurillaTJ . Problem-solving therapy. In: KazantzisN , ReineckeMA , FreemanA , editors(s). Cognitive and Behavioral Theories in Clinical Practice. New York, NY: Guilford Press, 2010.">Nezu 2010</a>). PST typically involves identification of the problem, generation of a range of solutions, implementation of chosen solutions based on appraisal, and the evaluation of these solutions (<a href="./references#CD013667-bbs2-0093" title="D'ZurillaTJ , NezuAM . Problem-solving therapy. In: DobsonKS , editors(s). Handbook of Cognitive-Behavioral Therapies. 3rd edition. New York, NY: Guilford Press, 2010.">D'Zurilla 2010</a>). Treatment goals include helping people to develop a positive problem‐solving orientation, use rational problem‐solving strategies, reduce the tendency to avoid problem‐solving, and reduce the use of impulsive problem‐solving strategies (<a href="./references#CD013667-bbs2-0248" title="WashburnJJ , RichardtSL , StyerDM , GebhardtM , JuzwinKR , YourekA , et al. Psychotherapeutic approaches to non-suicidal self-injury in adolescents. Child and Adolescent Psychiatry and Mental Health2012;6:14.">Washburn 2012</a>). </p> </section> <section id="CD013667-sec-0018"> <h5 class="title">Dialectical behaviour therapy</h5> <p>In contrast to CBT and PST, which focus on changing behaviour and cognitive patterns, the focus of dialectical behavioural therapy (DBT) is to provide people with the skills to develop an awareness and acceptance of thoughts and emotions, including painful or distressing internal experiences, without judgement or attempts to alter, suppress, avoid, or otherwise change these experiences (<a href="./references#CD013667-bbs2-0180" title="LynchTR , ChapmanAL , RosenthalMZ , KuoJR , LinehanMM . Mechanisms of change in dialectical behavior therapy: theoretical and empirical observations. Journal of Clinical Psychology2006;62:459-80.">Lynch 2006</a>). The primary treatment goals of DBT are three‐fold: to reduce SH, reduce behaviours that interfere with the success of treatment, such as treatment non‐adherence, and reduce any other factors that may adversely affect the person's quality of life (e.g. frequency or duration of psychiatric hospitalisations) (<a href="./references#CD013667-bbs2-0176" title="LinehanMM . Skills Training Manual for Treating Borderline Personality Disorder. New York, NY: Guildford Press, 1993.">Linehan 1993</a>). </p> <p><a href="./references#CD013667-bbs2-0195" title="MillerAL , RathusJH , LinehanMM . Dialectical Behavior Therapy with Suicidal Adolescents. New York, NY: Guilford Press, 2007.">Miller 2007</a> adapted dialectical behaviour therapy for adolescents (DBT‐A) from Linehan’s initial conceptualisation of DBT, which was developed for adults diagnosed with borderline personality disorder. DBT‐A typically includes a combination of weekly individual and family therapy sessions, and telephone support as needed. As the aim of DBT‐A is to help children and adolescents adjust to maladaptive personality characteristics, the treatment is intensive and relatively prolonged, although usually less so than in adults (<a href="./references#CD013667-bbs2-0160" title="JamesAC , TaylorA , WinmillL , AlfoadariK . A preliminary community study of dialectical behavior therapy (DBT) with adolescent females demonstrating persistent, deliberate self-harm (DSH). Child and Adolescent Mental Health2008;13:7.">James 2008</a>; <a href="./references#CD013667-bbs2-0195" title="MillerAL , RathusJH , LinehanMM . Dialectical Behavior Therapy with Suicidal Adolescents. New York, NY: Guilford Press, 2007.">Miller 2007</a>). </p> </section> <section id="CD013667-sec-0019"> <h5 class="title">Mentalisation‐based therapy</h5> <p>Mentalisation refers to the ability to understand the behaviour of both one's self and others in terms of motivational and emotional states (<a href="./references#CD013667-bbs2-0058" title="AllenJG , FonagyP , BatemanAW . Mentalizing in Clinical Practice. Washington DC, USA: American Psychiatric Publishing, 2008.">Allen 2008</a>). Maladaptive and impulsive coping behaviours, including SH, are presumed to arise from a disrupted ability to engage in these processes. In mentalisation‐based therapy (MBT), the goal is to help people understand their emotions and behaviours, and develop strategies to regulate them to minimise the risk that they will engage in SH during times of distress (<a href="./references#CD013667-bbs2-0223" title="RossouwT . Mentalization-based therapy for adolescents: managing storms in youth presenting with self-harm and suicidal states. In: SteeleH , SteeleM , editors(s). Handbook of Attachment-Based Interventions. New York, NY: Guilford Press, 2018.">Rossouw 2018</a>). </p> <p>Mentalisation‐based therapy for adolescents (MBT‐A) is a relatively prolonged (one year) treatment which typically includes weekly individual sessions, and monthly family sessions (<a href="./references#CD013667-bbs2-0115" title="FonagyP , CampbellC , RossouwT , BatemanA . Mentalization-based therapy for adolescents. In: Evidence-Based Treatment Approaches for Suicidal Adolescents: Translating Science into Practice. Washington, DC: American Psychiatric Publishing, 2019.">Fonagy 2019</a>). </p> </section> <section id="CD013667-sec-0020"> <h5 class="title">Group‐based psychotherapy</h5> <p>Group‐based psychotherapy treatment of children and adolescents who have self‐harmed integrates techniques from several therapies, including CBT, DBT‐A, MBT‐A, and specific group techniques. Group‐based psychotherapy may be more effective for children and adolescents than individual psychotherapy, as it provides them with a chance to work on skills related to developing interpersonal relationships and problem‐solving, which have been identified as important modifiable proximal risk factors for SH behaviours in this age group (<a href="./references#CD013667-bbs2-0165" title="KaessM , EppelmannL , BrunnerR , ParzerP , ReschF , CarliV , et al. Life events predicting the first onset of adolescent direct self-injurious behavior — a prospective multicentre study. Journal of Adolescent Health2020;66:195-201.">Kaess 2020b</a>). </p> </section> <section id="CD013667-sec-0021"> <h5 class="title">Enhanced assessment approaches</h5> <p>Enhanced therapeutic assessment approaches combine standard psychosocial history and risk assessment techniques with brief cognitive analytic therapy and PST. Children and adolescents learn to identify sources of psychological pain and their connection to problem behaviours, such as SH, and identify ways to break this cycle (<a href="./references#CD013667-bbs2-0209" title="OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self-harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20.">Ougrin 2012</a>). The aim is to enhance adherence with subsequent treatment, and the potential benefit from it. </p> </section> <section id="CD013667-sec-0022"> <h5 class="title">Compliance enhancement approaches</h5> <p>Of particular concern regarding after‐care of children and adolescents who present to hospital following an episode of SH, is the fact that adherence to recommended treatment tends to be relatively poor; between 25% and 50% of children and adolescents will not attend any follow‐up outpatient treatment sessions (<a href="./references#CD013667-bbs2-0130" title="GranboulanV , Roudot-ThoravalF , LemerleS , AlvinP . Predictive factors of post-discharge follow-up care among adolescent suicide attempters. Acta Psychiatrica Scandinavica2001;104:31-6.">Granboulan 2001</a>; <a href="./references#CD013667-bbs2-0241" title="TaylorEA , StansfeldSA . Children who poison themselves. II. Prediction of attendance for treatment. British Journal of Psychiatry1984;145:132-5.">Taylor 1984</a>). Efforts to maintain contact with children and adolescents, such as following up with them in the community, as well as efforts to address factors likely to impede attendance at treatment sessions, may be effective in improving treatment engagement and adherence in this population (<a href="./references#CD013667-bbs2-0264" title="YuanSNV , KwokKHR , OugrinD . Treatment engagement in specific psychological treatment vs. treatment as usual for adolescents with self-harm: systematic review and meta-analysis. Frontiers in Psychology2019;10:104.">Yuan 2019</a>). </p> </section> <section id="CD013667-sec-0023"> <h5 class="title">Family interventions</h5> <p>Family interventions typically involve conjoint therapy sessions with the child or adolescent and family members. It includes negotiation of goals, exploration of the episode of SH, communication between family members, problem‐solving, and discussion of developmental issues and their impact on the family. The basis of this therapy is that SH in children and adolescents may relate to family dysfunction, and therefore, efforts to improve family cohesion, attachment, adaptability, support, and parental warmth could help families function better and hence, reduce the risk of SH (<a href="./references#CD013667-bbs2-0116" title="FortuneS , CottrellD , FifeS . Family factors associated with adolescent self-harm: a review. Journal of Family Therapy2016;38:226-56.">Fortune 2016</a>). </p> </section> <section id="CD013667-sec-0024"> <h5 class="title">Remote contact interventions</h5> <p>Remote contact interventions, which may include letters, brief text messages delivered by telephone, telephone calls, and postcards, are low resource and non‐intrusive interventions that seek to maintain long‐term contact with children and adolescents. These interventions provide a sense of ongoing concern, and may mitigate the sense of social isolation reported by many children and adolescents who engage in SH. They may also help to improve their knowledge about triggers and warning signs for SH, provide them with information on alternative coping behaviours to SH, and where they can access help (<a href="./references#CD013667-bbs2-0197" title="MilnerA , SpittalMJ , KapurN , WittK , PirkisJ , CarterG . Mechanisms of brief contact interventions in clinical populations: a systematic review. BMC Psychiatry2016;16:194.">Milner 2016</a>). </p> <p>These interventions may also be combined with emergency card interventions, which encourage children and adolescents to seek help when they feel distressed, and offer on‐demand emergency contact with psychiatric services or inpatient care. The aim is to reduce the risk of SH by facilitating rapid access to care. </p> </section> </section> <section id="CD013667-sec-0025"> <h4 class="title">Pharmacological interventions</h4> <section id="CD013667-sec-0026"> <h5 class="title">Antidepressants</h5> <p>In relation to the prevention of SH and suicidal behaviour, the primary mechanism would be the effect of antidepressants on depression. However, there might also be other relevant specific effects, such as with drugs acting on the serotonin system, it having been suggested that serotonin levels are relevant to impulsivity, which is a feature sometimes associated with suicidal behaviour (<a href="./references#CD013667-bbs2-0245" title="Van HeeringenK , MannJJ . The neurobiology of suicide. Lancet Psychiatry2014;1:63-72.">Van Heeringen 2014</a>).  </p> <p>While different classifications of antidepressants have been suggested, a currently accepted classification is non‐selective monomamine inhibitors (e.g. amitriptyline, imipramine, dosulepin), selective serotonin reuptake inhibitors, subgrouped as non‐selective monomaine oxidase inhibitors (e.g., phenelzine) and monoamine oxidase A inhibitors (e.g., moclobemide), and other antidepressants (e.g., venlafaxine, mirtazapine, trazadone) (<a href="./references#CD013667-bbs2-0253" title="World Health Organization Collaborating Centre for Drug Statistics and Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: World Health Organization, 2014.">WHO 2014b</a>). </p> <p>An earlier approach was to group antidepressants as tricyclics, newer generation antidepressants (NGAs) (while recognising that many specific drugs in this category were introduced many years ago), and other antidepressants. This approach was used in the previous version of this review (<a href="./references#CD013667-bbs2-0269" title="HawtonK , WittKG , Taylor SalisburyTL , ArensmanE , GunnellD , TownsendE , et al. Interventions for self-harm in children and adolescents. Cochrane Database of Systematic Reviews2015, Issue 12. Art. No: CD012013. [DOI: 10.1002/14651858.CD012013]">Hawton 2015</a>). For pragmatic reasons, we have therefore continued to use this categorisation in this update. </p> <p>Antidepressants are often prescribed in the same dose range used to treat major depression. However, owing to the increased risk of overdose in this population, including the likelihood that children and adolescents who engage in self‐poisoning may use their own medication (<a href="./references#CD013667-bbs2-0123" title="GjelsvikB , HeyerdahlF , LunnD , HawtonK . Change in access to prescribed medication following an episode of deliberate self-poisoning: a multilevel approach. PLOS One2014;9:e98086.">Gjelsvik 2014</a>), antidepressants associated with lower case fatality indices (e.g. SSRIs) are generally preferred (<a href="./references#CD013667-bbs2-0141" title="HawtonK , BergenH , SimkinS , CooperK , WaterK , GunnellD , et al. Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. British Journal of Psychiatry2010;196:354-8.">Hawton 2010</a>), especially in people thought to be at risk of suicide. </p> <p>In children and adolescents, there have been significant concerns that certain classes of antidepressants, particularly SSRIs, may increase suicidal ideation (<a href="./references#CD013667-bbs2-0149" title="HealyD . Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychotherapy and Psychosomatics2003;72:71-9.">Healy 2003</a>). As a result, regulatory agencies in the UK (Medicines and Healthcare products Regulatory Agency; <a href="./references#CD013667-bbs2-0192" title="Medicines and Healthcare Products Regulatory Authority (MHRA). Selective Serotonin Reuptake Inhibitors (SSRIs): overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents including a summary of available safety and efficacy data. www.mhra.gov.uk/Safetyinformation/Safetywarningsalertandrecalls/Safetywarningsandmessagesformedicines/CON019494 (accessed 18 September 2014).">MHRA 2003</a>), the US (US Food and Drug Administration; <a href="./references#CD013667-bbs2-0110" title="US Food and Drug Administration. Relationship between psychotropic drugs and pediatric suicidality: review and evaluation of clinical data. www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf (accessed prior to 10 Feb 2021).">FDA 2004</a>), and Europe (the European Medicines Agency; <a href="./references#CD013667-bbs2-0104" title="European Medicines Agency. European Medicines Agency finalises review of antidepressants in children and adolescents. www.ema.europa.eu/en/news/european-medicines-agency-finalises-review-antidepressants-childrenand-adolescents (accessed 7 July 2020).">EMA 2005</a>) have cautioned practitioners on the use of SSRIs in children and adolescents. More recently, review evidence suggests that risks may be elevated regardless of antidepressant class (<a href="./references#CD013667-bbs2-0151" title="HetrickSE , McKenzieJE , CoxGR , SimmonsMB , MerrySN . Newer generation antidepressants for depressive disorder in children and adolescents. Cochrane Database of Systematic Reviews2012, Issue 11. Art. No: CD004851. [DOI: 10.1002/14651858.CD004851.pub3]">Hetrick 2012</a>). However, warnings from regulatory agencies may have had unintended consequences (<a href="./references#CD013667-bbs2-0121" title="GibbonsRD , BrownCH , HurK , MarcusSM , BhaumikDK , ErkensJA , et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry2007;164:1356-63.">Gibbons 2007</a>; <a href="./references#CD013667-bbs2-0179" title="LuC , ZhangF , LakomaMD , MaddenJM , RusinakD , PenfordRB , et al. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: a quasi-experimental study. BMJ2014;348:g3596.">Lu 2014</a>), although the evidence is mixed (<a href="./references#CD013667-bbs2-0214" title="PlöderlM , HengartnerMP . Antidepressant prescription rates and suicide attempt rates from 2004 to 2016 in a nationally representative sample of adolescents in the USA. Epidemiology and Psychiatric Sciences2019;28:589-91.">Plöderl 2019</a>; <a href="./references#CD013667-bbs2-0251" title="WhitelyM , RavenM , JureidiniJ . Antidepressant prescribing and suicide/self-harm by young Australians: regulatory warnings, contradictory advice, and long-term trends. Frontiers in Psychiatry2020;11:478.">Whitely 2020</a>).  </p> </section> <section id="CD013667-sec-0027"> <h5 class="title">Antipsychotics</h5> <p>In people with a history of repeat SH, treatment with antipsychotics may be used to reduce heightened levels of arousal often experienced by them, especially in relation to stressful life events. By reducing this arousal, the urge to engage in SH may be reduced. Low potency second generation antipsychotics may reduce SH in children and adolescents diagnosed with major depression (<a href="./references#CD013667-bbs2-0126" title="GoodCR . Adjunctive quetiapine targets self-harm behaviors in adolescent females with major depressive disorder. Journal of Child and Adolescent Psychopharmacology2006;16:235-6.">Good 2006</a>), and schizophrenia (<a href="./references#CD013667-bbs2-0181" title="Ma C-H, Chang S-S, Tsai H-J, Gau SS-F, Chen I-M, Lian S-C, et al. Comparative effect of antipsychotics on risk of self-harm among patients with schizophrenia. Acta Psychiatrica Scandinavica2018;137:296-305.">Ma 2018</a>). Lower doses may be prescribed to obtain this effect than is generally used in the treatment of psychotic disorders. </p> </section> <section id="CD013667-sec-0028"> <h5 class="title">Anxiolytics, including both benzodiazepines and non‐benzodiazepine anxiolytics</h5> <p>Given that this population experiences a high prevalence of anxiety disorders (<a href="./references#CD013667-bbs2-0145" title="HawtonK , SaundersKEA , TopiwalaA , HawC . Psychiatric disorders in patients presenting to hospital following self-harm: a systematic review. Journal of Affective Disorders2013;151:821-30.">Hawton 2013</a>), anxiolytics, including benzodiazepines and non‐benzodiazepine anxiolytics,  may be used to reduce suicidal behaviour through their specific effects on anxiety (<a href="./references#CD013667-bbs2-0244" title="TyrerP . Why benzodiazepines are not going away: commentary on benzodiazepines for anxiety disorders. Advances in Psychiatric Treatment2012;18:259-62.">Tyrer 2012</a>). However, because of their GABAminergic effects, benzodiazepines may increase aggression and disinhibition (<a href="./references#CD013667-bbs2-0057" title="AlbrechtB , StaigerPK , HallK , MillerP , BestD , LubmanDI . Benzodiazepine use and aggressive behaviour: a systematic review. Australian and New Zealand Journal of Psychiatry2014;48:1096-114.">Albrecht 2014</a>). In children and adolescents, current evidence from case series is that benzodiazepines are associated with an increased risk of suicidal ideation and SH (<a href="./references#CD013667-bbs2-0166" title="KandemirH , YumruM , KulM , KandemirSB . Behavioural disinhibition, suicidal ideation, and self-mutilation related to clonazepam. Journal of Child and Adolescent Psychopharmacology2008;18:409.">Kandemir 2008</a>). Therefore, it is usually recommended that benzodiazepines are used very cautiously, if at all, in children and adolescents at risk of SH. </p> </section> <section id="CD013667-sec-0029"> <h5 class="title">Mood stabilisers (including antiepileptics)</h5> <p>Mood stabilisers may have a role for children and adolescents diagnosed with bipolar disorder or unipolar depression, especially to prevent the recurrence of episodes of mood disorder (<a href="./references#CD013667-bbs2-0085" title="CiprianiA , ReidK , YoungAH , MacritchieK , GeddesJ . Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database of Systematic Reviews2013, Issue 10. Art. No: CD003196. [DOI: 10.1002/14651858.CD003196.pub2]">Cipriani 2013b</a>). Therefore, these drugs may reduce the risk of SH. However, to date, this effect has only been found for lithium in adults (<a href="./references#CD013667-bbs2-0084" title="CiprianiA , HawtonK , StocktonS , GeddesJR . Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ2013;346:f3646.">Cipriani 2013a</a>). Lithium may reduce the risk of SH via a serotonin‐mediated reduction in impulsivity and aggression. It is also possible that the long‐term clinical monitoring, which all persons prescribed lithium treatment must undergo, might contribute to a reduction in SH (<a href="./references#CD013667-bbs2-0084" title="CiprianiA , HawtonK , StocktonS , GeddesJR . Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ2013;346:f3646.">Cipriani 2013a</a>). </p> </section> <section id="CD013667-sec-0030"> <h5 class="title">Other pharmacological agents</h5> <p>Other pharmacological agents, particularly the N‐Methyl‐D‐aspartate receptor antagonist, ketamine, may also be trialed. Ketamine has been shown to have an antisuicidal effect, independent of its antidepressant effects (<a href="./references#CD013667-bbs2-0226" title="SanacoraG , FryeMA , McDonaldW , MathewSJ , TurnerMS , SchatzbergAF , et al, American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry2017;74:399-405.">Sanacora 2017</a>). As a result, the FDA has recently granted approval for the use of both ketamine and esketamine as adjunctive treatments to antidepressant therapy (<a href="./references#CD013667-bbs2-0111" title="US Food and Drug Administration. FDA approves new nasal spray medication for treatment-resistant depression. www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified (accessed 18 March 2020).">FDA 2019</a>). Ketamine has been associated with reduced suicidal ideation severity in the short term in adults with treatment‐resistant mood disorders (<a href="./references#CD013667-bbs2-0254" title="WilkinsonST , BallardED , BlochMH , MathewSJ , MurroughJW , FederA , et al. The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. American Journal of Psychiatry2018;175:150-8.">Wilkinson 2018</a>; <a href="./references#CD013667-bbs2-0258" title="WittK , PottsJ , HubersA , GrunebaumMF , MurroughJW , LooC , et al. Ketamine for suicidal ideation in adults with psychiatric disorders: a systematic review and meta-analysis of treatment trials. Australian and New Zealand Journal of Psychiatry2020;54:29-45.">Witt 2020a</a>). However, few trials have investigated the effect of ketamine over longer time periods. The effectiveness of ketamine on SH, and potential adverse effects of ketamine administration, such as dissociation, emergence psychosis, and rebound suicidal ideation, or behaviour, or both, remain under‐studied (<a href="./references#CD013667-bbs2-0258" title="WittK , PottsJ , HubersA , GrunebaumMF , MurroughJW , LooC , et al. Ketamine for suicidal ideation in adults with psychiatric disorders: a systematic review and meta-analysis of treatment trials. Australian and New Zealand Journal of Psychiatry2020;54:29-45.">Witt 2020a</a>). </p> </section> <section id="CD013667-sec-0031"> <h5 class="title">Natural products</h5> <p>In adults, there is some interest in the use of natural products, for example dietary supplementation of omega‐3 fatty acids (fish oils; <a href="./references#CD013667-bbs2-0240" title="TanskanenA , HibbelnJR , HintikkaJ , HaatainenK , HonkalampiK , ViinamakiH . Fish consumption, depression, and suicidality in a general population. Archives of General Psychiatry2001;58:512-3.">Tanskanen 2001</a>). Omega‐3 fatty acids have been implicated in the neural network, which is shown to correlate with the lethality of recent SH (<a href="./references#CD013667-bbs2-0184" title="MannJJ . The serotonergic system in mood disorders and suicidal behaviour. Philosophical Transactions of The Royal Society (B Biological Sciences)2013;368:20120537.">Mann 2013</a>). Blood plasma polyunsaturated fatty acid levels have also been implicated in the serotonin‐mediated link between low cholesterol and SH, suggesting that low omega‐3 fatty acid levels may have a negative impact on serotonin function (<a href="./references#CD013667-bbs2-0238" title="SubletteME , HibbelnJR , GalfalvyH , OquendoMA , MannJJ . Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. American Journal of Psychiatry2006;163:1100-02.">Sublette 2006</a>). For those in whom SH is impulsive, omega‐3 supplementation may stimulate serotonin activity, thereby reducing the likelihood of engaging in SH (<a href="./references#CD013667-bbs2-0076" title="BrunnerJ , ParhoferKG , SchwandtP , BronischT . Cholesterol, essential fatty acids, and suicide. Pharmacopsychiatry2002;35:1-5.">Brunner 2002</a>). </p> </section> </section> <section id="CD013667-sec-0032"> <h4 class="title">Combined psychosocial and pharmacological interventions</h4> <p>A growing number of trials have investigated the effectiveness of combined psychosocial and pharmacological interventions, particularly in children and adolescents diagnosed with major depression. Given that achieving treatment response for psychosocial therapy alone may take up to four weeks or longer, combined approaches may provide a faster treatment response, and may have a superior effect to psychosocial intervention alone (<a href="./references#CD013667-bbs2-0088" title="CoxGR , CallahanP , ChurchillR , HunotV , MerrySN , ParkerAG , et al. Psychological therapies versus antidepressant medication, alone and in combination, for depression in children and adolescents. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD008324. [DOI: 10.1002/14651858.CD008324.pub3]">Cox 2014</a>). However, the effect of combined approaches on SH remains unclear (<a href="./references#CD013667-bbs2-0088" title="CoxGR , CallahanP , ChurchillR , HunotV , MerrySN , ParkerAG , et al. Psychological therapies versus antidepressant medication, alone and in combination, for depression in children and adolescents. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD008324. [DOI: 10.1002/14651858.CD008324.pub3]">Cox 2014</a>). </p> </section> </section> <section id="CD013667-sec-0033"> <h3 class="title" id="CD013667-sec-0033">Why it is important to do this review</h3> <p>SH in children and adolescents is a major social and healthcare problem. It represents significant morbidity, is often repeated, and is linked with suicide. Many countries now have suicide prevention strategies, all of which include a focus on improved management of children and adolescents who engage in SH (<a href="./references#CD013667-bbs2-0252" title="World Health Organization. Preventing Suicide: A Global Imperative. Geneva, Switzerland: World Health Organization, 2014.">WHO 2014a</a>). SH is also associated with substantial healthcare costs (<a href="./references#CD013667-bbs2-0170" title="KinchinI , DoranCM , HallWD , MeurkC . Understanding the true economic impact of self-harming behaviour. Lancet Psychiatry2017;4:900-1.">Kinchin 2017</a>; <a href="./references#CD013667-bbs2-0232" title="SinclairJMA , GrayA , Rivero-AriasO , SaundersKEA , HawtonK . Healthcare and social services resource use and costs of self-harm patients. Social Psychiatry and Psychiatric Epidemiology2011;46:263-71.">Sinclair 2011</a>). </p> <p>In the UK, the National Collaborating Centre for Mental Health (NCCMH) produced the first guideline on the treatment of SH behaviours in 2004 (<a href="./references#CD013667-bbs2-0203" title="National Collaborating Centre for Mental Health. Clinical Guideline 16. Self-Harm: The Short-Term Physical and Psychological Management and Secondary Prevention of Self-Harm in Primary and Secondary Care. London, UK: National Institute for Clinical Excellence, 2004.">NCCMH 2004</a>). This guideline focused on the short‐term physical and psychological management of SH. They updated this guidance in 2011, using interim data from a previous version of this review as the evidence‐base, and focused on the longer‐term psychological management of SH (<a href="./references#CD013667-bbs2-0205" title="National Institute for Health and Clinical Excellence. Self-harm: Longer-Term Management [National Institute for Health and Care Excellence clinical guideline 133]. Accessed 26 June 2020 from: www.nice.org.uk/guidance/cg133/evidence/full-guideline-pdf-184901581. London, UK: National Institute for Health and Clinical Excellence, 2011.">NICE 2011</a>). Subsequently, similar guidelines have been published by the Royal College of Psychiatrists (<a href="./references#CD013667-bbs2-0224" title="Royal College of Psychiatrists. Managing Self-Harm in Young People (Guideline number CR192). London, UK: Royal College of Psychiatrists, 2014.">Royal College of Psychiatrists 2014</a>), the Royal Australian and New Zealand College of Psychiatrists (<a href="./references#CD013667-bbs2-0081" title="CarterG , PageA , LargeM , HetrickS , MilnerAJ , BenditN , et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guideline for the management of deliberate self-harm. Australian and New Zealand Journal of Psychiatry2016;50:939-1000.">Carter 2016</a>), and German Professional Associations and Societies (<a href="./references#CD013667-bbs2-0213" title="PlenerPL , BrunnerR , FegertJM , GroschwitzRC , In-AlbonT , KaessM , et al. Treating nonsuicidal self-injury (NSSI) in adolescents: consensus based German guidelines. Child and Adolescent Psychiatry and Mental Health2016;10:46.">Plener 2016</a>), amongst others (<a href="./references#CD013667-bbs2-0087" title="CourtneyDB , DudaS , SzatmariP , HendersonJ , BennettK . Systematic review and quality appraisal of practice guidelines for self-harm in children and adolescents. Suicide &amp; Life-threatening Behavior2019;49:707-23.">Courtney 2019</a>). </p> <p>In 2021, the guidance contained in the 2011 NICE guidelines for the longer‐term management of SH will be due for updating. Therefore, we are updating our review (<a href="./references#CD013667-bbs2-0269" title="HawtonK , WittKG , Taylor SalisburyTL , ArensmanE , GunnellD , TownsendE , et al. Interventions for self-harm in children and adolescents. Cochrane Database of Systematic Reviews2015, Issue 12. Art. No: CD012013. [DOI: 10.1002/14651858.CD012013]">Hawton 2015</a>), in order to provide contemporary evidence to guide clinical policy and practice. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013667-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013667-sec-0034"></div> <p>To assess the effects of psychosocial or pharmacological interventions for self‐harm (SH) compared to comparison types of care (e.g. treatment‐as‐usual, routine psychiatric care, enhanced usual care, active comparator, placebo, alternative pharmacological treatment, or a combination of these) for children and adolescents (up to 18 years of age) who engage in SH. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013667-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013667-sec-0035"></div> <section id="CD013667-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013667-sec-0037"> <h4 class="title">Types of studies</h4> <p>We considered all randomised controlled trials (RCTs) of specific psychosocial or pharmacological treatments versus treatment‐as‐usual, routine psychiatric care, enhanced usual care, active comparator, placebo, alternative pharmacological treatment, or a combination of these, in the treatment of children and adolescents with a recent (within six months of trial entry) presentation for SH. All RCTs (including cluster‐RCTs and cross‐over trials) were eligible for inclusion regardless of publication type or language; however, we excluded quasi‐randomised trials. </p> </section> <section id="CD013667-sec-0038"> <h4 class="title">Types of participants</h4> <p>While exact eligibility criteria often differ both within and between regions and countries (<a href="./references#CD013667-bbs2-0259" title="WittK , TownsendE , ArensmanE , GunnellD , HazellP , Taylor SalisburyT , et al. Psychosocial interventions for people who self-harm: methodological issues involved in trials to evaluate effectiveness. Archives of Suicide Research2020;24(sup2):S32-93. [DOI: 10.1080/13811118.2019.1592043]">Witt 2020b</a>), we included participants of both sexes and all ethnicities, who were up to 18 years of age, with a recent (i.e. within six months of trial entry) presentation to hospital or clinical services for SH. </p> <p>We defined SH as all intentional acts of self‐poisoning (such as intentional drug overdoses) or self‐injury (such as self‐cutting), regardless of degree of suicidal intent or other types of motivation (<a href="./references#CD013667-bbs2-0137" title="HawtonK , HarissL , HallS , SimkinS , BaleE , BondA . Deliberate self-harm in Oxford, 1990-2000: a time of change in patient characteristics. Psychological Medicine2003;33:987-96.">Hawton 2003</a>). This definition includes acts intended to result in death ('attempted suicide'), those without suicidal intent (e.g. to communicate distress, to temporarily reduce unpleasant feelings; sometimes termed 'non‐suicidal self‐injury'), and those with mixed motivation. We did not distinguish between attempted suicide and non‐suicidal self‐injury in this review, because there is a high level of co‐occurrence between them, particularly in children and adolescents (<a href="./references#CD013667-bbs2-0059" title="AndoverMS , MorrisBW , WrenA , BruzzeseME . The co-occurrence of non-suicidal self-injury and attempted suicide among adolescents: distinguishing risk and psychosocial correlates. Child and Adolescent Psychiatry and Mental Health2012;6:11.">Andover 2012</a>). Attempted suicide and non‐suicidal self‐injury cannot be distinguished in any reliable way, including on levels of suicidal intent (<a href="./references#CD013667-bbs2-0171" title="KlonskyED . Non-suicidal self-injury in United States adults: prevalence, socio-demographics, topography and functions. Psychological Medicine2011;41:1981-6.">Klonsky 2011</a>). Lastly, the motivations for SH are complex and can change, even within a single episode (<a href="./references#CD013667-bbs2-0095" title="De BeursD , VancayseeleN , Van BorkuloC , PortzkyG , Van HeeringenK . The association between motives, perceived problems and current thoughts of self-harm following an episode of self-harm: a network analysis. Journal of Affective Disorders2018;240:262-70.">De Beurs 2018</a>). </p> <p>We excluded trials in which participants were hospitalised for suicidal ideation only (i.e. without evidence of SH). </p> </section> <section id="CD013667-sec-0039"> <h4 class="title">Types of interventions</h4> <section id="CD013667-sec-0040"> <h5 class="title">Psychosocial interventions</h5> <p>These included:</p> <p> <ol id="CD013667-list-0001"> <li> <p>Individual CBT‐based psychotherapy;</p> </li> <li> <p>Dialectical behavioural therapy;</p> </li> <li> <p>Mentalisation therapy;</p> </li> <li> <p>Group‐based psychotherapy;</p> </li> <li> <p>Enhanced assessment approaches;</p> </li> <li> <p>Compliance enhancement approaches;</p> </li> <li> <p>Family interventions;</p> </li> <li> <p>Remote contact interventions.</p> </li> </ol> </p> </section> <section id="CD013667-sec-0041"> <h5 class="title">Comparators</h5> <p>Treatment‐as‐usual (TAU) is likely to vary widely both between settings and between trials conducted over different time periods (<a href="./references#CD013667-bbs2-0255" title="WittK , Pache de MoraesD , Taylor SalisburyT , ArensmanE , GunnellD , HazellP , et al. Treatment as usual (TAU) as a control condition in trials of cognitive behavioural-based psychotherapy for self-harm: impact of content and quality on outcomes in a systematic review. Journal of Affective Disorders2018;235:434-47.">Witt 2018</a>). Following previous work, we defined TAU as routine clinical service provision that children and adolescents would receive had they not been included in the trial (i.e. routine care or 'standard disposition'; <a href="./references#CD013667-bbs2-0157" title="HuntGE , SiegfriedN , MorleyK , SitharthanT , ClearyM . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2013, Issue 10. Art. No: CD001088. [DOI: 10.1002/14651858.CD001088.pub3]">Hunt 2013</a>). Other comparators could include no specific treatment or enhanced usual care, which refers to TAU that has in some way been supplemented, such as providing psychoeducation, assertive outreach, or more regular contact with case managers, and standard assessment approaches. </p> </section> <section id="CD013667-sec-0042"> <h5 class="title">Pharmacological interventions</h5> <p>These included:</p> <p> <ol id="CD013667-list-0002"> <li> <p>Tricyclic antidepressants (TADs, e.g. amitriptyline);</p> </li> <li> <p>Newer generation antidepressants (NGAs), such as selective serotonin reuptake inhibitor (SSRIs, e.g. fluoxetine), serotonin and noradrenaline reuptake inhibitors (SNRIs, e.g. venlafaxine), norepinephrine reuptake inhibitors (NRIs, e.g. reboxetine), norepinephrine‐dopamine reuptake inhibitors (NDRIs, e.g. bupropion),  tetracyclic antidepressants (e.g. maprotiline), noradrenergic specific serotonergic antidepressants (NaSSAs, e.g. mirtazapine), serotonin antagonist or reuptake inhibitors (SARIs, e.g. trazodone), or reversible inhibitors of monoamine oxidase type A (RIMAs, e.g. moclobemide); </p> </li> <li> <p>Other antidepressants, such as irreversible monoamine oxidase inhibitors (MAOIs, e.g. phenelzine); </p> </li> <li> <p>Antipsychotics (e.g. quetiapine);</p> </li> <li> <p>Anxiolytics, including both benzodiazepines (e.g. diazepam), and non‐benzodiazepine anxiolytics (e.g. buspirone); </p> </li> <li> <p>Mood stabilisers, including antiepileptics (e.g. sodium valporate) and lithium;</p> </li> <li> <p>Other pharmacological agents (e.g. ketamine);</p> </li> <li> <p>Natural products (e.g. omega‐3 essential fatty acid supplementation).</p> </li> </ol> </p> </section> <section id="CD013667-sec-0043"> <h5 class="title">Comparators</h5> <p>In pharmacological trials, where a comparison with the specific effects of a drug is being made, the comparator is typically placebo, which consists of any pharmacologically inactive treatment, such as sugar pills or injections with saline. We also included trials in which another pharmacological intervention (such as another standard pharmacological agent, reduced dose of the intervention agent, or active comparator) was used. </p> </section> </section> <section id="CD013667-sec-0044"> <h4 class="title">Types of outcome measures</h4> <p>For all outcomes, we were primarily interested in quantifying the effect of treatment assignment to the intervention at baseline, regardless of whether the intervention was received as intended (i.e. the intention‐to‐treat effect). </p> <section id="CD013667-sec-0045"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome measure in this review was the occurrence of repeated SH over a maximum follow‐up period of two years. Repetition of SH was identified through self‐report, collateral report, clinical records, or research monitoring systems. As we wished to incorporate the maximum data from each trial, we included both self‐reported and hospital records of SH, where available. Preference was given to clinical records over self‐report where a study reported both measures. We also reported proportions of participants repeating SH, frequency of repeat episodes, and time to SH repetition (where available). </p> </section> <section id="CD013667-sec-0046"> <h5 class="title">Secondary outcomes</h5> <p>Given increasing interest in the measurement of outcomes of importance to those who engage in SH (<a href="./references#CD013667-bbs2-0210" title="OwensC , FoxF , RedwoodS , DaviesR , FooteL , SalisburyN , et al. Measuring outcomes in trials of interventions for people who self-harm: qualitative study of service users' views. British Journal of Psychiatry Open2020;6:e22.">Owens 2020</a>), we analysed data for the following secondary outcomes (where available) over a maximum follow‐up period of two years. </p> <section id="CD013667-sec-0047"> <h6 class="title">Treatment adherence</h6> <p>This was assessed using a range of measures of adherence, including: pill counts, changes in blood measures, and the proportion of participants that both started and completed treatment. </p> </section> <section id="CD013667-sec-0048"> <h6 class="title">Depression</h6> <p>This was assessed as either continuous data, by scores on psychometric measures of depression symptoms, for example, total scores on the Beck Depression Inventory (BDI; <a href="./references#CD013667-bbs2-0063" title="BeckAT , WardCH , MendelsonM , MockJ , ErbaughJ . An inventory for measuring depression. Archives of General Psychiatry1961;4:561.">Beck 1961</a>), or scores on the depression subscale of the Hospital Anxiety and Depression Scale (HADS; <a href="./references#CD013667-bbs2-0268" title="ZigmondAS , SnaithRP . The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica1983;67:361-70.">Zigmond 1983</a>), or as dichotomous data as the proportion of children and adolescents who met defined diagnostic criteria for depression. </p> </section> <section id="CD013667-sec-0049"> <h6 class="title">Hopelessness</h6> <p>This was assessed as either continuous data, by scores on psychometric measures of hopelessness, for example, total scores on the Beck Hopelessness Scale (BHS; <a href="./references#CD013667-bbs2-0064" title="BeckAT , WeissmanA , LesterD , TrexlerL . The measurement of pessimism: the Hopelessness Scale. Journal of Consulting and Clinical Psychology1974;42:861-5.">Beck 1974</a>), or as dichotomous data as the proportion of children and adolescents reporting hopelessness. </p> </section> <section id="CD013667-sec-0050"> <h6 class="title">General functioning</h6> <p>This was assessed as either continuous data, by scores on psychometric measures of general functioning, for example, total scores on the Global Assessment of Functioning (GAF; <a href="./references#CD013667-bbs2-0061" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000.">APA 2000</a>), or as dichotomous data as the proportion of children and adolescents reporting improved general functioning. </p> </section> <section id="CD013667-sec-0051"> <h6 class="title">Social functioning</h6> <p>This was assessed as either continuous data, by scores on psychometric measures of social functioning, for example, total scores on the Social Adjustment Scale (SAS; <a href="./references#CD013667-bbs2-0249" title="WeissmanMM , StaffMHS . Social Adjustment Scale - Self-Report (SAS-SR) User's Manual. North Tonawanda, NY: Multi-Health Systems, 1999.">Weissman 1999</a>), or as dichotomous data as the proportion of children and adolescents reporting improved social functioning. </p> </section> <section id="CD013667-sec-0052"> <h6 class="title">Suicidal ideation</h6> <p>This was assessed as either continuous data, by scores on psychometric measures of suicidal ideation, for example, total scores on the Beck Scale for Suicidal Ideation (BSSI; <a href="./references#CD013667-bbs2-0065" title="BeckAT , SteetRA , RanieriWF . Scale for Suicide Ideation: psychometric properties of a self-report version. Journal of Clinical Psychology1988;44:499-505.">Beck 1988</a>), or as dichotomous data as the proportion of children and adolescents reaching a defined cut‐off for ideation. </p> </section> <section id="CD013667-sec-0053"> <h6 class="title">Suicide</h6> <p>This included register‐recorded deaths, or reports from collateral informants, such as family members or neighbours. </p> </section> <section id="CD013667-sec-0054"> <h6 class="title">Other</h6> <p>We remain open to including additional secondary outcomes, based on current outcome prioritisation work being undertaken by the author team. </p> </section> </section> </section> </section> <section id="CD013667-sec-0055"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013667-sec-0056"> <h4 class="title">Electronic searches</h4> <p>An information specialist searched the following databases (to 4 July 2020), using relevant subject headings (controlled vocabularies) and search syntax as appropriate for each resource: Cochrane Common Mental Disorders Specialised Register (<a href="./appendices#CD013667-sec-0250">Appendix 1</a>), Cochrane Library (Cochrane Central Register of Controlled Trials; CENTRAL), Cochrane Database of Systematic Reviews (CDSR), MEDLINE Ovid, Embase Ovid, and PsycINFO Ovid (<a href="./appendices#CD013667-sec-0251">Appendix 2</a>). </p> <p>A date restriction was applied as the search was to update an earlier version of this review (<a href="./references#CD013667-bbs2-0269" title="HawtonK , WittKG , Taylor SalisburyTL , ArensmanE , GunnellD , TownsendE , et al. Interventions for self-harm in children and adolescents. Cochrane Database of Systematic Reviews2015, Issue 12. Art. No: CD012013. [DOI: 10.1002/14651858.CD012013]">Hawton 2015</a>). However, we did not apply any further restrictions on language or publication status to the searches. </p> <p>We searched for retraction statements and errata once the included studies were selected.</p> <p>We also searched the World Health Organization International Clinical Trials Registry Platform, and the US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov to identify ongoing trials. </p> <p>The search was based on population only, participants who self‐harm (all ages). Records were screened to identify trials which were relevant to this review and two others (<a href="./references#CD013667-bbs2-0261" title="Witt  KG, Hetrick  SE, Rajaram  G, Hazell  P, Taylor Salisbury  TL, Townsend  E, et al. Pharmacological interventions for self‐harm in adults. Cochrane Database of Systematic Reviews2021, Issue 1. Art. No: CD013669. [DOI: 10.1002/14651858.CD013669.pub2]">Witt 2021</a>; <a href="./references#CD013667-bbs2-0260" title="Witt  KG, Hawton  K, Hetrick  SE, Taylor Salisbury  TL, Townsend  E, Hazell  P. Psychosocial interventions for self‐harm in adults. Cochrane Database of Systematic Reviews2020, Issue 7. Art. No: CD013668. [DOI: 10.1002/14651858.CD013668]">Witt 2020c</a>). </p> </section> <section id="CD013667-sec-0057"> <h4 class="title">Searching other resources</h4> <section id="CD013667-sec-0058"> <h5 class="title">Conference abstracts</h5> <p>In addition to conference abstracts retrieved via the main electronic search, we also screened the proceedings of recent (last five years) conferences organised by the largest scientific committees in the field: </p> <p> <ol id="CD013667-list-0003"> <li> <p>International Association for Suicide Prevention (both global congresses and regional conferences), and; </p> </li> <li> <p>Joint International Academy of Suicide Research and American Foundation for Suicide Prevention International Summits on Suicide Research. </p> </li> </ol> </p> </section> <section id="CD013667-sec-0059"> <h5 class="title">Reference lists</h5> <p>We also checked the reference lists of all relevant RCTs, and the reference lists of major reviews that included a focus on interventions for SH in children and adolescents (<a href="./references#CD013667-bbs2-0062" title="AsarnowJR , MehlumL . Practitioner review: treatment for suicidal and self-harming adolescents - advances in suicide prevention care. Journal of Child Psychology and Psychiatry2019;60:1046-54.">Asarnow 2019</a>; <a href="./references#CD013667-bbs2-0067" title="BerkMS , HughesJ . Cognitive behavioral approaches for treating suicidal behavior in adolescents. Current Psychiatry Reviews2016;12:4-13.">Berk 2016</a>; <a href="./references#CD013667-bbs2-0075" title="BrentDA . Master clinician review: saving Holden Caulfield: suicide prevention in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2019;58:25-35.">Brent 2019</a>; <a href="./references#CD013667-bbs2-0077" title="BusbyDR , HatkevichC , McGuireTC , KingCA . Evidence-based interventions for youth suicide risk. Current Psychiatry Reports2020;22:5.">Busby 2020</a>; <a href="./references#CD013667-bbs2-0080" title="CalearAL , ChristensenH , FreemanA , FentonK , Busby GrantJ , Van SpijkerB , et al. A systematic review of psychosocial suicide prevention interventions for youth. European Child and Adolescent Psychiatry2016;25:467-82.">Calear 2016</a>; <a href="./references#CD013667-bbs2-0089" title="CoxG , HetrickS . Psychosocial interventions for self-harm, suicidal ideation and suicide attempt in children and young people: What? How? Who? and Where?Evidence Based Mental Health2017;20:35-40.">Cox 2017</a>; <a href="./references#CD013667-bbs2-0094" title="DavasaambuuS , ItzhakyL , EllisSP , CisnerosS , ScolaroK , LemberanskyJ , et al. Systematic review and meta-analysis of randomized clinical trials of nonpharmacologic interventions to reduce suicide risk among adolescents. Neuropsychopharmacology2019;44:S103-4.">Davasaambuu 2019</a>; <a href="./references#CD013667-bbs2-0097" title="DevenishB , BerkL , LewisAJ . The treatment of suicidality in adolescents by psychosocial interventions for depression: a systematic literature review. Australian and New Zealand Journal of Psychiatry2016;50:726-40.">Devenish 2016</a>; <a href="./references#CD013667-bbs2-0113" title="FlahertyHB . Treating adolescent nonsuicidal self-injury: a review of psychosocial interventions to guide clinical practice. Child and Adolescent Social Work Journal2018;35:85-95.">Flaherty 2018</a>; <a href="./references#CD013667-bbs2-0124" title="GlennCR , EspositoEC , PorterAC , RobinsonDJ . Evidence base update of psychosocial treatments for self-injurious thoughts and behaviors in youth. Journal of Clinical Child and Adolescent Psychology2019;48:357-92.">Glenn 2019</a>; <a href="./references#CD013667-bbs2-0269" title="HawtonK , WittKG , Taylor SalisburyTL , ArensmanE , GunnellD , TownsendE , et al. Interventions for self-harm in children and adolescents. Cochrane Database of Systematic Reviews2015, Issue 12. Art. No: CD012013. [DOI: 10.1002/14651858.CD012013]">Hawton 2015</a>; <a href="./references#CD013667-bbs2-0159" title="IyengarU , SnowdenN , AsarnowJR , MoranP , TranahT , OugrinD . A further look at therapeutic interventions for suicide attempts and self-harm in adolescents: an updated systematic review of randomized controlled trials. Frontiers in Psychiatry2018;9:583.">Iyengar 2018</a>; <a href="./references#CD013667-bbs2-0161" title="JoeS , ScottML , BanksA . What works for adolescent black males at risk of suicide: a review. Research on Social Work Practice2018;28:340-5.">Joe 2018</a>; <a href="./references#CD013667-bbs2-0172" title="KothgassnerOD , RobinsonK , GoreisA , OugrinD , PlenerPL . Does treatment method matter? A meta-analysis of the past 20 years of research on therapeutic interventions for self-harm and suicidal ideation in adolescents. Borderline Personality Disorder and Emotion Dysregulation2020;7:9.">Kothgassner 2020</a>; <a href="./references#CD013667-bbs2-0173" title="LabelleR , PouliotL , JanelleA . A systematic review and meta-analysis of cognitive behavioural treatments for suicidal and self-harm behaviours in adolescents. Canadian Psychology2015;56:368-78.">Labelle 2015</a>; <a href="./references#CD013667-bbs2-0201" title="MorkenIS , DahlgrenA , LundeI , TovenS . The effects of interventions preventing self-harm and suicide in children and adolescents: an overview of systematic reviews. F1000Research2020;8:890.">Morken 2020</a>; <a href="./references#CD013667-bbs2-0221" title="RobinsonJ , BaileyE , WittK , StefanacN , MilnerA , CurrierD , et al. What works in youth suicide prevention? A systematic review and meta-analysis. eClinical Medicine2018;4:P52-91.">Robinson 2018</a>; <a href="./references#CD013667-bbs2-0264" title="YuanSNV , KwokKHR , OugrinD . Treatment engagement in specific psychological treatment vs. treatment as usual for adolescents with self-harm: systematic review and meta-analysis. Frontiers in Psychology2019;10:104.">Yuan 2019</a>). </p> </section> <section id="CD013667-sec-0060"> <h5 class="title">Correspondence</h5> <p>We consulted the corresponding authors of trials, and other experts in the field to find out if they were aware of any ongoing or unpublished RCTs on the treatment of children and adolescents who engage in SH that were not identified by the electronic searches. </p> </section> </section> </section> <section id="CD013667-sec-0061"> <h3 class="title" id="CD013667-sec-0061">Data collection and analysis</h3> <section id="CD013667-sec-0062"> <h4 class="title">Selection of studies</h4> <p>Review authors KW, KH, and one of either SH, GR, TTS, ET, or PH, independently assessed the titles of reports identified by the electronic search for eligibility. We distinguished between: </p> <p> <ol id="CD013667-list-0004"> <li> <p>eligible or potentially eligible trials for retrieval, in which any psychosocial or psychopharmacological treatment was compared with a comparator (e.g. treatment‐as‐usual, routine psychiatric care, enhanced usual care, active comparator, placebo, alternative pharmacological treatment, or a combination of these); </p> </li> <li> <p>ineligible general treatment trials, not for retrieval (i.e. where there was no control treatment). </p> </li> </ol> </p> <p>All trials identified as potentially eligible for inclusion then underwent a second screening. Pairs of review authors, working independently from one another, screened the full text of eligible or potentially eligible trials to identify whether the trial met our inclusion criteria. We resolved disagreements in consultation with the senior review author (KH). Where disagreements could not be resolved from the information reported in the trial, or where it was unclear whether the trial satisfied our inclusion criteria, we contacted corresponding trial authors for additional clarification. </p> <p>We identified and excluded duplicate records, and collated multiple reports of the same trial, so that each trial, rather than each report, represented the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram, and completed a '<a href="./references#CD013667-sec-0262" title="">Characteristics of excluded studies</a>' table (<a href="./references#CD013667-bbs2-0175" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GøtzschePC , IoannidisJP , et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Medicine2009;6:e1000100.">Liberati 2009</a>). </p> </section> <section id="CD013667-sec-0063"> <h4 class="title">Data extraction and management</h4> <p>Review author KW and one of either SH or GR independently extracted data from the included trials, using a standardised extraction form. Where there were any disagreements, they were resolved in consensus discussions with KH. </p> <p>Data extracted from each eligible trial included:</p> <p> <ol id="CD013667-list-0005"> <li> <p>Participant information: number randomised, number lost to follow‐up or withdrawn, number analysed, mean or median age, sex composition, diagnoses, diagnostic criteria, inclusion criteria, and exclusion criteria. </p> </li> <li> <p>Methods: trial design, total duration of the trial, details of any 'run in' period (if applicable), number of trial centres and their location, setting, and date. </p> </li> <li> <p>Intervention(s): details of the intervention, including dose, duration, route of administration, whether concomitant treatments were permitted and details of these treatments, and any excluded treatments. </p> </li> <li> <p>Comparators(s): details on the comparator, including dose, duration, route of administration, whether concomitant treatments were permitted and details of these treatments, and any excluded treatments. </p> </li> <li> <p>Outcomes: raw data for each eligible outcome (see <a href="#CD013667-sec-0044">Types of outcome measures</a>), details of other outcomes specified and reported, and time points at which outcomes were reported. </p> </li> <li> <p>Notes: source of trial funding, and any notable conflicts of interest of trial authors.</p> </li> </ol> </p> <p>We extracted both dichotomous and continuous outcomes data from eligible trials. As the use of non‐validated psychometric scales is associated with bias, we extracted continuous data only if the psychometric scale used to measure the outcome of interest had been previously published in a peer‐reviewed journal, and was not subjected to item, scoring, or other modification by the trial authors (<a href="./references#CD013667-bbs2-0186" title="MarshallM , LockwoodA , BradleyC , AdamsC , JoyC , FentonM . Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry2000;176:249-52.">Marshall 2000</a>). </p> <p>We planned the following main comparisons:</p> <p> <ol id="CD013667-list-0006"> <li> <p>Individual CBT‐based psychotherapy (e.g. CBT, PST) versus treatment as usual (TAU) or other comparator; </p> </li> <li> <p>Dialectical behaviour therapy (DBT) versus TAU or other comparator;</p> </li> <li> <p>Mentalisation‐based therapy versus TAU or other comparator;</p> </li> <li> <p>Group‐based psychotherapy versus TAU or other comparator;</p> </li> <li> <p>Enhanced assessment approaches versus TAU or other comparator;</p> </li> <li> <p>Compliance enhancement approaches versus TAU or other comparator;</p> </li> <li> <p>Family interventions versus TAU or other comparator;</p> </li> <li> <p>Remote contact interventions versus TAU or other comparator;</p> </li> <li> <p>Tricyclic antidepressants versus placebo or other comparator drug or dose;</p> </li> <li> <p>Newer generation antidepressants versus placebo or other comparator drug or dose;</p> </li> <li> <p>Any other antidepressants versus placebo or other comparator drug or dose;</p> </li> <li> <p>Antipsychotics versus placebo or other comparator drug or dose;</p> </li> <li> <p>Anxiolytics, including both benzodiazepines and non‐benzodiazepine anxiolytics, versus placebo or other comparator drug or dose; </p> </li> <li> <p>Mood stabilisers, including antiepileptics and lithium, versus placebo or other comparator drug or dose; </p> </li> <li> <p>Other pharmacological agents versus placebo or other comparator drug or dose;</p> </li> <li> <p>Natural products versus placebo or other comparator drug or dose.</p> </li> </ol> </p> </section> <section id="CD013667-sec-0064"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Highly biased studies are more likely to overestimate treatment effectiveness (<a href="./references#CD013667-bbs2-0198" title="MoherD , PhamB , JonesA , CookDJ , JadadAR , MoherM , et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?Lancet1998;352:609-13.">Moher 1998</a>). Review author KW and one of either SH or GR independently evaluated the risk of bias for the primary outcome (i.e., repetition of SH at post‐intervention) by using version 2 of the Cochrane Risk of Bias tool, RoB 2 (<a href="./references#CD013667-bbs2-0236" title="SterneJAC , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019;366:I4898.">Sterne 2019</a>). This tool encourages consideration of the following domains: </p> <p> <ol id="CD013667-list-0007"> <li> <p>Bias in the randomisation process.</p> </li> <li> <p>Deviations from the intended intervention (assignment to intervention).</p> </li> <li> <p>Missing outcome data.</p> </li> <li> <p>Bias in the measurement of the outcome.</p> </li> <li> <p>Bias in the selection of the reported result.</p> </li> </ol> </p> <p>For cluster‐RCTs, we also evaluated the following:</p> <p> <ol id="CD013667-list-0008"> <li> <p>Bias arising from the timing of identification and recruitment of participants.</p> </li> </ol> </p> <p>Signalling questions in the RoB 2 tool provided the basis for the tool’s domain‐level judgements about the risk of bias. Two review authors independently judged each source of potential bias as low risk, high risk, or some concerns. An overall 'Risk of bias' judgement was then made for each study by combining ratings across these domains. Specifically, if any of the above domains were rated at high risk, the overall 'Risk of bias' judgement was rated as high risk. We reported this overall judgement, which could be low risk, high risk, or some concerns, in the text of the review, and in the 'Risk of bias' tables. </p> <p>Where inadequate details were provided in the original report, we contacted corresponding trial authors to provide clarification. We resolved disagreements through discussions with KH. </p> <p>We entered and organised our RoB 2 assessments on an Excel spreadsheet (<a href="./references#CD013667-bbs2-0193" title="Version 6. Risk of Bias 2 Development Group, 22 August 2019. Available at: sites.google.com/site/riskofbiastool/welcome/rob-2-0-tool/current-version-of-rob-2.">Microsoft Excel RoB2 Macro</a>), and made them available as electronic supplements. </p> </section> <section id="CD013667-sec-0065"> <h4 class="title">Measures of treatment effect</h4> <section id="CD013667-sec-0066"> <h5 class="title">Dichotomous outcomes</h5> <p>We summarised dichotomous outcomes, such as the number of participants engaging in a repeat SH episode, or number of deaths by suicide, using the summary odds ratio (OR) and the accompanying 95% confidence interval (CI), as the OR is the most appropriate effect size statistic for summarising associations between two dichotomous groups (<a href="./references#CD013667-bbs2-0114" title="FleissJL . Measures of effect size for categorical data. In: CooperH , HedgesLV , editors(s). The Handbook of Research Synthesis. New York, NY: Russell Sage Foundation, 1994.">Fleiss 1994</a>). </p> </section> <section id="CD013667-sec-0067"> <h5 class="title">Continuous outcomes</h5> <p>For outcomes measured on a continuous scale, we used mean differences (MD) and accompanying 95% CI where the same outcome measure was used. Where different outcome measures were used, we used the standardised mean difference (SMD) and its accompanying 95% CI. </p> <p>We aggregated trials in a meta‐analysis only where treatments were sufficiently similar. For trials that could not be included in a meta‐analysis, we provided narrative descriptions of the results. </p> </section> <section id="CD013667-sec-0068"> <h5 class="title">Hierarchy of outcomes</h5> <p>Where a trial measured the same outcome (for example, depression) in two or more ways, we planned to use the most common measure across trials in any meta‐analysis. We also planned to report scores from other measures in a supplementary table. </p> </section> <section id="CD013667-sec-0069"> <h5 class="title">Timing of outcome assessment</h5> <p>The primary end point for this review was post‐intervention (i.e. at the conclusion of the treatment period). We also reported outcomes for the following secondary end points (where data were available): </p> <p> <ol id="CD013667-list-0009"> <li> <p>Between zero and six months after the conclusion of the treatment period.</p> </li> <li> <p>Between six and 12 months after the conclusion of the treatment period.</p> </li> <li> <p>Between 12 and 24 months after the conclusion of the treatment period.</p> </li> </ol> </p> <p>Where there was more than one outcome assessment within a time period, we used data from the last assessment in the time period, unless different outcomes were assessed at different points. For treatment adherence, we also planned to use within‐treatment period results. </p> </section> </section> <section id="CD013667-sec-0070"> <h4 class="title">Unit of analysis issues</h4> <section id="CD013667-sec-0071"> <h5 class="title">Zelen design trials</h5> <p>Trials in this area are increasingly using Zelen’s method, in which consent is obtained subsequent to randomisation and treatment allocation (<a href="./references#CD013667-bbs2-0259" title="WittK , TownsendE , ArensmanE , GunnellD , HazellP , Taylor SalisburyT , et al. Psychosocial interventions for people who self-harm: methodological issues involved in trials to evaluate effectiveness. Archives of Suicide Research2020;24(sup2):S32-93. [DOI: 10.1080/13811118.2019.1592043]">Witt 2020b</a>). This design may lead to bias if, for example, participants allocated to one particular arm of the trial disproportionally refuse to provide consent for participation or, alternatively, if participants only provide consent if they are allowed to cross over to the other treatment arm (<a href="./references#CD013667-bbs2-0243" title="TorgersonD . The use of Zelen's design in randomised trials. British Journal of Obstetrics and Gynaecology2004;111:2.">Torgerson 2004</a>). </p> <p>Although no trial included in this review used Zelen's design, should we identify a trial using Zelen's method in future updates of this review, we plan to extract data for all randomised participants as this is consistent with Zelen's original intention (<a href="./references#CD013667-bbs2-0267" title="ZelenM . A new design for randomized clinical trials. New England Journal of Medicine1979;300:1242-5.">Zelen 1979</a>), and preserves randomisation. This will typically be possible for our primary outcome, repetition of SH, as this will generally be ascertained from clinical, hospital, and/or medical records. However, for certain self‐reported outcome measures, data may only be reported on the basis of those who consented to participation. We therefore also plan to conduct sensitivity analyses to investigate what impact, if any, the inclusion of these trials may have on the pooled estimate of treatment effectiveness. </p> </section> <section id="CD013667-sec-0072"> <h5 class="title">Cluster‐randomised trials</h5> <p>Cluster randomisation, for example by clinician or general practice, can lead to overestimation of the significance of a treatment effect, resulting in an inflation of the nominal type I error rate, unless appropriate adjustment is made for the effects of clustering (<a href="./references#CD013667-bbs2-0100" title="DonnerA , KlarN . Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine2002;21:2971-80.">Donner 2002</a>; <a href="./references#CD013667-bbs2-0169" title="KerrySM , BlandJM . Analysis of a trial randomised in clusters. BMJ1998;316:54.">Kerry 1998</a>). </p> <p>One trial included in this review used cluster randomisation (<a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>). We had planned to follow the guidance outlined in <a href="./references#CD013667-bbs2-0154" title="HigginsJPT , EldridgeS , LiT , editor(s). Chapter 23: Including variants on randomized trials. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019a</a>. Specifically, where possible, we planned to analyse data using measures that statistically accounted for the cluster design. Where this is was not possible, we planned to analyse data using the effective sample size. However, the trial authors were unable to provide values for either the inter‐cluster correlation coefficient or the design effect, and further, there was no similar cluster RCT of this intervention approach from which these values could be approximated. We were therefore unable to statistically account for the effects of clustering for this trial. </p> <p>In future updates of this review, should we be able to obtain information on either the inter‐cluster correlation coefficient or the design effect, we will follow the guidance outlined in <a href="./references#CD013667-bbs2-0154" title="HigginsJPT , EldridgeS , LiT , editor(s). Chapter 23: Including variants on randomized trials. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019a</a>. </p> </section> <section id="CD013667-sec-0073"> <h5 class="title">Cross‐over trials</h5> <p>A primary concern with cross‐over trials is the carry‐over effect, in which the effect of the intervention treatment (e.g. pharmacological, physiological, or psychological) influences the participant’s response to the subsequent control condition (<a href="./references#CD013667-bbs2-0103" title="ElbourneDR , AltmanDG , HigginsJPT , CurtinF , WorthingtonHV , VailA . Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology2002;31:140-9.">Elbourne 2002</a>). As a consequence, on entry to the second phase of the trial, participants may differ systematically from their initial state, despite a wash‐out phase. In turn, this may result in a concomitant underestimation of the effectiveness of the treatment intervention (<a href="./references#CD013667-bbs2-0091" title="CurtinF , ElbourneD , AltmanDG . Meta-analysis combining parallel and cross-over clinical trials. III. The issue of carry-over. Statistics in Medicine2002;21:2161-73.">Curtin 2002a</a>; <a href="./references#CD013667-bbs2-0092" title="CurtinF , AltmanDG , ElbourneD . Meta-analysis combining parallel and cross-over clinical. I. Continuous outcomes. Statistics in Medicine2002;21:2131-44.">Curtin 2002b</a>). No trial included in this review used cross‐over methodology. However, should we identify any cross‐over trials in future updates of this review, we will only extract data from the first phase of the trial, prior to cross‐over, to protect against the carry‐over effect. </p> </section> <section id="CD013667-sec-0074"> <h5 class="title">Studies with multiple treatment arms</h5> <p>No trial included multiple treatment arms. Should any trial include multiple treatment groups where the intervention arms are sufficiently similar, for example, where comparison is made between two interventions of the same type, we will combine dichotomous data. For outcomes reported on a continuous scale, we will combine data using the formula in <a href="./references#CD013667-bbs2-0153" title="HigginsJPT , DeeksJJ . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011</a>. </p> <p>Where the interventions are not sufficiently similar, we will split the comparator arm data following the advice in <a href="./references#CD013667-bbs2-0153" title="HigginsJPT , DeeksJJ . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011</a>. </p> </section> <section id="CD013667-sec-0075"> <h5 class="title">Studies with adjusted effect sizes</h5> <p>Where trials reported both unadjusted and adjusted effect sizes, we included only observed, unadjusted effect sizes. </p> </section> </section> <section id="CD013667-sec-0076"> <h4 class="title">Dealing with missing data</h4> <p>We did not impute missing data, as we considered that the bias that would be introduced by doing this would outweigh any benefit of increased statistical power that may have been gained by including imputed data. However, where authors omitted standard deviations (SD) for continuous measures, we contacted corresponding authors to request missing data. Where missing data could not be provided, we calculated missing SDs using other data from the trial, such as CIs, based on methods outlined in <a href="./references#CD013667-bbs2-0155" title="HigginsJPT , LiT , DeeksJJ , editor(s). Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019b</a>. </p> </section> <section id="CD013667-sec-0077"> <h4 class="title">Assessment of heterogeneity</h4> <p>Between‐study heterogeneity can be assessed using either the Chi² or I² statistics. However, in this review, we used only the I² statistic to quantify inconsistency, as this is considered to be more reliable (<a href="./references#CD013667-bbs2-0096" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Deeks 2019</a>). The I² statistic indicates the percentage of between‐study variation due to chance, and can take any value from 0% to 100% (<a href="./references#CD013667-bbs2-0096" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Deeks 2019</a>). </p> <p>We used the following values to denote relative importance of heterogeneity, as per <a href="./references#CD013667-bbs2-0096" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Deeks 2019</a>: </p> <p> <ol id="CD013667-list-0010"> <li> <p>unimportant: 0% to 40%;</p> </li> <li> <p>moderate: 30% to 60%;</p> </li> <li> <p>substantial: 50% to 90%;</p> </li> <li> <p>considerable: 75% to 100%.</p> </li> </ol> </p> <p>We also took the magnitude and direction of effects and strength of evidence for heterogeneity into account (e.g. the CI for I²). </p> <p>Where substantial levels of heterogeneity were found, we explored reasons for this heterogeneity (see <a href="#CD013667-sec-0080">Subgroup analysis and investigation of heterogeneity</a> for details). </p> </section> <section id="CD013667-sec-0078"> <h4 class="title">Assessment of reporting biases</h4> <p>Reporting bias occurs when the decision to publish a particular trial is influenced by the direction and significance of the results (<a href="./references#CD013667-bbs2-0102" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315:629-34.">Egger 1997</a>). Research suggests, for example, that trials with statistically significant findings are more likely to be submitted for publication, and subsequently, be accepted for publication, leading to possible overestimation of the true treatment effect (<a href="./references#CD013667-bbs2-0156" title="HopewellS , LoudonK , ClarkeMJ , OxmanAD , DickersinK . Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database of Systematic Reviews2009, Issue 1. Art. No: MR000006. [DOI: 10.1002/14651858.MR000006.pub3]">Hopewell 2009</a>). </p> <p>To assess whether trials included in any meta‐analysis were affected by reporting bias, we planned to enter data into a funnel plot when a meta‐analysis included results of at least 10 trials. Should evidence of any small study effects be identified, we planned to explore reasons for funnel plot asymmetry, including the presence of possible publication bias (<a href="./references#CD013667-bbs2-0102" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315:629-34.">Egger 1997</a>). </p> </section> <section id="CD013667-sec-0079"> <h4 class="title">Data synthesis</h4> <p>For the purposes of this review, we calculated the pooled OR and accompanying 95% CI using the random‐effects model, as this is the most appropriate model for incorporating heterogeneity between studies (<a href="./references#CD013667-bbs2-0096" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Deeks 2019</a>). We used the Mantel‐Haenszel method for dichotomous data, and the inverse variance method for continuous data. We conducted all analyses in Review Manager 5.4 (<a href="./references#CD013667-bbs2-0217" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">Review Manager 2020</a>). </p> </section> <section id="CD013667-sec-0080"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD013667-sec-0081"> <h5 class="title">Subgroup analyses</h5> <p>We planned to undertake the following subgroup analyses where there were sufficient data to do so: </p> <p> <ol id="CD013667-list-0011"> <li> <p>sex (males versus females);</p> </li> <li> <p>repeater status (first SH episode versus repeat SH episode).</p> </li> </ol> </p> <p>Given the increasing use of enhanced usual care rather than TAU in trials in the field (<a href="./references#CD013667-bbs2-0259" title="WittK , TownsendE , ArensmanE , GunnellD , HazellP , Taylor SalisburyT , et al. Psychosocial interventions for people who self-harm: methodological issues involved in trials to evaluate effectiveness. Archives of Suicide Research2020;24(sup2):S32-93. [DOI: 10.1080/13811118.2019.1592043]">Witt 2020b</a>), we also planned to undertake subgroup analyses to determine whether comparator choice influenced the pattern of results observed. </p> <p>Formal tests for subgroup differences were undertaken in Review Manager 5.4 (<a href="./references#CD013667-bbs2-0217" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">Review Manager 2020</a>). However, it is only possible to undertake these subgroup analyses if randomisation was stratified by these factors, otherwise, there is the risk that doing so could lead to confounding. Randomisation was stratified by sex in one trial (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>). We therefore requested data for the primary outcome of interest, repetition of SH, disaggregated by sex from the authors for this trial. No included trial stratified randomisation by repeater status or comparator choice. </p> </section> <section id="CD013667-sec-0082"> <h5 class="title">Investigation of heterogeneity</h5> <p>Several meta‐analyses were associated with substantial levels of heterogeneity (i.e. I² ≥ 75%). For these analyses, KW and KH firstly independently triple‐checked data to ensure these were correctly entered. Next, we investigated the source of this heterogeneity using a formal statistical approach as outlined in <a href="./references#CD013667-bbs2-0246" title="ViechtbauerW , Cheung MW-L. Outlier and influence diagnostics for meta-analysis. Research Synthesis Methods2020;1:112-25.">Viechtbauer 2020</a>. </p> </section> </section> <section id="CD013667-sec-0083"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to undertake the following sensitivity analyses, where appropriate, to test whether key methodological factors or decisions may have influenced the main result: </p> <p> <ol id="CD013667-list-0012"> <li> <p>Where a trial made use of Zelen's method of randomisation (see <a href="#CD013667-sec-0070">Unit of analysis issues</a>); </p> </li> <li> <p>Where a trial contributed to substantial between‐study heterogeneity (see <a href="#CD013667-sec-0080">Subgroup analysis and investigation of heterogeneity</a>). </p> </li> </ol> </p> <p>No included trial made use of Zelen's method of randomisation. We were therefore unable to undertake sensitivity analyses to investigate what impact, if any, Zelen's design had on the pooled estimate of treatment effectiveness. </p> <p>However, several meta‐analyses were associated with substantial levels of between‐study heterogeneity. We therefore reported results of these sensitivity analyses in the text, alongside discussion of the likely causes of these differences. </p> </section> <section id="CD013667-sec-0084"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>For each comparison, we constructed a 'Summary of findings' table for our primary outcome measure, repetition of SH at post‐intervention, following the recommendations outlined in <a href="./references#CD013667-bbs2-0227" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Schünemann 2019</a>. These tables provide information concerning the overall quality of the evidence from all included trials that measured the outcome. We assessed the quality of evidence across the following domains: </p> <p> <ol id="CD013667-list-0013"> <li> <p>'Risk of bias' assessment.</p> </li> <li> <p>Indirectness of evidence.</p> </li> <li> <p>Unexplained heterogeneity or inconsistency of results.</p> </li> <li> <p>Imprecision of effect estimates.</p> </li> <li> <p>Potential publication bias.</p> </li> </ol> </p> <p>For each of these domains, we downgraded the evidence from high certainty by one level (for serious) or by two levels (for very serious). For risk of bias, we downgraded this domain by one level when we rated any of the sources of risk of bias (as described in <a href="#CD013667-sec-0064">Assessment of risk of bias in included studies</a>) at high risk for any of the studies included in the pooled estimate, or by two levels when we rated multiple studies at high risk for any of these sources. For indirectness of evidence, we considered the extent to which trials included in any meta‐analysis used proxy measures to ascertain repetition of SH; we downgraded this domain by one level if one study used proxy measures, and by two levels if multiple studies used proxy measures. For unexplained heterogeneity or inconsistency of results, we downgraded this domain by one level where the I² value indicated substantial levels of heterogeneity, or by two levels where the I² value indicated considerable levels of heterogeneity. For imprecision, we downgraded this domain by one level where the 95% CI for the pooled effect included the null value. Finally, for the potential publication bias domain, we considered any evidence of funnel plot asymmetry (if available), as well as other evidence such as suspected selective availability of data, and downgraded by one or more levels where publication bias was suspected. </p> <p>We then used these domains to rate the overall certainty of evidence for the primary outcome according to the following: </p> <p> <ol id="CD013667-list-0014"> <li> <p>High certainty: further research is very unlikely to change our confidence in the estimate of effect; </p> </li> <li> <p>Moderate certainty: further research is likely to have an important impact on our confidence in the estimate of effect, and may change the estimate; </p> </li> <li> <p>Low certainty: further research is very likely to have an important impact on our confidence in the estimate of effect, and may change the estimate; </p> </li> <li> <p>Very low certainty: we are very uncertain about the estimate.</p> </li> </ol> </p> <p>We constructed 'Summary of findings' tables using GRADEpro GDT software (<a href="./references#CD013667-bbs2-0129" title="GRADEpro GDT. Version accessed 26 June 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at www.gradepro.org.">GRADEpro GDT 2015</a>). </p> <section id="CD013667-sec-0085"> <h5 class="title">Reaching conclusions</h5> <p>We based our conclusions only on findings from the quantitative or narrative synthesis of the studies included in this review. Our recommendations for practice and research suggest priorities for future research, and outline the remaining uncertainties in the area. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013667-sec-0086" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013667-sec-0086"></div> <section id="CD013667-sec-0087"> <h3 class="title">Description of studies</h3> <section id="CD013667-sec-0088"> <h4 class="title">Results of the search</h4> <p>For this update, a total of 7186 records were found using the search strategy as outlined in <a href="./appendices#CD013667-sec-0250">Appendix 1</a> and <a href="./appendices#CD013667-sec-0251">Appendix 2</a>. Five further records were identified following correspondence and discussion with researchers in the field. After deduplication, the initial number was reduced to 4678. Of these, 4454 were excluded following title/abstract screening, whilst a further 157 were excluded after reviewing the full texts (<a href="#CD013667-fig-0001">Figure 1</a>). There were 23 new studies (representing nine independent trials) of interventions for SH in children and adolescents identified by this update. </p> <div class="figure" id="CD013667-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study Flow Diagram" data-id="CD013667-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study Flow Diagram</p> </div> </div> </div> </section> <section id="CD013667-sec-0089"> <h4 class="title">Included studies</h4> <p>In the previous version of this review (<a href="./references#CD013667-bbs2-0269" title="HawtonK , WittKG , Taylor SalisburyTL , ArensmanE , GunnellD , TownsendE , et al. Interventions for self-harm in children and adolescents. Cochrane Database of Systematic Reviews2015, Issue 12. Art. No: CD012013. [DOI: 10.1002/14651858.CD012013]">Hawton 2015</a>), 11 trials of interventions for SH in children and adolescents were included. The present update located six new trials of interventions for SH in children and adolescents. The present review therefore includes 17 non‐overlapping trials (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>). </p> <p>All trials have been published. Unpublished data were obtained from the study authors for 13 of these trials (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>). </p> <section id="CD013667-sec-0090"> <h5 class="title">Design</h5> <p>Most trials (94.1%) were randomised at the individual level employing either simple randomisation (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>), or a restricted randomisation scheme, such as a blocking (<a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>) or minimisation (<a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>) procedure. Two trials used stratification (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>). In one trial, cluster randomisation was used (<a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>). </p> </section> <section id="CD013667-sec-0091"> <h5 class="title">Setting</h5> <p>Of the 17 independent RCTs included in this review, eight were from the UK (<a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>; <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>), four were from the USA (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>), and one was from each of Australia (<a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>), Canada (<a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>), New Zealand (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>), Norway (<a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>), and Spain (<a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>). </p> <p>In the majority of trials, participants were recruited following a clinical presentation for SH. In one trial (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>), a minority (&lt; 5%) of participants were recruited from schools; however, all participants in this trial had a history of multiple episodes of SH resulting in presentation to clinical services within three months preceding trial entry. </p> <p>For most trials, treatment was delivered in an outpatient setting or the participants' home environment. In the remaining two trials, one of compliance enhancement (<a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>) and one of enhanced therapeutic assessment (<a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>), the intervention was delivered whilst the adolescent was receiving treatment in hospital and/or the emergency department. </p> </section> <section id="CD013667-sec-0092"> <h5 class="title">Participants and participant characteristics</h5> <p>The included trials comprised a total of 2280 participants. All had engaged in at least one episode of SH prior to trial entry. A history of SH prior to the index episode (i.e. a history of multiple episodes of SH) was a requirement for participation in nine trials (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>; <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>). In two further trials, around half the sample had a history of multiple episodes of SH (<a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>). For the remaining six trials, information on the proportion of participants with a history of multiple episodes of SH prior to the index episode was not reported (<a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>; <a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>). </p> <p>Information on the methods of SH for the index episode was not reported in the majority of trials. In one trial, only those who had engaged in self‐poisoning were eligible to participate (<a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>), whilst in three further trials, the majority of participants had engaged in self‐poisoning (<a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>). Full details on the methods used at the index episode is provided in <a href="#CD013667-tbl-0005">Table 1</a>. Whilst the predominance of participants engaging in self‐poisoning in the majority of these trials reflects the typical pattern observed in those who present to hospital, SH in the community more often involves self‐cutting and other forms of self‐injury (<a href="./references#CD013667-bbs2-0120" title="GeulayovG , CaseyD , McDonaldKC , FosterP , PritchardK , WellsC , et al. Incidence of suicide, hospital-presenting non-fatal self-harm, and community-occurring non-fatal self-harm in adolescents in England (the Iceberg Model of Self-Harm): a retrospective study. Lancet Psychiatry2018;5:167-74.">Geulayov 2018</a>; <a href="./references#CD013667-bbs2-0202" title="MüllerA , ClaesL , BrählerE , De ZwaanM . Prevalence and correlates of self-harm in the German general population. PLOS One2016;11:e0157928.">Müller 2016</a>). </p> <div class="table" id="CD013667-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Methods used at the index episode of self‐harm</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Reference</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>Method</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Self‐poisoning</b> </p> <p><b>n (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Self‐injury</b> </p> <p><b>n (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Combined self‐poisoning<br/>and self‐injury</b> </p> <p><b>n (%)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101 (96.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>184 (22.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>594 (71.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54 (6.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 (84.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 (2.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67 (36.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111 (60.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>162 (100.0)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28 (40.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37 (52.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 (7.2)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a><sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54 (85.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a><sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>n:</b> number; <b>%:</b> percentage. </p> <p><sup>1</sup>The method used by the remaining two (1.9%) participants was not reported. </p> <p><sub> 2</sub> The method used by the remaining six (15.4%) participants was not reported. </p> <p><sup>3</sup>Over half (n = 92; 56.8%) used paracetamol/acetaminophen. </p> <p><sup>4</sup>Participants engaged in multiple forms of SH: cutting (97%); head banging (71%); intentional drug overdose (57%); smothering (36%); strangling (25%); other self‐poisoning (19%); attempted drowning (19%); jumping from a height (17%); and other self‐harm (35%). </p> <p><sup>5</sup>The method used by the remaining nine (14.3%) participants was not reported. </p> <p><sup>6</sup>Data on the proportion with a lifetime history of self‐poisoning or self‐injury were reported; however, data on the proportion using these methods at the index episode were not clearly reported. </p> </div> </div> <p>Whilst all trials included both male and female participants, the majority of participants was female (87.6%), reflecting the typical pattern for SH (<a href="./references#CD013667-bbs2-0140" title="HawtonK , HarrissL . The changing gender ratio in occurrence of deliberate self-harm across the lifecycle. Crisis2008;29:4-10.">Hawton 2008</a>). Of the 15 trials that reported information on age, the weighted mean age of participants at trial entry was 14.7 years (SD 1.5 years). In the 15 trials that reported information on psychiatric diagnoses (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>), participants were most commonly diagnosed with major depression (64.3%), followed by any anxiety disorder (54.4%), any mood disorder (49.2%), substance use disorder (33.9%), and bipolar disorder (25.4%). Around half (49.1%) were diagnosed with borderline personality disorder. Only two studies reported information on the proportion of participants without psychiatric diagnoses at trial entry (<a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>); in these two trials, just over one‐third (34.5%) were not diagnosed with a major psychiatric disorder. </p> <p>Information on comorbid diagnoses was reported in two trials (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>). Around two‐thirds (67.6%) were diagnosed with comorbid psychiatric diagnoses; however, the nature of these co‐morbidities was not clearly reported in either trial. </p> </section> <section id="CD013667-sec-0093"> <h5 class="title">Interventions</h5> <p>The trials included in this review investigated the effectiveness of various forms of psychosocial interventions: </p> <p> <ol id="CD013667-list-0015"> <li> <p>Individual CBT‐based psychotherapy (e.g. CBT, PST) versus treatment‐as‐usual (TAU) or other comparator (<a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>). </p> </li> <li> <p>Dialectical behaviour therapy (DBT) versus TAU or other comparator (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>). </p> </li> <li> <p>Mentalisation‐based therapy versus TAU or other comparator (<a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>). </p> </li> <li> <p>Group‐based psychotherapy versus TAU or other comparator (<a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>). </p> </li> <li> <p>Enhanced assessment approaches versus TAU or other comparator (<a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>). </p> </li> <li> <p>Compliance enhancement approaches versus TAU or other comparator (<a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>). </p> </li> <li> <p>Family interventions versus TAU or other comparator (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>). </p> </li> <li> <p>Remote contact interventions versus TAU or other comparator (<a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>). </p> </li> </ol> </p> <p>There were no eligible trials of pharmacological interventions for SH in children and adolescents. </p> </section> <section id="CD013667-sec-0094"> <h5 class="title">Comparators</h5> <p>Of the 17 RCTs included in this review, the majority (64.7%) compared the intervention to TAU (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>; <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>). The remaining trials compared the effectiveness of the intervention to enhanced usual care (EUC; <a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>), or to alternative forms of psychotherapy (<a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>). </p> </section> <section id="CD013667-sec-0095"> <h5 class="title">Outcomes</h5> <section id="CD013667-sec-0096"> <h6 class="title">Primary outcome</h6> <p>All trials reported data on the primary outcome of this review, repetition of SH. In the majority of these trials this was based on self‐reported information (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>), self‐reported information supplemented with information from a collateral informant such as a parent (<a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>), or self‐reported information supplemented by clinical records (<a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>). For the remaining three trials, information on repetition of SH was obtained from clinical or hospital records supplemented with information from general practitioners, social workers, and psychologists, where relevant (<a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>), or on re‐presentation to hospital (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>) or emergency departments (<a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>). </p> </section> <section id="CD013667-sec-0097"> <h6 class="title">Secondary outcomes</h6> <section id="CD013667-sec-0098"> <p><b>Treatment adherence</b></p> <p>Treatment adherence was assessed as the proportion of participants that completed the full course of treatment (<a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>), or the total number of treatment sessions attended (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>). </p> </section> <section id="CD013667-sec-0099"> <p><b>Depression</b></p> <p>Depression was assessed using the Mood and Feelings Questionnaire (MFQ; <a href="./references#CD013667-bbs2-0060" title="AngoldA , CostelloEJ , MesserSC , PicklesA . The development of a short questionnaire for use in epidemiological studies in depression in children and adolescents. International Journal of Methods in Psychiatric Research1995;5:237-49.">Angold 1995</a>) in the majority of trials (<a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>), followed by the Montgomery‐Åsberg Depression Rating Scale (MADRS; <a href="./references#CD013667-bbs2-0199" title="MontgomerySA , ÅsbergM . A new depression scale designed to be sensitive to change. British Journal of Psychiatry1979;134:382-9.">Montgomery 1979</a>) (<a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>), the BDI (<a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>), the Children's Depression Rating Scale‐Revised (CDRS‐R; <a href="./references#CD013667-bbs2-0215" title="PoznanskiEO , FreemanLN , MokrosHB . Children's Depression Rating Scale - Revised. Psychopharmacology Bulletin1985;21:979-89.">Poznanski 1985</a>) (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>), the Center for Epidemiologic Studies Depression Scale (CES‐D; <a href="./references#CD013667-bbs2-0216" title="RadloffLS . The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults. Journal of Youth and Adolescence1991;20:149-66.">Radloff 1991</a>) (<a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>), and the depression subscale of the Revised Child Anxiety and Depression Scale (RCADS; <a href="./references#CD013667-bbs2-0083" title="ChorpitaBF , YimL , MoffittC , UmemotoLA , FrancisSE . Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale. Behaviour Research and Therapy2000;38:835-55.">Chorpita 2000</a>) (<a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>). </p> </section> <section id="CD013667-sec-0100"> <p><b>Hopelessness</b></p> <p>Hopelessness was assessed using the Beck Hopelessness Scale (BHS) in two trials (<a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>), followed by the Hopelessness Scale for Children (HSC; <a href="./references#CD013667-bbs2-0168" title="KazdinAE , FrenchNH , UnisAS , Esveldt-DawsonK , SherickRB . The Hopelessness Scale for Children: psychometric characteristics and concurrent validity. Journal of Consulting and Clinical Psychology1983;51:504-10.">Kazdin 1983</a>) (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>), and by the future optimism subscale score on the Reasons for Living Inventory‐Adolescent (RFL‐A; <a href="./references#CD013667-bbs2-0208" title="OsmanA , DownsWR , KopperBA , BarriosFX , BesettFX , LinehanMM , et al. The Reasons for Living Inventory for Adolescents (RFL-A): development and psychometric properties. Journal of Clinical Psychology1998;54:1063-78.">Osman 1998</a>), which was reverse coded in the present review to indicate a perceived lack of optimism about the future (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>). </p> </section> <section id="CD013667-sec-0101"> <p><b>General functioning</b></p> <p>General functioning was assessed using the Children's Global Assessment Scale (C‐GAS; <a href="./references#CD013667-bbs2-0229" title="ShafferD , GouldMS , BrasicP , AmbrosiniP , FisherP , BirdH , et al. A Children's Global Assessment Scale (CGAS). Psychopharmacology Bulletin1985;21:747-8.">Shaffer 1985</a>) in three trials (<a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>), and by the Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA; <a href="./references#CD013667-bbs2-0128" title="GowersSG , HarringtonRC , WhittonA , LelliottP , BeevorA , WingJ , et al. Brief scale for measuring the outcomes of emotional and behavioural disorders in children: the Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA). British Journal of Psychiatry1999;174:413-6.">Gowers 1999</a>) in one trial (<a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>). </p> </section> <section id="CD013667-sec-0102"> <p><b>Social functioning</b></p> <p>No included trial reported data on social functioning.</p> </section> <section id="CD013667-sec-0103"> <p><b>Suicidal ideation</b></p> <p>Suicidal ideation was assessed using the Suicidal Ideation Questionnaire‐Junior (SIQ‐JR; <a href="./references#CD013667-bbs2-0218" title="ReynoldsWM . Suicidal Ideation Questionnaire: Professional Manual. Odessa, FL: Psychological Assessment Resources, 1985.">Reynolds 1985</a>; <a href="./references#CD013667-bbs2-0219" title="ReynoldsWM . Suicidal Ideation Questionnaire: Professional Manual. Odessa, FL: Psychological Assessment Resources, 1988.">Reynolds 1988</a>) in the majority of trials (<a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>), followed by the BSSI (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>). </p> </section> <section id="CD013667-sec-0104"> <p><b>Suicide</b></p> <p>Suicide was assessed using medical or health service records (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>; <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>), or via interviews with collateral informants, like parents (<a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>). In the majority of trials, however, it was unclear how suicide was assessed (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>). </p> </section> </section> </section> </section> <section id="CD013667-sec-0105"> <h4 class="title">Excluded studies</h4> <p>A total of 157 studies were excluded from this update. The most common reason for exclusion was that not all trial participants had engaged in SH within six month of trial entry (90 studies). Reasons for exclusion for the remaining studies are reported in <a href="#CD013667-fig-0001">Figure 1</a>. </p> <p>Details on the reasons for exclusion for the 28 trials related to interventions in children and adolescents identified by this update are reported in the <a href="./references#CD013667-sec-0262" title="">Characteristics of excluded studies</a> section. </p> <section id="CD013667-sec-0106"> <h5 class="title">Ongoing studies</h5> <p>Of the five ongoing trials identified in the previous version of this review (<a href="./references#CD013667-bbs2-0269" title="HawtonK , WittKG , Taylor SalisburyTL , ArensmanE , GunnellD , TownsendE , et al. Interventions for self-harm in children and adolescents. Cochrane Database of Systematic Reviews2015, Issue 12. Art. No: CD012013. [DOI: 10.1002/14651858.CD012013]">Hawton 2015</a>), three were included in this update (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>). Two were excluded: one was subsequently published as a case report, and one recruited participants from non‐clinical settings. </p> <p>Thirteen ongoing studies were identified in this update (see <a href="./references#CD013667-sec-0263" title="">Characteristics of ongoing studies</a> section for further information). </p> </section> <section id="CD013667-sec-0107"> <h5 class="title">Studies awaiting classification</h5> <p>There were no potentially eligible studies which have not been included in this review.</p> </section> </section> </section> <section id="CD013667-sec-0108"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias was evaluated for the primary outcome repetition of SH at post‐intervention. The results of the 'Risk of bias' assessments can be seen in <a href="#CD013667-fig-0002">Figure 2</a>. Full 'Risk of bias' assessments, including the evidence we used to justify our ratings, are available here: <a href="https://doi.org/10.6084/m9.figshare.14152364" target="_blank">doi.org/10.6084/m9.figshare.14152364</a>. </p> <div class="figure" id="CD013667-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Results of 'Risk of bias' assessments for each study" data-id="CD013667-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-FIG-02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Results of 'Risk of bias' assessments for each study</p> </div> </div> </div> <section id="CD013667-sec-0109"> <h4 class="title">Bias arising from randomisation process</h4> <p>All trials used random allocation to assign participants to the intervention and comparator arms. We therefore rated the majority (76.5%) as having a low risk of bias for this domain. Most trials (94.1%) randomised at the individual level. In one trial, cluster randomisation was used (<a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>). Three trials were rated as having some concerns for this domain. For two older trials (<a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>), insufficient detail on allocation concealment was reported. For the third, baseline differences between the intervention and comparator arms suggested there may have been a problem with the randomisation process. Specifically, over half (55.0%) of those allocated to the intervention arm were diagnosed with probable borderline personality disorder, compared to 15.0% of those allocated to the comparator arm (<a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>). One trial was rated as having high risk of bias for this domain as those allocated to the intervention arm had very significantly higher hopelessness scores at baseline compared to those in the comparator arm (<a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>), suggesting there may have been a problem with the randomisation process. Additionally, no information on allocation concealment was reported in this trial. </p> </section> <section id="CD013667-sec-0110"> <h4 class="title">Bias due to deviations from intended interventions</h4> <p>Whilst participants and clinical personnel were, typically, not blind to allocation owing to likely differences in treatment intensity between the intervention and control arms, most trials (82.3%) were nonetheless rated as at low risk of bias for this domain as no deviations from the intended intervention were apparent and analyses were conducted on an intention‐to‐treat (ITT) basis, although the statistical method(s) used to undertake these analyses was not always clearly reported. Two trials were rated as having some concerns for this domain. For one of these (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>), per protocol analyses were undertaken and, additionally, some minor departures from the intended intervention occurred as a result of the experimental context. In the second, insufficient information was reported on the analysis method(s) used (<a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>). One trial was rated as having high risk of bias for this domain (<a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>). In this trial, some participants randomised to the control group mistakenly received the intervention and it is unclear how these cases were assessed in subsequent analyses. Additionally, the trial authors claimed the intervention was effective in preventing repeat SH even though comparison of repetition rates did not show a difference between arms, suggesting that selective reporting may have been apparent. </p> </section> <section id="CD013667-sec-0111"> <h4 class="title">Bias due to missing outcome data</h4> <p>The majority of trials (88.2%) were at low risk of bias for this domain as fewer than 5% of the data were missing at the post‐intervention assessment, or the proportion of missing data was balanced between the intervention and control arms at post‐intervention. However, there were some concerns with respect to this domain for two trials. For one of these, there was evidence of a slightly larger proportion of missing data for the comparator arm as compared to the intervention arm (<a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>), whilst in the second, the proportion of missing data in the intervention arm was over double that of the proportion missing from the comparator arm (<a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>). Neither of these trials undertook sensitivity analyses to investigate the impact that missing data may have had on the estimate of treatment effectiveness. </p> </section> <section id="CD013667-sec-0112"> <h4 class="title">Bias in measurement of the outcome</h4> <p>There were some concerns regarding bias in the measurement of the outcome for around half (52.9%) of the trials included in this review. Typically, this was because repetition of SH was ascertained from self‐reported information alone and participants were either not blind to treatment allocation and/or participant blinding was unlikely to have been possible given the differences in therapeutic intensity between the intervention and control arms (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>). Two trials were rated as having high risk of bias for this domain (<a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>). In the first trial, repetition of SH was determined from cut‐scores on the RTSHI and it is unclear how this scale may relate to actual self‐harming behaviour. In the second, the definition of repetition of SH was based on there being two or more further episodes, whilst in the two remaining trials of this intervention approach (i.e. group‐based psychotherapy; <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>), repetition was based on there being any further episodes of SH. </p> </section> <section id="CD013667-sec-0113"> <h4 class="title">Bias in selection of the reported result</h4> <p>Only two trials (11.8%) were rated as being at low risk of bias for this domain. Of these, only one trial clearly reported that data had been analysed in accordance with a prespecified analysis plan that had been finalised before unblinded outcome data had been made available for analysis (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>), whilst for the second, there had been no major departures from the analysis plan as outlined in either a published trial protocol or clinical trials register (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>). </p> <p>Instead, the majority (70.6%) of the trials included in this review were rated as having some concerns for this domain. In the majority of cases, this was because trials were published prior to the International Committee of Medical Journal Editors' (ICMJE) requirement in 2015 that all trials be preregistered in a publicly available clinical trials registry. It was, therefore, difficult to determine whether data had been analysed according to a prespecified plan, although there were no apparent departures from the analyses outlined in the methods section of these trials (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>). For two trials published subsequent to the ICMJE requirement, this domain was also rated as having some concerns, as the information provided within the clinical trials record was not sufficiently detailed to determine whether there had been departures from the proposed analysis plan (<a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>). For three further trials, there were some concerns for this domain as data on repetition of SH for one or more eligible time point(s) was not reported (<a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>); however, in all three of these trials, it was unlikely that the results were selectively reported for favourability. </p> <p>Three trials were rated as being at high risk of bias for this domain as, although repetition of SH was a prespecified outcome, data had to be requested from the trial authors (<a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>) and one trials had not been preregistered with a clinical trials register despite being published subsequent to 2015 (<a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>). </p> </section> <section id="CD013667-sec-0114"> <h4 class="title">Overall bias</h4> <p>As a consequence, most trials (94.1%) were rated as either having some concerns (k = 10; 58.8%) or were at high risk of bias ( k = 6; 35.3%). </p> </section> </section> <section id="CD013667-sec-0115"> <h3 class="title" id="CD013667-sec-0115">Effects of interventions</h3> <p>See: <a href="./full#CD013667-tbl-0001"><b>Summary of findings 1</b> Comparison 1: Individual CBT‐based psychotherapy compared to TAU or other comparator for self‐harm in children and adolescents</a>; <a href="./full#CD013667-tbl-0002"><b>Summary of findings 2</b> Comparison 2: DBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</a>; <a href="./full#CD013667-tbl-0003"><b>Summary of findings 3</b> Comparison 3: MBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</a>; <a href="./full#CD013667-tbl-0004"><b>Summary of findings 4</b> Comparison 7: Family therapy compared to placebo for self‐harm in children and adolescents</a> </p> <section id="CD013667-sec-0116"> <h4 class="title">Comparison 1: Individual CBT‐based psychotherapy (e.g. CBT, PST) versus treatment‐as‐usual (TAU) or other comparator </h4> <p>The effectiveness of CBT‐based psychotherapy (i.e. up to 10 treatment sessions) versus alternative psychotherapy was assessed in two trials of children and adolescents (weighted mean age: 16.1 ±  2.7 years; 77.8% female) presenting to clinical services following an episode of SH. In the first trial, the comparator was supportive relationship therapy, which was designed to be as close as possible to TAU for this population (<a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>, N = 39). In the second, the comparator was minimally‐directive supportive psychotherapy (<a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>, N = 24). </p> <section id="CD013667-sec-0117"> <h5 class="title">Primary outcome</h5> <section id="CD013667-sec-0118"> <h6 class="title">1.1 Repetition of SH</h6> <p>Data from two trials did not show that CBT‐based psychotherapy reduces repetition of SH by post‐intervention (i.e. conclusion of the acute phase) compared to alternative psychotherapy (OR 0.93, 95% CI 0.12 to 7.24; N = 51, k = 2; I<sup>2 </sup>= 29%; <a href="./references#CD013667-fig-0003" title="">Analysis 1.1</a>). The overall risk of bias was high for one trial (<a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>) and there were some concerns for the other trial (<a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>). According to GRADE criteria, we judged the evidence to be of low certainty.  </p> <p>For the second of these trials (<a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>), whilst time to SH repetition was also recorded, correspondence with trial authors revealed that so few participants remained in the study until the conclusion of the booster phase that the data for this outcome were determined to be too unreliable. </p> </section> </section> <section id="CD013667-sec-0119"> <h5 class="title">Secondary outcomes</h5> <section id="CD013667-sec-0120"> <h6 class="title">1.2 Treatment adherence</h6> <p>There was no evidence of an effect for CBT‐based psychotherapy on the proportion of participants who completed the acute treatment phase (<a href="./references#CD013667-fig-0004" title="">Analysis 1.2</a>). </p> <p>One trial also reported information on the proportion of participants who completed both the acute and booster phases of treatment; however, there was no evidence of an effect for CBT‐based psychotherapy (1/12 versus 4/12; OR 0.18, 95% CI 0.02 to 1.95; N = 24; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>). </p> <p>There was no evidence of an effect on the number of sessions attended (<a href="./references#CD013667-fig-0005" title="">Analysis 1.3</a>). However, data on the number of treatment sessions attended were only available for those who completed the three‐ and six‐month follow‐up assessments in one trial (<a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>), whilst only data on the number of treatment sessions attended during the acute phase of treatment were reported for the second trial as so few participants attended any sessions during the booster phase in this trial (<a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>). </p> </section> <section id="CD013667-sec-0121"> <h6 class="title">1.3 Depression</h6> <p>There was no evidence of an effect of CBT‐based psychotherapy on depression scores at post‐intervention (<a href="./references#CD013667-fig-0006" title="">Analysis 1.4</a>), or at 12 months in one of these trials (mean 10.33, SD 11.45, n = 15 versus mean 13.89, SD 8.28, n = 15; MD ‐3.56, 95% CI ‐10.71 to 3.59; N = 30; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>). </p> <p>For one of these trials (<a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>), depression was also measured using the MADRS. Using these values did not materially affect this result (mean 17.36, SD 13.12, n = 11 versus mean 22.30, SD 12.55, n = 10; MD ‐5.90, 95% CI ‐16.57 to 4.77; N = 21; k = 1; I² = not applicable). </p> </section> <section id="CD013667-sec-0122"> <h6 class="title">1.4 Hopelessness</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0123"> <h6 class="title">1.5 General functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0124"> <h6 class="title">1.6 Social functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0125"> <h6 class="title">1.7 Suicidal ideation</h6> <p>There was also no evidence of an effect of CBT‐based psychotherapy on suicidal ideation scores at post‐intervention (<a href="./references#CD013667-fig-0007" title="">Analysis 1.5</a>), or at 12 months in one trial (mean 24.89, SD 28.52, n = 15 versus mean 33.33, SD 30.42, n = 15; MD ‐8.44, 95% CI ‐29.54 to 12.66; N = 30; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>). </p> </section> <section id="CD013667-sec-0126"> <h6 class="title">1.8 Suicide</h6> <p>No participants died by suicide in either of these trials, including by the 12‐month follow‐up assessment in one of them (<a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>). </p> </section> </section> <section id="CD013667-sec-0127"> <h5 class="title">Subgroup analyses</h5> <p>No included trial stratified randomisation by sex or repeater status.</p> </section> <section id="CD013667-sec-0128"> <h5 class="title">Sensitivity analyses</h5> <p>Not applicable.</p> </section> </section> <section id="CD013667-sec-0129"> <h4 class="title">Comparison 2: Dialectical behaviour therapy (DBT) versus TAU or another comparator</h4> <p>Four trials evaluated the effectiveness of a DBT program specially adapted for adolescents (i.e. DBT‐A), comprising individual, group‐based, and family therapy sessions, in children and adolescents (weighted mean age: 15.2 ± 1.5 years; 90.4% female) with a history of multiple episodes of SH compared to either TAU (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>, N = 29), EUC (<a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>, N = 77; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>, N = 35), or alternative psychotherapy (<a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>, N = 173). </p> <section id="CD013667-sec-0130"> <h5 class="title">Primary outcome</h5> <section id="CD013667-sec-0131"> <h6 class="title">2.1 Repetition of SH</h6> <p>Data from these four trials showed there was evidence of an effect of DBT‐A on repetition of SH at post‐intervention (OR 0.46, 95% CI 0.26 to 0.82; N = 270; k = 4; I² = 0%; <a href="./references#CD013667-fig-0008" title="">Analysis 2.1</a>). Although there were some concerns with regards to the overall risk of bias for all four trials, according to the GRADE criteria, we judged the evidence to be of high certainty.  There was no evidence of a difference by comparator (i.e. TAU versus EUC versus alternative psychotherapy).  </p> <p>However, there was no longer evidence of an effect for DBT‐A, as compared to alternative psychotherapy, on repetition of SH by 12 months in one of these trials (27/71 versus 30/58; OR 0.57, 95% CI 0.28 to 1.16; N = 129; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>). </p> <p>With respect to frequency of repeat SH episodes, there was no evidence of an effect of DBT‐A at the post‐intervention assessment (<a href="./references#CD013667-fig-0009" title="">Analysis 2.2</a>). Once again, there was no evidence of a difference based on comparator. </p> <p>There was also no evidence of an effect for DBT‐A, as compared to alternative psychotherapy, on frequency of repeated SH by the 12‐month follow‐up assessment in one of these trials (mean 2.54, SD 11.92, n = 71 versus mean 4.53, SD 18.30, n = 58; MD ‐1.99, 95% CI ‐7.46 to 3.48; N = 129; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>). </p> </section> </section> <section id="CD013667-sec-0132"> <h5 class="title">Secondary outcomes</h5> <section id="CD013667-sec-0133"> <h6 class="title">2.2 Treatment adherence</h6> <p>There was evidence of an effect for DBT‐A when compared with alternative psychotherapy on the proportion of children and adolescents who completed treatment in one trial (39/86 versus 14/87; OR 4.33, 95% CI 2.12 to 8.82; N = 173; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>). </p> <p>There was no evidence of an effect for DBT‐A on the number of individual therapy sessions attended (<a href="./references#CD013667-fig-0010" title="">Analysis 2.3</a>); however, there was evidence of an effect by comparator (test for subgroup differences: Chi² = 36.7, df = 2, P &lt; 0.001, I² = 94.5%). Specifically, when compared to either TAU or alternative psychotherapy, participants randomised to DBT‐A attended a greater number of individual therapy sessions. </p> <p>There was no evidence of an effect for DBT‐A on the number of group therapy sessions attended (<a href="./references#CD013667-fig-0011" title="">Analysis 2.4</a>). There was no evidence of a difference based on comparator. There was also no evidence that children and adolescents randomised to DBT‐A attended a greater number of family therapy sessions (<a href="./references#CD013667-fig-0012" title="">Analysis 2.5</a>); however, there was evidence of a difference by comparator for this outcome (test for subgroup differences: Chi² = 5.4, df = 1, P = 0.02, I² = 81.5%). </p> <p>Compared with TAU, participants randomised to DBT‐A attended a greater number of family therapy sessions. Finally, there was no evidence of an effect for DBT‐A on the number of telephone therapy sessions in two trials (<a href="./references#CD013667-fig-0013" title="">Analysis 2.6</a>), or on the number of medication review meetings attended in one trial (mean 2.40, SD 2.20, n = 14 versus mean 1.60, SD 2.90, n = 15; MD 0.80, 95% CI ‐1.07 to 2.67; N = 29; k = 1; <a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>). </p> </section> <section id="CD013667-sec-0134"> <h6 class="title">2.3 Depression</h6> <p>There was evidence of an effect for DBT‐A as compared to EUC on depression scores at post‐intervention in two trials (SMD ‐0.42, 95% CI ‐0.81 to ‐0.03; N = 103; k = 2; I² = 0%; <a href="./references#CD013667-fig-0014" title="">Analysis 2.7</a>). Data on depression was also measured as scores on the depression subscale of the MFQ in one of these trials (<a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>); however, there was no evidence of an effect for DBT‐A according to this measure (mean 10.2, SD 5.0, n = 39 versus mean 12.6, SD 6.6, n = 38; MD ‐2.39, 95% CI ‐5.02 to 0.24; N = 77; k = 1; I² = not applicable). </p> <p>Data on depression scores, measured using both the MADRS and the depression subscale of the MFQ were also available for one of these trials by the 12‐month assessment (<a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>); however, there was no evidence of an effect for DBT‐A according to either measure by this time point in this trial (MADRS: mean 15.09, SD 8.08, n = 38 versus mean 15.73, SD 9.06, n = 37; MD ‐0.64, 95% CI ‐4.53 to 3.25; N = 75; k = 1; I² = not applicable; SMFQ: mean 9.88, SD 5.53, n = 38 versus mean 9.19, SD 6.57, n = 37; MD 0.69, 95% CI ‐2.06 to 3.44; N = 75; k = 1; I² = not applicable). </p> </section> <section id="CD013667-sec-0135"> <h6 class="title">2.4 Hopelessness</h6> <p>There was evidence of an effect for DBT‐A on hopelessness scores at the post‐intervention assessment (SMD ‐0.62, 95% CI ‐1.07 to ‐0.16; N = 100; k = 2; I² =  13%; <a href="./references#CD013667-fig-0015" title="">Analysis 2.8</a>). There was no evidence of a difference by comparator. </p> <p>However, there was no longer evidence of an effect for DBT‐A, as compared to EUC, on hopelessness scores by the 12‐month assessment in one of these trials (mean 6.97, SD 5.66, n = 38 versus mean 7.26, SD 6.57, n = 37; MD ‐0.29, 95% CI ‐3.07 to 2.49; N = 75; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>). </p> </section> <section id="CD013667-sec-0136"> <h6 class="title"><i>2</i>.5 General functioning </h6> <p>There was no evidence of an effect for DBT‐A, as compared to EUC, on general functioning scores at post‐intervention in two trials (<a href="./references#CD013667-fig-0016" title="">Analysis 2.9</a>). The means obtained by correspondence for <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a> differ modestly from those published (i.e. 65.00 versus 64.60 for the DBT‐A arm and 54.29 versus 54.60 for the comparator arm). </p> <p>There was also no evidence of an effect for DBT‐A on general functioning scores by the 12‐month follow‐up assessment in one of these trials (mean 65.68, SD 11.81, n = 38 versus mean 64.22, SD 14.13, n = 37; MD 1.46, 95% CI ‐4.44 to 7.36; N = 75; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>). </p> </section> <section id="CD013667-sec-0137"> <h6 class="title">2.6 Social functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0138"> <h6 class="title">2.7 Suicidal ideation</h6> <p>There was evidence of an effect of DBT‐A on suicidal ideation at the post‐intervention assessment in four trials (SMD ‐0.43, 95% CI ‐0.68 to ‐0.18; N = 256; k = 4; I² = 0%; <a href="./references#CD013667-fig-0017" title="">Analysis 2.10</a>). There was no evidence of a difference based on comparator. </p> <p>However, there was no longer evidence of an effect for DBT‐A (as compared to either EUC or alterative psychotherapy) on suicidal ideation scores by the 12‐month follow‐up assessment in two of these trials (<a href="./references#CD013667-fig-0018" title="">Analysis 2.11</a>). Once again, there was no evidence of a difference based on comparator. </p> </section> <section id="CD013667-sec-0139"> <h6 class="title">2.8 Suicide</h6> <p>Data obtained by correspondence with trial authors indicated there were no suicides in either arm either at post‐intervention or by the 12‐month follow‐up assessment in <a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>, <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>, or <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>. In <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>, one participant who had been assigned to the alternative comparator group died by suicide by the 12‐month follow‐up assessment. </p> <p>Correspondence with trial authors for <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a> further indicated there had been no suicide deaths in either arm by the 24‐month follow‐up assessment in this trial. </p> </section> </section> <section id="CD013667-sec-0140"> <h5 class="title">Subgroup analyses</h5> <p>No included trial stratified randomisation by sex or repeater status.</p> </section> <section id="CD013667-sec-0141"> <h5 class="title">Sensitivity analyses</h5> <p>Four analyses within this comparison were associated with substantial levels of heterogeneity (<a href="./references#CD013667-fig-0010" title="">Analysis 2.3</a>, I² = 92%; <a href="./references#CD013667-fig-0011" title="">Analysis 2.4</a>, I² = 94%; <a href="./references#CD013667-fig-0012" title="">Analysis 2.5</a>, I² = 88%; <a href="./references#CD013667-fig-0016" title="">Analysis 2.9</a>, I² = 85%); however, analyses did not indicate any individual study was associated with excessive influence for any of these analyses. </p> </section> </section> <section id="CD013667-sec-0142"> <h4 class="title">Comparison 3: Mentalisation‐based therapy versus TAU or other comparator</h4> <p>Two trials investigated the effectiveness of mentalisation‐based therapy for adolescents (MBT‐A) in children and adolescents (weighted mean age: 15.3 ± 1.3 years; 82.8% female) presenting to clinical services following SH (<a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>, N = 48; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; N = 80). </p> <section id="CD013667-sec-0143"> <h5 class="title">Primary outcome</h5> <section id="CD013667-sec-0144"> <h6 class="title">3.1 Repetition of SH</h6> <p>Data from two trials did not show that MBT‐A reduced repetition of SH compared with TAU at post‐intervention (OR 0.70, 95% CI 0.06 to 8.46; N = 85; k = 2; I<sup>2</sup> = 68%; <a href="./references#CD013667-fig-0019" title="">Analysis 3.1</a>). There was substantial heterogeneity when comparing MBT‐A and TAU for repetition of SH at post‐intervention (I<sup>2</sup> = 68%), and the pooled estimate was imprecise. As a consequence, according to the GRADE criteria, we judged the evidence to be of very low certainty. A sensitivity analysis using data for the proportion of participants who scored above the cut‐point suggesting likely SH on the Risk‐Taking and Self‐Harm Inventory (RTSHI; <a href="./references#CD013667-bbs2-0247" title="VrouvaI , FonagyP , FearonPRM , RoussowT . The Risk-Taking and Self-Harm Inventory for adolescents: development and psychometric evaluation. Psychological Assessment2010;22:853-65.">Vrouva 2010</a>) for both trials did not materially affect this result (<a href="./references#CD013667-fig-0020" title="">Analysis 3.2</a>). </p> <p>There was also no evidence of an effect for MBT‐A on repetition of SH by the six‐month follow‐up assessment in one of these trials (2/2 versus 5/9; OR 4.09, 95% CI 0.15 to 108.94; N = 11; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>). </p> <p>Once again, a <i>post‐hoc </i>sensitivity analysis using data for the proportion of participants who scored above the cut‐point on the RTSHI did not materially affect this result (17/22 versus 26/26; OR 0.06, 95% CI 0.00 to 1.16; N = 48; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>). </p> </section> </section> <section id="CD013667-sec-0145"> <h5 class="title">Secondary outcomes</h5> <section id="CD013667-sec-0146"> <h6 class="title">3.2 Treatment adherence</h6> <p>There was no evidence of an effect for MBT‐A on treatment adherence, as measured by the number of adolescents who completed all 12 months of treatment in one of these trials (20/40 versus 17/40; OR 1.35, 95% CI 0.56 to 3.27; N = 80; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>). </p> <p>One trial reported data on treatment adherence for the intervention arm only (<a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>). In this trial, correspondence with trial authors indicated: "50% [of] young people attended 50% or more sessions. Additionally, there were six (27.3%) young people who did not attend any sessions; a further five (22.7%) who attended at least one but less than half of the sessions; four (18.2%) who attended between 50‐75% of sessions; and seven (31.8%) who attended 75% or more." </p> </section> <section id="CD013667-sec-0147"> <h6 class="title">3.3 Depression</h6> <p>There was no evidence of an effect for MBT‐A on depression scores at the post‐intervention assessment in two trials (<a href="./references#CD013667-fig-0021" title="">Analysis 3.3</a>), or by the six‐month assessment in one of these trials (mean 20.1, SD 5.7, n = 22 versus mean 18.5, SD 7.0, n = 26; MD 1.60, 95% CI ‐1.99 to 5.19; N = 48; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>). </p> <p>Depression was also measured dichotomously, as the proportion of participants scoring above the cut‐point on the depression subscale of the MFQ in one trial (<a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>). Although fewer adolescents in the intervention arm scored above this cut‐point, there was no evidence of an effect for MBT‐A by the post‐intervention assessment (19/39 versus 25/37; OR 0.46, 95% CI 0.18 to 1.16; N = 76; k = 1; I² = not applicable). </p> </section> <section id="CD013667-sec-0148"> <h6 class="title">3.4 Hopelessness</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0149"> <h6 class="title">3.5 General functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0150"> <h6 class="title">3.6 Social functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0151"> <h6 class="title">3.7 Suicidal ideation</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0152"> <h6 class="title">3.8 Suicide</h6> <p>Correspondence with trial authors indicated that no participant died by suicide by the 6‐month follow‐up assessment in one of these trials (<a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>), or by the 12‐month follow‐up assessment in the second of these trials (<a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>). </p> </section> </section> <section id="CD013667-sec-0153"> <h5 class="title">Subgroup analyses</h5> <p>No included trial stratified randomisation by sex or repeater status.</p> </section> <section id="CD013667-sec-0154"> <h5 class="title">Sensitivity analyses</h5> <p>One analysis within this comparison was associated with substantial levels of heterogeneity (<a href="./references#CD013667-fig-0021" title="">Analysis 3.3</a>, I² = 97%); however, analyses did not indicate any individual study was associated with excessive influence. </p> </section> </section> <section id="CD013667-sec-0155"> <h4 class="title">Comparison 4: Group‐based psychotherapy versus TAU or other comparator</h4> <p>The effectiveness of group therapy was assessed in three trials in children and adolescents (weighted mean age: 14.4 ±  1.4 years; 87.4% female) presenting to clinical services following SH (<a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>, N = 366; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>, N = 68; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>, N = 63). </p> <p>Given that the <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a> and <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a> trials were based in a large part on <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>, employed the same treatment manual (<a href="./references#CD013667-bbs2-0263" title="WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001.">Wood 2001b</a>), and involved authors of the earlier trial in the design of the intervention, we grouped these trials within a single analysis. </p> <p>In all three trials, group therapy involved a variety of techniques, including CBT, PST, DBT, and group psychodynamic psychotherapy. The intervention consisted of six weekly acute group sessions, followed by weekly or bi‐weekly group therapy sessions continuing until the adolescent felt ready to leave the service. </p> <section id="CD013667-sec-0156"> <h5 class="title">Primary outcome</h5> <section id="CD013667-sec-0157"> <h6 class="title">4.1 Repetition of SH</h6> <p>There was no evidence of an effect for group‐based psychotherapy on repetition of SH by the six‐month (<a href="./references#CD013667-fig-0022" title="">Analysis 4.1</a>) or 12‐month (<a href="./references#CD013667-fig-0023" title="">Analysis 4.2</a>) assessments. </p> <p>As no trial reported information on repetition of SH by the post‐intervention assessment (i.e. the primary outcome of this review) we were unable to determine the quality of evidence for this outcome according to the GRADE criteria. </p> </section> </section> <section id="CD013667-sec-0158"> <h5 class="title">Secondary outcomes</h5> <section id="CD013667-sec-0159"> <h6 class="title">4.2 Treatment adherence</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0160"> <h6 class="title">4.3 Depression</h6> <p>There was no evidence of an effect of group‐based psychotherapy on depression scores at either the six‐month (<a href="./references#CD013667-fig-0024" title="">Analysis 4.3</a>) or 12‐month (<a href="./references#CD013667-fig-0025" title="">Analysis 4.4</a>) assessments. </p> </section> <section id="CD013667-sec-0161"> <h6 class="title">4.4 Hopelessness</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0162"> <h6 class="title">4.5 General functioning</h6> <p>There was no evidence of an effect of group‐based psychotherapy on general functioning scores by either the six‐month (<a href="./references#CD013667-fig-0026" title="">Analysis 4.5</a>) or 12‐month (<a href="./references#CD013667-fig-0027" title="">Analysis 4.6</a>) assessments in two trials. </p> </section> <section id="CD013667-sec-0163"> <h6 class="title">4.6 Social functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0164"> <h6 class="title">4.7 Suicidal ideation</h6> <p>There was no evidence of an effect of group‐based psychotherapy on suicidal ideation scores at either the six‐month (<a href="./references#CD013667-fig-0028" title="">Analysis 4.7</a>) or 12‐month (<a href="./references#CD013667-fig-0029" title="">Analysis 4.8</a>) assessments. </p> </section> <section id="CD013667-sec-0165"> <h6 class="title">4.8 Suicide</h6> <p>There were no suicide deaths in either arm in any of the three trials of group‐based psychotherapy by the final follow‐up assessment. </p> </section> </section> <section id="CD013667-sec-0166"> <h5 class="title">Subgroup analyses</h5> <p>No included trial stratified randomisation by sex or repeater status.</p> </section> <section id="CD013667-sec-0167"> <h5 class="title">Sensitivity analyses</h5> <p>One analysis within this comparison was associated with substantial levels of heterogeneity (<a href="./references#CD013667-fig-0023" title="">Analysis 4.2</a>, I² = 77%); however, analyses did not indicate any individual study was associated with excessive influence. </p> </section> </section> <section id="CD013667-sec-0168"> <h4 class="title">Comparison 5: Enhanced assessment approaches versus TAU or other comparator</h4> <p>One cluster‐RCT examined the effectiveness of enhanced assessment for the treatment of SH in children and adolescents (mean age: 15.6 ± 1.3 years; 80.0% female) referred for a psychological assessment following SH (<a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>, N = 70). </p> <p>As the trial authors were unable to provide values for either the inter‐cluster correlation coefficient or the design effect, and further, there was no similar cluster‐RCT of this intervention approach from which these values could be approximated, we were unable to statistically account for the effects of clustering. Results presented in this section may therefore overestimate the effectiveness of this intervention. </p> <section id="CD013667-sec-0169"> <h5 class="title">Primary outcome</h5> <section id="CD013667-sec-0170"> <h6 class="title">5.1 Repetition of SH</h6> <p>There was no evidence of an effect for enhanced therapeutic assessment on repetition of SH by the 12‐month (4/35 versus 5/34; OR 0.75, 95% CI 0.18 to 3.06; N = 69; k = 1; I² = not applicable) or the 24‐month (7/35 versus 9/34; OR 0.69, 95% CI 0.23 to 2.14; N = 69; k = 1; I² = not applicable) assessments. </p> <p>As this trial did not report information on repetition of SH by the post‐intervention assessment (i.e. the primary outcome of this review) we were unable to determine the quality of evidence for this outcome according to the GRADE criteria. </p> </section> </section> <section id="CD013667-sec-0171"> <h5 class="title">Secondary outcomes</h5> <section id="CD013667-sec-0172"> <h6 class="title">5.2 Treatment adherence</h6> <p>There was an effect for enhanced therapeutic assessment on treatment adherence. Children and adolescents in the enhanced therapeutic assessment arm were more likely to attend their first aftercare appointment (29/35 versus 17/35; OR 5.12, 95% CI 1.70 to 15.39; N = 70; k = 1; I² = not applicable). </p> </section> <section id="CD013667-sec-0173"> <h6 class="title">5.3 Depression</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0174"> <h6 class="title">5.4 Hopelessness</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0175"> <h6 class="title">5.5 General functioning</h6> <p>There was no evidence of an effect for enhanced therapeutic assessment on general functioning at post‐intervention (mean 64.6, SD 12.9, n = 35 versus mean 60.1, SD 9.9, n = 35; MD 4.50, 95% CI ‐0.89 to 9.89; N = 70; k = 1; I² = not applicable). </p> </section> <section id="CD013667-sec-0176"> <h6 class="title">5.6 Social functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0177"> <h6 class="title">5.7 Suicidal ideation</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0178"> <h6 class="title">5.8 Suicide</h6> <p>Correspondence with trial authors confirmed there were no suicide deaths in either arm by the final 24‐month follow‐up assessment. </p> </section> </section> <section id="CD013667-sec-0179"> <h5 class="title">Subgroup analyses</h5> <p>No included trial stratified randomisation by sex or repeater status.</p> </section> <section id="CD013667-sec-0180"> <h5 class="title">Sensitivity analyses</h5> <p>Not applicable.</p> </section> </section> <section id="CD013667-sec-0181"> <h4 class="title">Comparison 6: Compliance enhancement approaches versus TAU or other comparator</h4> <p>One trial investigated the effectiveness of standard aftercare planning plus an added compliance enhancement approach (consisting of a series of four telephone calls at 1, 2, 4 and 8 weeks' post‐discharge) to standard aftercare planning alone in children and adolescents (mean age: not reported; 86.2% female) admitted to the emergency department of a general hospital following an episode of SH (<a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>, N = 76). </p> <section id="CD013667-sec-0182"> <h5 class="title">Primary outcome</h5> <section id="CD013667-sec-0183"> <h6 class="title">6.1 Repetition of SH</h6> <p>There was no evidence of an effect for compliance enhancement on repetition of SH by the six‐month follow‐up assessment (3/29 versus 5/34; OR 0.67, 95% CI 0.15 to 3.08; N = 63; k = 1; I² = not applicable). Participants in the compliance enhancement group did, however, “engage in fewer repeat SH episodes” over this period compared to participants in the control group (mean 0.10 versus 0.15; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>), although insufficient information was available to allow formal testing of this. </p> <p>As this trial did not report information on repetition of SH by the post‐intervention assessment (i.e. the primary outcome of this review), we were unable to determine the quality of evidence for this outcome according to the GRADE criteria. </p> </section> </section> <section id="CD013667-sec-0184"> <h5 class="title">Secondary outcomes</h5> <section id="CD013667-sec-0185"> <h6 class="title">6.2 Treatment adherence</h6> <p>There was no evidence of an effect for compliance enhancement on the proportion of participants that completed the full course of treatment (17/29 versus 16/34; OR 1.59, 95% CI 0.59 to 4.33; N = 63; k = 1; I² = not applicable), or on the average number of therapy sessions attended (mean 7.70, SD 5.80, n = 29 versus mean 6.40, SD 4.40, n = 34; MD 1.30, 95% CI ‐1.28 to 3.88; N = 63; k = 1; I² = not applicable). </p> </section> <section id="CD013667-sec-0186"> <h6 class="title">6.3 Depression</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0187"> <h6 class="title">6.4 Hopelessness</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0188"> <h6 class="title">6.5 General functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0189"> <h6 class="title">6.6 Social functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0190"> <h6 class="title">6.7 Suicidal ideation</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0191"> <h6 class="title">6.8 Suicide</h6> <p>There were no suicide deaths in either arm by the final follow‐up assessment.</p> </section> </section> <section id="CD013667-sec-0192"> <h5 class="title">Subgroup analyses</h5> <p>No included trial stratified randomisation by sex or repeater status.</p> </section> <section id="CD013667-sec-0193"> <h5 class="title">Sensitivity analyses</h5> <p>Not applicable.</p> </section> </section> <section id="CD013667-sec-0194"> <h4 class="title">Comparison 7: Family interventions versus TAU or other comparator</h4> <p>Three trials compared the effectiveness of a family intervention to either TAU (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>, N = 832; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>, N = 162) or EUC (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>, N = 42) in children and adolescents (weighted mean age: 14.3 ± 1.4 years; 88.7% female) presenting to clinical services following SH. </p> <p>In one older trial, therapy was delivered in the adolescent's home (<a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>) whilst in the remaining two trials, therapy was delivered in an outpatient setting (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>). </p> <section id="CD013667-sec-0195"> <h5 class="title">Primary outcome</h5> <section id="CD013667-sec-0196"> <h6 class="title">7.1 Repetition of SH</h6> <p>There was no evidence of an effect for family therapy interventions on repetition of SH at post‐intervention in two trials (OR 1.00, 95% CI 0.49 to 2.07; N = 191; k = 2; I<sup>2 </sup>= 0%; <a href="./references#CD013667-fig-0030" title="">Analysis 5.1</a>). There was no evidence of a difference based on comparator (i.e. TAU versus EUC) for this outcome. According to GRADE criteria, we judged the evidence to be of moderate certainty.  </p> <p>There was also no evidence of an effect for family therapy on repetition of SH by the 18‐month follow‐up assessment in one further trial (118/415 versus 103/417; OR 1.21, 95% CI 0.89 to 1.65; N = 832; k = 1; I² = 0%; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>). </p> <p>Two trials also reported data on time to SH repetition. There was no evidence of an effect for family therapy, as compared to EUC, on time to repetition by the post‐intervention assessment (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>). There was also no effect on time to SH repetition for family therapy as compared to TAU by the 18‐month assessment in one further trial (HR 1.14, 95% CI 0.87 to 1.49; P = 0.33; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>). </p> </section> </section> <section id="CD013667-sec-0197"> <h5 class="title">Secondary outcomes</h5> <section id="CD013667-sec-0198"> <h6 class="title">7.2 Treatment adherence</h6> <p>Treatment adherence was measured as the proportion of children and adolescents who completed the full course of treatment in two trials (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>). There was evidence of an effect for family therapy on treatment adherence by six months (OR 1.99, 95% CI 1.55 to 2.57; N = 993; k = 2; I² = 0%; <a href="./references#CD013667-fig-0031" title="">Analysis 5.2</a>). </p> </section> <section id="CD013667-sec-0199"> <h6 class="title">7.3 Depression</h6> <p>There was no evidence of an effect for family therapy on depression scores at either the 12‐month (mean 33.2, SD 22.9, n = 248 versus mean 33.9, SD 21.7, n = 189; MD ‐0.70, 95% CI ‐4.91 to 3.51; N = 437; k = 1; I² = not applicable), or 18‐month (mean 30.6, SD 21.9, n = 204 versus mean 31.6, SD 19.0, n = 165; MD ‐1.00, 95% CI ‐5.18 to 3.18; N = 369; k = 1; I² = not applicable) assessments in one trial (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>). </p> </section> <section id="CD013667-sec-0200"> <h6 class="title">7.4 Hopelessness</h6> <p>There was no evidence of an effect for family therapy on hopelessness scores at either the six‐month (mean 4.40, SD 3.30, n = 74 versus mean 4.20, SD 3.60, n = 74; MD 0.20, 95% CI ‐0.91 to 1.32, N = 148; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>), 12‐month (mean 4.90, SD 4.14, n = 255 versus mean 5.20, SD 4.14, n = 201; MD ‐0.30, 95% CI ‐1.07 to 0.47; N = 456; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>), or 18‐month (mean 4.60, SD 4.26, n = 213 versus mean 4.80, SD 4.00, n = 179; MD ‐0.20, 95% CI ‐1.02 to 0.62; N = 392; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>). </p> </section> <section id="CD013667-sec-0201"> <h6 class="title">7.5 General functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0202"> <h6 class="title">7.6 Social functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0203"> <h6 class="title">7.7 Suicidal ideation</h6> <p>There was no evidence of an effect for family therapy on suicidal ideation scores at the six‐month follow‐up assessment in one trial (mean 23.6, SD 40.0, n = 74 versus mean 28.7, SD 36.3, n = 75; MD ‐5.10, 95% CI ‐17.37 to 7.17; N = 149; k = 1; I² = not applicable; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>). </p> <p>In one further trial, information on the proportion of participants with clinically significant suicidal ideation, as determined from cut‐scores on the BSSI, was reported in a secondary publication (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>). There was no evidence of an effect for family therapy on the proportion of participants with suicidal ideation at the 12‐month (111/257 versus 98/202; OR 0.81, 95% CI 0.56 to 1.17; N = 459; k = 1; I² = not applicable) or 18‐month (85/212 versus 80/180; OR 0.84, 95% CI 0.56 to 1.25; N = 392; k = 1; I² = not applicable) assessments in this trial. </p> </section> <section id="CD013667-sec-0204"> <h6 class="title">7.8 Suicide</h6> <p>There were no deaths, including by suicide, in either arm by the 18‐month follow‐up assessment in one trial (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>). </p> <p>In the remaining trial, there was no evidence of a difference in effect for suicide by the six‐month follow‐up assessment. One patient in the family therapy arm died by suicide; none died by suicide in the control group (<a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>). As the denominators for the intervention and comparator arms for this outcome are not known, however, we could not calculate ORs for this trial. </p> </section> </section> <section id="CD013667-sec-0205"> <h5 class="title">Subgroup analyses</h5> <p>Randomisation was stratified by sex in two of these trials; however, for one of these trials we were did not receive these data from the trial authors in time for publication of this review (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>). </p> <p>For the second trial, data on repetition of SH disaggregated by sex were reported in a secondary publication (<a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>). There was no evidence of an effect for family therapy on repetition of SH by the 18‐month assessment in either males (11/47 versus 7/48; OR 1.79, 95% CI 0.63 to 5.10; N = 95; k = 1; I² = not applicable) or females (107/368 versus 96/369; OR 1.17, 95% CI 0.84 to 1.61; N = 737; k = 1; I² = not applicable) in this trial. There was also no evidence of a difference by sex for this outcome (test for subgroup differences: chi² = 0.59, df = 1, P = 0.44). </p> </section> <section id="CD013667-sec-0206"> <h5 class="title">Sensitivity analyses</h5> <p>Not applicable.</p> </section> </section> <section id="CD013667-sec-0207"> <h4 class="title">Comparison 8: Remote contact interventions versus TAU or other comparator</h4> <p>One trial investigated the effectiveness of an emergency card enabling children and adolescents (mean age: 14.9 years, SD not reported; 84.8% female) who were admitted to hospital following an episode of SH to re‐admit themselves to the paediatric ward of the same hospital on demand if they felt suicidal over a 12‐month period in addition to TAU (<a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>, N = 105). </p> <section id="CD013667-sec-0208"> <h5 class="title">Primary outcome</h5> <section id="CD013667-sec-0209"> <h6 class="title">8.1 Repetition of SH</h6> <p>There was no evidence of an effect for emergency cards on repetition of SH by the 12‐month follow‐up assessment (3/47 versus 7/58; OR 0.50, 95% CI 0.12 to 2.04; N = 105; k = 1; I² = not applicable). </p> <p>As this trial did not report information on repetition of SH by the post‐intervention assessment (i.e. the primary outcome of this review), we were unable to determine the quality of evidence for this outcome according to the GRADE criteria. </p> </section> </section> <section id="CD013667-sec-0210"> <h5 class="title">Secondary outcomes</h5> <section id="CD013667-sec-0211"> <h6 class="title">8.2 Treatment adherence</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0212"> <h6 class="title">8.3 Depression</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0213"> <h6 class="title">8.4 Hopelessness</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0214"> <h6 class="title">8.5 General functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0215"> <h6 class="title">8.6 Social functioning</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0216"> <h6 class="title">8.7 Suicidal ideation</h6> <p>No data available.</p> </section> <section id="CD013667-sec-0217"> <h6 class="title">8.8 Suicide</h6> <p>No data available.</p> </section> </section> <section id="CD013667-sec-0218"> <h5 class="title">Subgroup analyses</h5> <p>No included trial stratified randomisation by sex or repeater status.</p> </section> <section id="CD013667-sec-0219"> <h5 class="title">Sensitivity analyses</h5> <p>Not applicable.</p> </section> </section> <section id="CD013667-sec-0220"> <h4 class="title">Comparison 9: Tricyclic antidepressants versus placebo or other comparator drug or dose </h4> <p>There were no eligible trials in which tricyclic antidepressants were compared either to placebo or to other comparator drug or dose for children and adolescents engaging in SH. </p> </section> <section id="CD013667-sec-0221"> <h4 class="title">Comparison 10: Newer generation antidepressants versus placebo or other comparator drug or dose </h4> <p>There were no eligible trials in which NGAs were compared either to placebo or to other comparator drug or dose for children and adolescents engaging in SH. </p> </section> <section id="CD013667-sec-0222"> <h4 class="title">Comparison 11: Any other antidepressants versus placebo or other comparator drug or dose </h4> <p>There were no eligible trials in which any other antidepressants were compared either to placebo or to other comparator drug or dose for children and adolescents engaging in SH. </p> </section> <section id="CD013667-sec-0223"> <h4 class="title">Comparison 12: Antipsychotics versus placebo or other comparator drug or dose</h4> <p>There were no eligible trials in which antipsychotics were compared either to placebo or to other comparator drug or dose for children and adolescents engaging in SH. </p> </section> <section id="CD013667-sec-0224"> <h4 class="title">Comparison 13: Anxiolytics, including both benzodiazepines and non‐benzodiazepine anxiolytics, versus placebo or other comparator drug or dose </h4> <p>There were no eligible trials in which anxiolytics, including both benzodiazepines and non‐benzodiazepine anxiolytics, were compared either to placebo or to other comparator drug or dose for children and adolescents engaging in SH. </p> </section> <section id="CD013667-sec-0225"> <h4 class="title">Comparison 14: Mood stabilisers, including antiepileptics and lithium, versus placebo or other comparator drug or dose </h4> <p>There were no eligible trials in which mood stabilisers, including antiepileptics and lithium, were compared either to placebo or to other comparator drug or dose for children and adolescents engaging in SH. </p> </section> <section id="CD013667-sec-0226"> <h4 class="title">Comparison 15: Other pharmacological agents versus placebo or other comparator drug or dose </h4> <p>There were no eligible trials in which other pharmacological agents were compared either to placebo or to other comparator drug or dose for children and adolescents engaging in SH. </p> </section> <section id="CD013667-sec-0227"> <h4 class="title">Comparison 16: Natural products versus placebo or other comparator drug or dose</h4> <p>There were no eligible trials in which natural products were compared either to placebo or to other comparator drug or dose for children and adolescents engaging in SH. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013667-sec-0228" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013667-sec-0228"></div> <p>This review included 17 trials, six of which have been completed since the previous version of this review (<a href="./references#CD013667-bbs2-0269" title="HawtonK , WittKG , Taylor SalisburyTL , ArensmanE , GunnellD , TownsendE , et al. Interventions for self-harm in children and adolescents. Cochrane Database of Systematic Reviews2015, Issue 12. Art. No: CD012013. [DOI: 10.1002/14651858.CD012013]">Hawton 2015</a>). </p> <p>Previously, we commented on the small number of trials in this population, especially given the size of the problem of SH and its increase in young people in many countries (<a href="./references#CD013667-bbs2-0070" title="BouldH , MarsB , MoranP , BiddleL , GunnellD . Rising suicide rates among adolescents in England and Wales. Lancet2019;394:116-7.">Bould 2019</a>; <a href="./references#CD013667-bbs2-0174" title="LahtiA , RäsänenP , RialaK , KeränenS , HakkoH . Youth suicide trends in Finland, 1969-2008. Journal of Child Psychology and Psychiatry, and Allied Disciplines2011;52:984-91.">Lahti 2011</a>; <a href="./references#CD013667-bbs2-0222" title="RohBR , JungEH , HongHJ . A comparative study of suicide rates among 10-19-year-olds in 29 OECD countries. Psychiatry Investigations2018;15:376-83.">Roh 2018</a>; <a href="./references#CD013667-bbs2-0233" title="SkinnerR , McFaullS . Suicide among children and adolescents in Canada: trends and sex differences, 1980-2008. Canadian Medical Association Journal2012;184:1029-34.">Skinner 2012</a>; <a href="./references#CD013667-bbs2-0235" title="StefanacN , HetrickS , HulbertC , SpittalMJ , WittK , RobinsonJ . Are young female suicides increasing? A comparison of sex-specific rates and characteristics of youth suicides in Australia over 2004-2014. BMC Public Health2019;19:1389.">Stefanac 2019</a>; <a href="./references#CD013667-bbs2-0239" title="SullivanEM , AnnestJL , SimonTR , LuoF , DahlbergLL . Suicide trends among persons aged 10-24 years — United States, 1994-2012. Morbidity and Mortality Weekly Report. Surveillance Summaries: MMWR2015;64:201-5.">Sullivan 2015</a>), as well as its association with suicide and other adverse outcomes (e.g. alcohol and other substance misuse, and psychiatric morbidity) in adulthood (<a href="./references#CD013667-bbs2-0207" title="OhlisA , BjurebergJ , LichtensteinP , D’OnofrioBM , FruzzettiAE , CederlöfM , et al. Comparison of suicide risk and other outcomes among boys and girls who self-harm. European Child and Adolescent Psychiatry2020;29(12):1741-6. [DOI: 10.1007/s00787-020-01490-y]">Ohlis 2020</a>). The reasons for this paucity of trials are unclear. One reason may be that conducting such trials in children and adolescents who are engaging in SH can be particularly challenging, especially in very young individuals for whom parental consent will be required. However, there is a clear need for more and better quality trials that can inform clinical practice. </p> <section id="CD013667-sec-0229"> <h3 class="title" id="CD013667-sec-0229">Summary of main results</h3> <p>The trials included in this review investigated the effectiveness of various forms of psychosocial interventions. None of the included trials evaluated the effectiveness of pharmacological agents in this clinical population. </p> <section id="CD013667-sec-0230"> <h4 class="title">Individual CBT‐based psychotherapy</h4> <p>On the basis of data from two feasibility trials, there is probably little to no effect of individual CBT‐based psychotherapy (i.e. up to 10 acute sessions) compared with TAU on repetition of SH at post‐intervention.  There was also no evidence of effect for individual CBT‐based psychotherapy on any of the secondary outcomes. </p> </section> <section id="CD013667-sec-0231"> <h4 class="title">Dialectical behaviour therapy (DBT)</h4> <p>On the basis of data from four trials, DBT for adolescents (DBT‐A) reduces repetition of SH at post‐intervention compared with TAU (<a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>), EUC (<a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a>), and alternative psychotherapy (<a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>). </p> <p>Results for DBT‐A on frequency of repeated SH by this time point were less clear; although in contrast to our findings the trial authors for one of these trials analysed the longitudinal slope of decline in the mean number of SH episodes per participant based on information reported at the baseline, nine‐week, and 15‐week assessments, and reported an effect for DBT‐A (<a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>). It is difficult to rationalise these two sets of results. The results of our analyses would, however, suggest that any differences in frequency of SH repetition between the groups following treatment may not be marked. </p> <p>There was some evidence that those allocated to DBT‐A attended a greater number of individual therapy sessions and were more likely to experience some improvement by the end of the treatment phase in some of the secondary outcomes included in this review, including depression, hopelessness, and suicidal ideation scores. </p> </section> <section id="CD013667-sec-0232"> <h4 class="title">Mentalisation‐based therapy</h4> <p>We are uncertain whether MBT‐A reduced repetition of SH at the post‐intervention assessment as compared with TAU on the basis of data from two trials (<a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>). However, this was based on fewer adolescents scoring above the cut‐point on the Risk Taking and Self‐Harm Inventory (RTSHI). It is unclear how this scale may relate to actual SH behaviour. </p> <p>There was no apparent effect of MBT‐A on depression. However, in contrast to our findings, the authors of one trial reported that although "[t]he level of self‐rated depression decreased for participants in both groups...The linear rate of decrease was somewhat greater for the MBT‐A group (<i>p</i>&lt;0.04) and the model yielded a significant difference at 12 months" (<a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>, p. 1308). These results suggest there might be some effect for MBT‐A over usual care in terms of this outcome, but this treatment approach requires evaluation in further trials before a stronger conclusion can be reached. </p> </section> <section id="CD013667-sec-0233"> <h4 class="title">Group‐based psychotherapy</h4> <p>Three trials investigated group‐based therapy in adolescents with a history of multiple SH episodes (<a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>). On the basis of data from these three trials, there is probably little to no effect of group‐based psychotherapy compared with TAU on repetition of SH. However, considerable heterogeneity was found, with the results of the earlier two studies showing effects in different directions (<a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>), whilst the results of the third, much larger, trial indicated no superiority of group‐based psychotherapy compared with TAU (<a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>). It is important to note, when interpreting this result, that the definition of repetition in <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a> was based on there being two or more further episodes, whilst in the two remaining trials of this intervention approach (i.e. <a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>), repetition was based on there being any further episodes of SH.  </p> </section> <section id="CD013667-sec-0234"> <h4 class="title">Enhanced assessment approaches</h4> <p>Given the known poor treatment adherence of children and adolescents who engage in SH (<a href="./references#CD013667-bbs2-0130" title="GranboulanV , Roudot-ThoravalF , LemerleS , AlvinP . Predictive factors of post-discharge follow-up care among adolescent suicide attempters. Acta Psychiatrica Scandinavica2001;104:31-6.">Granboulan 2001</a>; <a href="./references#CD013667-bbs2-0241" title="TaylorEA , StansfeldSA . Children who poison themselves. II. Prediction of attendance for treatment. British Journal of Psychiatry1984;145:132-5.">Taylor 1984</a>), efforts have been made to increase adherence through therapeutic assessment following SH. Based on data from a single trial, there is probably little or no effect of an enhanced therapeutic assessment approach compared with TAU on repetition of SH at 12 or 24 months (<a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a>). This approach may increase treatment adherence in terms of the number of participants who attended their first treatment session. However, these results were based on a single cluster‐RCT, which may have overestimated the effectiveness of this intervention.  </p> </section> <section id="CD013667-sec-0235"> <h4 class="title">Compliance enhancement approaches</h4> <p>On the basis of data from a single trial, the evidence is uncertain as to whether compliance enhancement (consisting of standard discharged planning together with a series of four telephone calls at 1, 2, 4 and 8 weeks' post‐discharge) has any effect on repetition of SH when compared with TAU (<a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>). However, this trial was likely underpowered to evaluate these outcomes.  </p> </section> <section id="CD013667-sec-0236"> <h4 class="title">Family interventions</h4> <p>On the basis of data from three trials, there is probably little or no effect for either a home‐based (<a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>) or clinic‐based (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>) family intervention as compared with standard treatment on repetition of self‐harm either at post‐intervention or by the 18‐month follow‐up assessment.  </p> </section> <section id="CD013667-sec-0237"> <h4 class="title">Remote contact interventions</h4> <p>On the basis of data from a single trial, there is probably little or no effect of an emergency card allowing patients to re‐admit themselves to hospital compared with TAU on repetition of SH (<a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a>). However, the trial was underpowered to evaluate this outcome. Few adolescents made use of the emergency card (10.6%); however, none of those who used the card engaged in repeated SH. </p> </section> </section> <section id="CD013667-sec-0238"> <h3 class="title" id="CD013667-sec-0238">Overall completeness and applicability of evidence</h3> <section id="CD013667-sec-0239"> <h4 class="title">Completeness of evidence</h4> <p>There have been relatively few trials of interventions for SH in children and adolescents, especially compared with the number of trials of psychosocial interventions for adults (<a href="./references#CD013667-bbs2-0146" title="HawtonK , WittKG , Taylor SalisburyTL , ArensmanE , GunnellD , HazellP , et al. Psychosocial interventions for self-harm in adults. Cochrane Database of Systematic Reviews2016, Issue 5. Art. No: CD012189. [DOI: 10.1002/14651858.CD012189]">Hawton 2016</a>). Therefore, our conclusions are limited to a small range of interventions. Additionally, as there were no eligible trials of pharmacological interventions, perhaps due to concerns about safety in this clinical population, our findings are limited to psychosocial interventions. </p> <p>Where it was unclear that the trials satisfied our inclusion criteria, we contacted corresponding trial authors for clarification. We also contacted corresponding authors where data were either not clearly reported, or where we required data reported in a different format to allow for their inclusion in a meta‐analysis. However, despite engaging in over 80 emails with corresponding authors we were not always able to obtain all relevant data. This was due to a combination of non‐response to our enquiries and to authors being unable to access relevant data, either due to moving on to later positions or as a result of working from home due to COVID‐19 pandemic quarantine orders. This is a common problem in meta‐analyses (<a href="./references#CD013667-bbs2-0228" title="SelphSS , GinsburgAD , ChouR . Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis. Systematic Reviews2014;3:107.">Selph 2014</a>). </p> <p>Unfortunately, presence of publication bias could not be formally evaluated as no meta‐analysis in the present review included 10 or more trials. Therefore, we could not rule out the possibility that publication bias may have affected the studies within this review. This is a problem that commonly affects clinical data (<a href="./references#CD013667-bbs2-0101" title="EasterbrookPJ , GopalanR , BerlinJA , MatthewsDR . Publication bias in clinical research. Lancet1991;337:867-72.">Easterbrook 1991</a>). </p> <p>Whilst all of the included trials reported information on repetition of SH, publication bias may have been more common for the secondary outcomes assessed by this review. However, formal testing of publication bias was not possible due to the small number of trials. </p> </section> <section id="CD013667-sec-0240"> <h4 class="title">Applicability of evidence</h4> <p>The majority of participants in these trials were female, reflecting the typical pattern for SH in hospital‐presenting populations (<a href="./references#CD013667-bbs2-0140" title="HawtonK , HarrissL . The changing gender ratio in occurrence of deliberate self-harm across the lifecycle. Crisis2008;29:4-10.">Hawton 2008</a>). Only two trials stratified randomisation by sex (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a>). Given that there are some differences in the motivations for SH reported by males as compared to females (<a href="./references#CD013667-bbs2-0086" title="ClaesL , WandereyckenW , VertommenH . Self-injury in female versus male psychiatric patients: a comparison of characteristics, psychopathology and aggression regulation. Personality and Individual Differences2007;42:611-21.">Claes 2007</a>), further work is needed on the treatment needs and preferences of males who engage in SH, as well as their experiences of clinical services (<a href="./references#CD013667-bbs2-0136" title="HassettA , IsbisterC . Young men's experiences of accessing and receiving help from Child and Adolescent Mental Health Services following self-harm. SAGE Open2017;1:1-14.">Hassett 2017</a>), and how these may differ from females who engage in SH. </p> <p>The majority of trials included either children and adolescents who had all engaged in intentional drug overdoses or self‐poisoning, or samples where the majority had, again reflecting the typical pattern observed in patients who present to general hospitals following SH (<a href="./references#CD013667-bbs2-0139" title="HawtonK , BergenH , CaseyD , SimkinS , PalmerB , CooperJ , et al. Self-harm in England: a tale of three cities. Multicentre study of self-harm. Social Psychiatry and Psychiatric Epidemiology2007;42:513-21.">Hawton 2007</a>). However, there are other important patient subgroups, such as those who engage in self‐cutting, who may have different treatment needs (<a href="./references#CD013667-bbs2-0138" title="HawtonK , HarrissL , SimkinS , BaleE , BondA . Self-cutting: patient characteristics compared with self-poisoners. Suicide and Life-Threatening Behavior2004;34:199-208.">Hawton 2004</a>). None of the trials included in this review specifically focused on these patients, although it should be noted that method switching is common in those who engage in repeat episodes of SH (<a href="./references#CD013667-bbs2-0257" title="WittK , DalyC , ArensmanE , PirkisJ , LubmanD . Patterns of self-harm methods over time and the association with methods used at repeat episodes of non-fatal self-harm and suicide: a systematic review. Journal of Affective Disorders2019;245:250-64.">Witt 2019b</a>). Nine trials focused on those with a history of repeated SH, which is a particular issue in this clinical population given its association with subsequent SH repetition (<a href="./references#CD013667-bbs2-0142" title="HawtonK , BergenH , KapurN , CooperJ , SteegS , NessJ , et al. Repetition of self-harm and suicide following self-harm in children and adolescents: findings from the Multicentre Study of Self-Harm in England. Journal of Child Psychology and Psychiatry2012;53:1212-9.">Hawton 2012a</a>) and suicide (<a href="./references#CD013667-bbs2-0147" title="HawtonK , BaleL , BrandF , TownsendE , NessJ , WatersK , et al. Mortality in children and adolescents following presentation to hospital after non-fatal self-harm in the Multicentre Study of Self-harm: a prospective observational cohort study. Lancet Child &amp; Adolescent Health2020;4(2):111-20. [DOI: 10.1016/S2352-4642(19)30373-6]">Hawton 2020a</a>). However, no trial investigated impacts of psychosocial interventions for those with an initial episode of SH versus those engaging in repeated SH. We were therefore unable to undertake subgroup analyses to investigate the impact of these interventions by repeater status. </p> <p>This review focused exclusively on those who engaged in SH. As a result, we have excluded trials in which participants were diagnosed with conditions such as borderline personality disorder but where SH was not required for trial entry. We also excluded trials in which participants engaged in repetitive self‐injurious behaviour in the context of an intellectual disability or developmental disorder (e.g. an autism spectrum disorder). Readers interested in the use of psychosocial interventions for these patient groups are instead referred to the relevant reviews (<a href="./references#CD013667-bbs2-0082" title="ChezanLC , GableRA , McWhorterGZ , WhiteSD . Current perspectives on interventions for self-injurious behavior of children with autism spectrum disorder: a systematic review of the literature. Journal of Behavioral Education2017;26:293-329.">Chezan 2017</a>; <a href="./references#CD013667-bbs2-0262" title="WongJ , BahjiA , Khalid-KhanS . Psychotherapies for adolescents with subclinical and borderline personality disorder: a systematic review and meta-analysis. Canadian Journal of Psychiatry2020;65:5-15.">Wong 2020</a>). </p> </section> </section> <section id="CD013667-sec-0241"> <h3 class="title" id="CD013667-sec-0241">Quality of the evidence</h3> <p>Certainty of evidence, as assessed using the GRADE approach, was generally moderate to very low suggesting that further research is likely to have an important impact on our confidence in the estimates of treatment effectiveness, and may in fact change the estimates. This is particularly likely to affect results for those interventions that so far have only been assessed in single trials. </p> <p>Additionally, using the Cochrane 'Risk of bias' tool, version 2 (<a href="./references#CD013667-bbs2-0236" title="SterneJAC , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019;366:I4898.">Sterne 2019</a>), for almost all trials included in this review, there were some concerns of a high risk of bias in relation to at least one aspect of trial design, with weaknesses most commonly observed with respect to selection of the reported result and measurement of the outcome. </p> <p>For most trials (70.6%), insufficient information was reported to determine whether data were analysed in accordance with a prespecified analysis plan. In 2015, the International Committee of Medical Journal Editors (ICMJE) recommended all clinical trials should be preregistered in a public trials registry (<a href="./references#CD013667-bbs2-0259" title="WittK , TownsendE , ArensmanE , GunnellD , HazellP , Taylor SalisburyT , et al. Psychosocial interventions for people who self-harm: methodological issues involved in trials to evaluate effectiveness. Archives of Suicide Research2020;24(sup2):S32-93. [DOI: 10.1080/13811118.2019.1592043]">Witt 2020b</a>). Whilst the majority (83.3%) of the six trials published subsequent to this recommendation were registered, in some cases insufficient detail was provided within the clinical trial register to determine how key outcome(s) were defined. This made it difficult to determine whether there had been any substantive changes to the proposed analysis plan and, if so, the reasons for any such departures. Future trials should provide sufficient detail within the clinical trial register to determine how key outcome(s) are defined and measured to aid in the determination as to whether there has been any substantive changes to the proposed analysis plan and, if so, the reasons for any such departures. </p> <p>For around half of the trials (52.9%) included in this review, there were some concerns relating to bias in the measurement of repetition of SH. This was typically because repetition of SH was based on self‐reported information. Given that up to one‐fifth of SH episodes recorded in medical and clinical records are not reported by participants, prevalence estimates derived from self‐report alone may underestimate the true rate of SH (<a href="./references#CD013667-bbs2-0185" title="MarsB , CornishR , HeronJ , BoydA , CraneC , HawtonK , et al. Using data linkage to investigate inconsistent reporting of self-harm and questionnaire non-response. Archives of Suicide Research2016;20:113-41.">Mars 2016</a>). By supplementing data on self‐reported SH with information from clinical or medical records, future trials could compare results based on self‐reported information with those obtained from objective sources to investigate what impact, if any this bias may have had on the estimate of treatment effectiveness. </p> <p>Additionally, participants and clinical personnel were, typically, not blind to allocation owing to likely differences in treatment intensity between the intervention and control arms (<a href="./references#CD013667-bbs2-0259" title="WittK , TownsendE , ArensmanE , GunnellD , HazellP , Taylor SalisburyT , et al. Psychosocial interventions for people who self-harm: methodological issues involved in trials to evaluate effectiveness. Archives of Suicide Research2020;24(sup2):S32-93. [DOI: 10.1080/13811118.2019.1592043]">Witt 2020b</a>). Indeed, due to safety considerations, unbinding may be unavoidable in these types of trials. However, given that repetition of SH was based on self‐reported information in a number of the included trials (<a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a>; <a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a>; <a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a>; <a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a>; <a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a>; <a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a>; <a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>; <a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a>; <a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a>), this introduces potential bias.  </p> <p>Lastly, the trials included in this review were, in general, relatively small to detect differences in proportions of patients who engage in a repeat episode of SH, although it is acknowledged that some of the trials were feasibility studies (e.g. <a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a>; <a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a>; <a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a>). Whilst sample sizes have increased over time, most trials in this field are still underpowered. We have previously calculated that trials in this field may need to recruit a minimum of 1862 participants per arm to detect an effect for repetition of SH with 80% power at the conventional alpha level (<a href="./references#CD013667-bbs2-0259" title="WittK , TownsendE , ArensmanE , GunnellD , HazellP , Taylor SalisburyT , et al. Psychosocial interventions for people who self-harm: methodological issues involved in trials to evaluate effectiveness. Archives of Suicide Research2020;24(sup2):S32-93. [DOI: 10.1080/13811118.2019.1592043]">Witt 2020b</a>). Future trials should therefore supply a priori power calculations to justify their sample size. </p> </section> <section id="CD013667-sec-0242"> <h3 class="title" id="CD013667-sec-0242">Potential biases in the review process</h3> <p>We are confident we have identified all relevant trials of psychosocial interventions for SH in children and adolescents. However, we cannot rule out the possibility that some relevant outcome data may be missing from this review. Although data on repetition of SH were available for all of the included trials, limited data were available on secondary outcomes. Nevertheless, by using the random‐effects model in all analyses, our results possess greater generalisability than if we had used the fixed‐effect model (<a href="./references#CD013667-bbs2-0108" title="ErezA , BloomMC , WellsMT . Using random rather than fixed effects models in meta-analysis: implications for situation specificity and validity generalization. Personnel Psychology1996;49:275-306.">Erez 1996</a>). </p> </section> <section id="CD013667-sec-0243"> <h3 class="title" id="CD013667-sec-0243">Agreements and disagreements with other studies or reviews</h3> <p>This review is an update of the 2015 Cochrane Review on interventions for SH in children and adolescents (<a href="./references#CD013667-bbs2-0269" title="HawtonK , WittKG , Taylor SalisburyTL , ArensmanE , GunnellD , TownsendE , et al. Interventions for self-harm in children and adolescents. Cochrane Database of Systematic Reviews2015, Issue 12. Art. No: CD012013. [DOI: 10.1002/14651858.CD012013]">Hawton 2015</a>). The previous review included 11 trials of eight different approaches, finding that whilst there had been relatively few trials on interventions for children and adolescents who have engaged in SH, certain approaches warranted further evaluation. The results in this update largely concur with the previous iteration. There appear to be limited positive findings regarding DBT‐A on repetition of SH by the end of the treatment phase. Results of this review would also suggest that a comprehensive therapeutic assessment may increase engagement with subsequent treatment. </p> <p>We identified 18 further reviews that included a focus on interventions for SH in children and adolescents that have been completed since the previous version of this review was published. Four were systematic reviews (<a href="./references#CD013667-bbs2-0080" title="CalearAL , ChristensenH , FreemanA , FentonK , Busby GrantJ , Van SpijkerB , et al. A systematic review of psychosocial suicide prevention interventions for youth. European Child and Adolescent Psychiatry2016;25:467-82.">Calear 2016</a>; <a href="./references#CD013667-bbs2-0094" title="DavasaambuuS , ItzhakyL , EllisSP , CisnerosS , ScolaroK , LemberanskyJ , et al. Systematic review and meta-analysis of randomized clinical trials of nonpharmacologic interventions to reduce suicide risk among adolescents. Neuropsychopharmacology2019;44:S103-4.">Davasaambuu 2019</a>; <a href="./references#CD013667-bbs2-0097" title="DevenishB , BerkL , LewisAJ . The treatment of suicidality in adolescents by psychosocial interventions for depression: a systematic literature review. Australian and New Zealand Journal of Psychiatry2016;50:726-40.">Devenish 2016</a>; <a href="./references#CD013667-bbs2-0159" title="IyengarU , SnowdenN , AsarnowJR , MoranP , TranahT , OugrinD . A further look at therapeutic interventions for suicide attempts and self-harm in adolescents: an updated systematic review of randomized controlled trials. Frontiers in Psychiatry2018;9:583.">Iyengar 2018</a>), four included meta‐analyses (<a href="./references#CD013667-bbs2-0172" title="KothgassnerOD , RobinsonK , GoreisA , OugrinD , PlenerPL . Does treatment method matter? A meta-analysis of the past 20 years of research on therapeutic interventions for self-harm and suicidal ideation in adolescents. Borderline Personality Disorder and Emotion Dysregulation2020;7:9.">Kothgassner 2020</a>; <a href="./references#CD013667-bbs2-0173" title="LabelleR , PouliotL , JanelleA . A systematic review and meta-analysis of cognitive behavioural treatments for suicidal and self-harm behaviours in adolescents. Canadian Psychology2015;56:368-78.">Labelle 2015</a>; <a href="./references#CD013667-bbs2-0221" title="RobinsonJ , BaileyE , WittK , StefanacN , MilnerA , CurrierD , et al. What works in youth suicide prevention? A systematic review and meta-analysis. eClinical Medicine2018;4:P52-91.">Robinson 2018</a>; <a href="./references#CD013667-bbs2-0264" title="YuanSNV , KwokKHR , OugrinD . Treatment engagement in specific psychological treatment vs. treatment as usual for adolescents with self-harm: systematic review and meta-analysis. Frontiers in Psychology2019;10:104.">Yuan 2019</a>), and the remainder were narrative reviews (<a href="./references#CD013667-bbs2-0062" title="AsarnowJR , MehlumL . Practitioner review: treatment for suicidal and self-harming adolescents - advances in suicide prevention care. Journal of Child Psychology and Psychiatry2019;60:1046-54.">Asarnow 2019</a>; <a href="./references#CD013667-bbs2-0067" title="BerkMS , HughesJ . Cognitive behavioral approaches for treating suicidal behavior in adolescents. Current Psychiatry Reviews2016;12:4-13.">Berk 2016</a>; <a href="./references#CD013667-bbs2-0075" title="BrentDA . Master clinician review: saving Holden Caulfield: suicide prevention in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2019;58:25-35.">Brent 2019</a>; <a href="./references#CD013667-bbs2-0077" title="BusbyDR , HatkevichC , McGuireTC , KingCA . Evidence-based interventions for youth suicide risk. Current Psychiatry Reports2020;22:5.">Busby 2020</a>; <a href="./references#CD013667-bbs2-0089" title="CoxG , HetrickS . Psychosocial interventions for self-harm, suicidal ideation and suicide attempt in children and young people: What? How? Who? and Where?Evidence Based Mental Health2017;20:35-40.">Cox 2017</a>; <a href="./references#CD013667-bbs2-0113" title="FlahertyHB . Treating adolescent nonsuicidal self-injury: a review of psychosocial interventions to guide clinical practice. Child and Adolescent Social Work Journal2018;35:85-95.">Flaherty 2018</a>; <a href="./references#CD013667-bbs2-0124" title="GlennCR , EspositoEC , PorterAC , RobinsonDJ . Evidence base update of psychosocial treatments for self-injurious thoughts and behaviors in youth. Journal of Clinical Child and Adolescent Psychology2019;48:357-92.">Glenn 2019</a>; <a href="./references#CD013667-bbs2-0161" title="JoeS , ScottML , BanksA . What works for adolescent black males at risk of suicide: a review. Research on Social Work Practice2018;28:340-5.">Joe 2018</a>; <a href="./references#CD013667-bbs2-0201" title="MorkenIS , DahlgrenA , LundeI , TovenS . The effects of interventions preventing self-harm and suicide in children and adolescents: an overview of systematic reviews. F1000Research2020;8:890.">Morken 2020</a>). </p> <p>However, whilst these reviews generally indicated that delivering some form of psychotherapy is likely to be more effective than nothing (e.g. <a href="./references#CD013667-bbs2-0159" title="IyengarU , SnowdenN , AsarnowJR , MoranP , TranahT , OugrinD . A further look at therapeutic interventions for suicide attempts and self-harm in adolescents: an updated systematic review of randomized controlled trials. Frontiers in Psychiatry2018;9:583.">Iyengar 2018</a>; <a href="./references#CD013667-bbs2-0172" title="KothgassnerOD , RobinsonK , GoreisA , OugrinD , PlenerPL . Does treatment method matter? A meta-analysis of the past 20 years of research on therapeutic interventions for self-harm and suicidal ideation in adolescents. Borderline Personality Disorder and Emotion Dysregulation2020;7:9.">Kothgassner 2020</a>; <a href="./references#CD013667-bbs2-0221" title="RobinsonJ , BaileyE , WittK , StefanacN , MilnerA , CurrierD , et al. What works in youth suicide prevention? A systematic review and meta-analysis. eClinical Medicine2018;4:P52-91.">Robinson 2018</a>; <a href="./references#CD013667-bbs2-0264" title="YuanSNV , KwokKHR , OugrinD . Treatment engagement in specific psychological treatment vs. treatment as usual for adolescents with self-harm: systematic review and meta-analysis. Frontiers in Psychology2019;10:104.">Yuan 2019</a>), consistent with results found in adults (<a href="./references#CD013667-bbs2-0152" title="HetrickSE , RobinsonJ , SpittalMJ , CarterG . Effective psychological and psychosocial approaches to reduce repetition of self-harm: a systematic review, meta-analysis and meta-regression. BMJ Open2016;6:e011024.">Hetrick 2016</a>), these reviews have tended to statistically pool results from very different interventions together and so the results are largely meaningless for clinical practice as they provide little insight into which approach may be most beneficial for particular clinically relevant subgroups of patients. </p> <p>Future reviews should investigate which component(s) of these typically multi‐component intervention approaches are most effective. Individual participant data meta‐analyses would also assist with the identification of clinically relevant subgroups of patients who may benefit from certain more intensive forms of intervention. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013667-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study Flow Diagram" data-id="CD013667-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study Flow Diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Results of 'Risk of bias' assessments for each study" data-id="CD013667-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-FIG-02.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Results of 'Risk of bias' assessments for each study</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-FIG-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Individual CBT‐based psychotherapy versus TAU or other comparator, Outcome 1: Repetition of SH by post‐intervention" data-id="CD013667-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Individual CBT‐based psychotherapy versus TAU or other comparator, Outcome 1: Repetition of SH by post‐intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Individual CBT‐based psychotherapy versus TAU or other comparator, Outcome 2: Treatment adherence: Proportion completing treatment" data-id="CD013667-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Individual CBT‐based psychotherapy versus TAU or other comparator, Outcome 2: Treatment adherence: Proportion completing treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Individual CBT‐based psychotherapy versus TAU or other comparator, Outcome 3: Treatment adherence: Number of treatment sessions attended" data-id="CD013667-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Individual CBT‐based psychotherapy versus TAU or other comparator, Outcome 3: Treatment adherence: Number of treatment sessions attended </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Individual CBT‐based psychotherapy versus TAU or other comparator, Outcome 4: Depression scores at post‐intervention" data-id="CD013667-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Individual CBT‐based psychotherapy versus TAU or other comparator, Outcome 4: Depression scores at post‐intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Individual CBT‐based psychotherapy versus TAU or other comparator, Outcome 5: Suicidal ideation scores at post‐intervention" data-id="CD013667-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Individual CBT‐based psychotherapy versus TAU or other comparator, Outcome 5: Suicidal ideation scores at post‐intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: DBT‐A versus TAU or another comparator, Outcome 1: Repetition of SH at post‐intervention" data-id="CD013667-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: DBT‐A versus TAU or another comparator, Outcome 1: Repetition of SH at post‐intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: DBT‐A versus TAU or another comparator, Outcome 2: Frequency of SH repetition at post‐intervention" data-id="CD013667-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: DBT‐A versus TAU or another comparator, Outcome 2: Frequency of SH repetition at post‐intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: DBT‐A versus TAU or another comparator, Outcome 3: Treatment adherence: Number of individual therapy sessions attended" data-id="CD013667-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: DBT‐A versus TAU or another comparator, Outcome 3: Treatment adherence: Number of individual therapy sessions attended </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: DBT‐A versus TAU or another comparator, Outcome 4: Treatment adherence: Number of group therapy sessions attended" data-id="CD013667-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: DBT‐A versus TAU or another comparator, Outcome 4: Treatment adherence: Number of group therapy sessions attended </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: DBT‐A versus TAU or another comparator, Outcome 5: Treatment adherence: Number of family therapy sessions attended" data-id="CD013667-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: DBT‐A versus TAU or another comparator, Outcome 5: Treatment adherence: Number of family therapy sessions attended </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: DBT‐A versus TAU or another comparator, Outcome 6: Treatment adherence: Number of telephone therapy sessions" data-id="CD013667-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: DBT‐A versus TAU or another comparator, Outcome 6: Treatment adherence: Number of telephone therapy sessions </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: DBT‐A versus TAU or another comparator, Outcome 7: Depression scores at post‐intervention" data-id="CD013667-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: DBT‐A versus TAU or another comparator, Outcome 7: Depression scores at post‐intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: DBT‐A versus TAU or another comparator, Outcome 8: Hopelessness scores at post‐intervention" data-id="CD013667-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: DBT‐A versus TAU or another comparator, Outcome 8: Hopelessness scores at post‐intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: DBT‐A versus TAU or another comparator, Outcome 9: General functioning scores at post‐intervention" data-id="CD013667-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: DBT‐A versus TAU or another comparator, Outcome 9: General functioning scores at post‐intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: DBT‐A versus TAU or another comparator, Outcome 10: Suicidal ideation scores at post‐intervention" data-id="CD013667-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: DBT‐A versus TAU or another comparator, Outcome 10: Suicidal ideation scores at post‐intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-002.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: DBT‐A versus TAU or another comparator, Outcome 11: Suicidal ideation scores by 12‐months" data-id="CD013667-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-002.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2: DBT‐A versus TAU or another comparator, Outcome 11: Suicidal ideation scores by 12‐months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-002.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: MBT‐A versus TAU or another comparator, Outcome 1: Repetition of SH by post‐intervention" data-id="CD013667-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: MBT‐A versus TAU or another comparator, Outcome 1: Repetition of SH by post‐intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: MBT‐A versus TAU or another comparator, Outcome 2: Repetition of SH at post‐intervention (Risk‐Taking and Self‐Harm Inventory)" data-id="CD013667-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: MBT‐A versus TAU or another comparator, Outcome 2: Repetition of SH at post‐intervention (Risk‐Taking and Self‐Harm Inventory) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: MBT‐A versus TAU or another comparator, Outcome 3: Depression scores at post‐intervention" data-id="CD013667-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: MBT‐A versus TAU or another comparator, Outcome 3: Depression scores at post‐intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Group‐based psychotherapy, Outcome 1: Repetition of SH by six months" data-id="CD013667-fig-0022" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Group‐based psychotherapy, Outcome 1: Repetition of SH by six months</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Group‐based psychotherapy, Outcome 2: Repetition of SH by 12 months" data-id="CD013667-fig-0023" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Group‐based psychotherapy, Outcome 2: Repetition of SH by 12 months</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Group‐based psychotherapy, Outcome 3: Depression scores at six months" data-id="CD013667-fig-0024" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Group‐based psychotherapy, Outcome 3: Depression scores at six months</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Group‐based psychotherapy, Outcome 4: Depression scores at 12 months" data-id="CD013667-fig-0025" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Group‐based psychotherapy, Outcome 4: Depression scores at 12 months</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Group‐based psychotherapy, Outcome 5: General functioning scores at six months" data-id="CD013667-fig-0026" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: Group‐based psychotherapy, Outcome 5: General functioning scores at six months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-004.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Group‐based psychotherapy, Outcome 6: General functioning scores at 12 months" data-id="CD013667-fig-0027" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-004.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4: Group‐based psychotherapy, Outcome 6: General functioning scores at 12 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-004.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Group‐based psychotherapy, Outcome 7: Suicidal ideation scores at six months" data-id="CD013667-fig-0028" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-004.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4: Group‐based psychotherapy, Outcome 7: Suicidal ideation scores at six months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-004.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Group‐based psychotherapy, Outcome 8: Suicidal ideation scores at 12 months" data-id="CD013667-fig-0029" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-004.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4: Group‐based psychotherapy, Outcome 8: Suicidal ideation scores at 12 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-004.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Family therapy, Outcome 1: Repetition of SH at post‐intervention" data-id="CD013667-fig-0030" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Family therapy, Outcome 1: Repetition of SH at post‐intervention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013667-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/urn:x-wiley:14651858:media:CD013667:CD013667-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Family therapy, Outcome 2: Treatment adherence by six months" data-id="CD013667-fig-0031" src="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_t/tCD013667-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Family therapy, Outcome 2: Treatment adherence by six months</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/media/CDSR/CD013667/image_n/nCD013667-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013667-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Comparison 1: Individual CBT‐based psychotherapy compared to TAU or other comparator for self‐harm in children and adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Comparison 1: Individual CBT‐based psychotherapy compared to TAU or other comparator for self‐harm in children and adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> self‐harm in children and adolescents  (up to 18 years or age)<br/><b>Intervention:</b> Individual CBT‐based psychotherapy<br/><b>Comparison:</b> TAU or other comparator </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with TAU or other comparator</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Comparison 1: Individual CBT‐based psychotherapy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Repetition of SH by post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.93<br/>(0.12 to 7.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>51<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Our confidence in the effect estimate of individual CBT‐based psychotherapy on repetition of SH at post‐intervention is limited. The true effect may be substantially different from the estimate of the effect. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>160 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>150 per 1,000<br/>(22 to 580) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded this domain by one level as we rated any of the sources of risk of bias (as described in <a href="#CD013667-sec-0064">Assessment of risk of bias in included studies</a>) at high risk for one of the studies included in the pooled estimate. </p> <p><sup>2</sup> We downgraded this domain by one level where the 95% CI for the pooled effect included the null value. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Comparison 1: Individual CBT‐based psychotherapy compared to TAU or other comparator for self‐harm in children and adolescents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013667-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Comparison 2: DBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Comparison 2: DBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> self‐harm in children and adolescents  (up to 18 years or age)<br/><b>Intervention:</b> DBT‐A<br/><b>Comparison:</b> TAU or another comparator </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with TAU or another comparator</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Comparison 2: DBT‐A</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Repetition of SH at post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.46<br/>(0.26 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>270<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are very confident that the true effect lies close to that of the estimate of the effect estimate of DBT‐A on repetition of SH at post‐intervention. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>432 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>259 per 1,000<br/>(165 to 384) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Comparison 2: DBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013667-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Comparison 3: MBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Comparison 3: MBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> self‐harm in children and adolescents  (up to 18 years or age)<br/><b>Intervention:</b> MBT‐A<br/><b>Comparison:</b> TAU or another comparator </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with TAU or another comparator</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Comparison 3: MBT‐A</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Repetition of SH at post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.70<br/>(0.06 to 8.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>85<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The evidence is very uncertain about the effect of MBT‐A on repetition of self‐harm by post‐intervention. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>805 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>743 per 1,000<br/>(198 to 972) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded this domain by one level as we rated any of the sources of risk of bias (as described in <a href="#CD013667-sec-0064">Assessment of risk of bias in included studies</a>) at high risk for one of the studies included in the pooled estimate. </p> <p><sup>2</sup> We downgraded this domain by one level as one of the studies included in the pooled estimate used a proxy measure (i.e. cut‐scores on the Risk Taking and Self‐Harm Inventory) to ascertain repetition of SH. It is unclear how scores on this measure may relate to actual SH behaviour. </p> <p><sup>3</sup> We downgraded this domain by one level where the 95% CI for the pooled effect included the null value. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Comparison 3: MBT‐A compared to TAU or another comparator for self‐harm in children and adolescents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013667-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Comparison 7: Family therapy compared to placebo for self‐harm in children and adolescents</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Comparison 7: Family therapy compared to placebo for self‐harm in children and adolescents</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> self‐harm in children and adolescents  (up to 18 years or age)<br/><b>Intervention:</b> Family therapy<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Comparison 7: Family therapy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Repetition of SH at post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 1.00<br/>(0.49 to 2.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>191<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are moderately confident in the effect estimate of family therapy on repetition of SH at post‐intervention. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>216 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>216 per 1,000<br/>(119 to 364) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded this domain by one level where the 95% CI for the pooled effect included the null value. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Comparison 7: Family therapy compared to placebo for self‐harm in children and adolescents</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013667-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Methods used at the index episode of self‐harm</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>Reference</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>Method</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Self‐poisoning</b> </p> <p><b>n (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Self‐injury</b> </p> <p><b>n (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Combined self‐poisoning<br/>and self‐injury</b> </p> <p><b>n (%)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0001" title="AsarnowJR , BerkM , HughesJL , AndersonNL . The SAFETY Program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent suicide attempters. Journal of Clinical Child and Adolescent Psychology2015;44:194-203. AsarnowJR , HughesJL , BabevaKN , SugarCA . Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial. Journal of the American Academy Child and Adolescent Psychiatry2017;56:506-14. ">Asarnow 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0002" title="CooneyE , DavisK , ThompsonP , Wharewera-MikaJ , StewartJ . Feasibility of Evaluating DBT for Self-Harming Adolescents: A Small Randomised Controlled Trial. Auckland, New Zealand: Te Pou o Te Whakaaro Nui and The National Centre of Mental Health Research, Information and Workforce Development, 2010. ">Cooney 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0003" title="CotgroveA , ZirniskyL , BlackD , WestonD . Secondary prevention of attempted suicide in adolescence. Journal of Adolescence1995;18:569-77. ">Cotgrove 1995</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101 (96.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0004" title="CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention – Family Therapy (SHIFT) trial. Health Technology Assessment2018;22:1-222. [DOI: 10.3310/hta22120]CottrellDJ , Wright-HughesA , CollinsonM , BostonP , EislerI , FortuneS , et al. Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial. Lancet Psychiatry2018;5:203-16. CottrellDJ , Wright-HughesA , EislerI , FortuneS , GreenJ , HouseAO , et al. Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow-up of pragmatic randomised controlled trial. eClinical Medicine2020;18:100246. HollidayR , BrennanC , CottrellD . Understanding adolescents' experiences of self-harm: secondary analysis of family therapy sessions from the SHIFT trial. Archives of Suicide Research2020;24:190-203. TubeufS , Saloniki E-C, CottrellD . Parental health spillover in cost-effectiveness analysis: evidence from self-harming adolescents in England. PharmacoEconomics2019;37:513–30. Wright-HughesA , GrahamE , CottrellD , FarrinA . Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of family therapy vs. treatment as usual in adolescents following self-harm. Clinical Trials2018;15:197-206. Wright-HughesA , GrahamE , FarrinA , CollinsonM , BostonP , EislerI , et al. Self-Harm Intervention: Family Therapy (SHIFT), a study protocol for a randomised controlled trial of family therapy versus treatment as usual for young people seen after a second or subsequent episode of self-harm. Trials2015;16:501. ">Cottrell 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>184 (22.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>594 (71.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54 (6.5)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0005" title="DonaldsonD , SpiritoA , Esposito-SmythersC . Treatment for adolescents following a suicide attempt: results of a pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry2005;44:113-20. DonaldsonD , SpiritoA , OverholserJ . Treatment of adolescent suicide attempters. In: SpiritoA , OverholserJC , editors(s). Evaluating and Treating Adolescent Suicide Attempters: From Research to Practice. San Diego, CA: Academic Press, 2003:295-321. ">Donaldson 2005</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33 (84.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0006" title="AyodejiE , GreenJ , RobertsC , TrainorG , RothwellJ , WoodhamE , et al. The influence of personality disorder on outcome in adolescent self-harm. British Journal of Psychiatry2015;207:313-9. GreenJM , WoodAJ , KerfootMJ , TrainorG , RobertsC , RothwellJ , et al. Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. British Medical Journal2011;342:d682. ">Green 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 (2.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67 (36.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111 (60.7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0007" title="GriffithsH , DuffyF , DuffyL , BrownS , HockadayH , EliassonE , et al. Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry2019;19:167. ">Griffiths 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0008" title="AglanA , KerfootM , PicklesA . Pathways from adolescent deliberate self-poisoning to early adult outcomes: a six-year follow-up. Journal of Child Psychology and Psychiatry2008;49:508-15. ByfordS , HarringtonR , TorgersonD , KerfootM , DyerE , HarringtonV , et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves: results of a randomised controlled trial. British Journal of Psychiatry1999;174:56-62. ChitsabesanP , HarringtonR , HarringtonV , TomensonB . Predicting repeat self-harm in children: how accurate can we expect to be?European Child and Adolescent Psychiatry2003;12:23-9. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Deliberate self-poisoning in adolescence: why does a brief family intervention work in some cases and not others?Journal of Adolescence2000;23:13-20. HarringtonR , KerfootM , DyerE , McNivenF , GillJ , HarringtonV , et al. Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry1998;37:512-8. HarringtonR , PicklesA , AglanA , HarringtonV , BurroughsH , KerfootM . Early adult outcomes of adolescents who deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry2006;45:337-45. ">Harrington 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>162 (100.0)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0009" title="HazellPL , MartinG , McGillK , KayT , WoodA , TrainorG , et al. Group therapy for repeated deliberate self-harming adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2009;48:662-70. ">Hazell 2009</a><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0010" title="AdrianM , McCauleyE , BerkMS , AsarnowJR , KorslundK , AvinaC , et al. Predictors and moderators of recurring self-harm in adolescents participating in a comparative treatment trial of psychological interventions. Journal of Child Psychology and Psychiatry2019;60:1123-32. McCauleyE , AdrianM , CurtisA . 5.5. Youth suicide: how gender, sexual orientation, and gender-nonconforming status shape risk and inform intervention strategies. Journal of the American Academy of Child and Adolescent Psychiatry2018;57:S128. McCauleyE , BerkMS , AsarnowJR , AdrianM , CohenJ , KorslundK , et al. Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry2018;75:777-85. ">McCauley 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0011" title="HagaE , AasE , GrøholtB , TørmoenAJ , MehlumL . Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm. Child and Adolescent Psychiatry and Mental Health2018;12:22. MehlumL , RambergM , TørmoenAJ , HagaE , DiepLM , StanleyBH . Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry2016;55:295-300. MehlumL , TømoenAJ , RambergM , HagaE , DiepLM , LabergS , et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior - a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry2014;53:1082-91. Ramleth R-K, GroholtB , DiepLM , WalbyFA , MehlumL . The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personality Disorder and Emotion Dysregulation2017;4:22. ">Mehlum 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0012" title="OugrinD , BoegeI , StahlD , BanarseeR , TaylorE . Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up. Archives of Diseases in Childhood2013;98:772-6. OugrinD , ZundelT , KyriakopoulosM , BanarseeR , StahlD , TaylorE . Adolescents with suicidal and nonsuicidal self harm: clinical characteristics and response to therapeutic assessment. Psychological Assessment2012;24:11-20. OugrinD , ZundelT , NgA , BanarseeR , BottleA , TaylorE . Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self harm. Archives of Disease in Childhood2011;96:148-53. ">Ougrin 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28 (40.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37 (52.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 (7.2)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0013" title="RossouwT . Self-harm in young people: is MBT the answer? In: MidgleyN , VrouvaI , editors(s). Minding the Child: Mentalization-Based Interventions with Children, Young People and their Families. New York, NY: Routledge, 2012:131-44. RossouwT . W1-02-02. Mentalisation based treatment for adolescents with self harm: an RCT. European Child and Adolescent Psychiatry2015;24:S113. RossouwTI , FonagyP . Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2012;51:304-13. ">Rossouw 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0014" title="SantamarinaP , Mendez-BlancoI , PicadoM , FontE , MorenoE , MartínezE , et al. 3.65. Dialectical behavior therapy versus supportive therapy for adolescents with suicidal behavior: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry2017;56:S226. Santamarina-PérezP , CelaR , Méndez-BlancoI , Font-MartínezE , Picado-RossiM , Martínez-MallénE , et al. P.2.f.013. Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. European Neuropsychopharmacology2017;27:S853. Santamarina-PérezP , MendezI , SinghMK , BerkM , PicadoM , FontE , et al. Adapted dialectical behavior therapy for adolescents with a high risk of suicide in a community clinic: a pragmatic randomized controlled trial. Suicide and Life Threatening Behavior2020;50:652-67. ">Santamarina‐Pérez 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0015" title="SinyorM , WilliamsM , MitchellR , ZaheerR , BryanCJ , SchafferA , et al. Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. Journal of Affective Disorders2020;266:686-94. WilliamsM , TienH , SchafferA , EllisJ , CheungA , GoldsteinB , et al. T68. Hope and borderline-personality disorder as predictors of study drop-out among inpatient youth receiving psychotherapy treatment for an episode of deliberate self-harm. Biological Psychiatry2018;83:S155. ">Sinyor 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0016" title="SpiritoA , BoergersJ , DonaldsonD , BishopD , LewanderW . An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. Journal of Child and Adolescent Psychiatry2002;41:435-42. SpiritoA , StantonC , DonaldsonD , BoergersJ . Treatment-as-usual for adolescent suicide attempters: implications for the choice of comparison groups in psychotherapy research. Journal of Clinical Child and Adolescent Psychology2002;31:41-7. ">Spirito 2002</a><sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54 (85.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013667-bbs2-0017" title="WoodA , TrainorG , RothwellJ , MooreA , HarringtonR . Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry2001;40:1246-53. WoodA , TrainorG . Developmental Group Psychotherapy for Adolescents: A Manual for Mental Health Professionals. Manchester, UK: University of Manchester, 2001. ">Wood 2001a</a><sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><b>n:</b> number; <b>%:</b> percentage. </p> <p><sup>1</sup>The method used by the remaining two (1.9%) participants was not reported. </p> <p><sub> 2</sub> The method used by the remaining six (15.4%) participants was not reported. </p> <p><sup>3</sup>Over half (n = 92; 56.8%) used paracetamol/acetaminophen. </p> <p><sup>4</sup>Participants engaged in multiple forms of SH: cutting (97%); head banging (71%); intentional drug overdose (57%); smothering (36%); strangling (25%); other self‐poisoning (19%); attempted drowning (19%); jumping from a height (17%); and other self‐harm (35%). </p> <p><sup>5</sup>The method used by the remaining nine (14.3%) participants was not reported. </p> <p><sup>6</sup>Data on the proportion with a lifetime history of self‐poisoning or self‐injury were reported; however, data on the proportion using these methods at the index episode were not clearly reported. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Methods used at the index episode of self‐harm</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/full#CD013667-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013667-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Individual CBT‐based psychotherapy versus TAU or other comparator</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Repetition of SH by post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.12, 7.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Treatment adherence: Proportion completing treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.20, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Treatment adherence: Number of treatment sessions attended <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.23 [‐2.07, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Depression scores at post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.39 [‐0.95, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Suicidal ideation scores at post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.69, 0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Individual CBT‐based psychotherapy versus TAU or other comparator</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013667-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">DBT‐A versus TAU or another comparator</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Repetition of SH at post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.26, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Comparator: TAU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.55 [0.20, 31.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Comparator: Enhanced usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.10, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 Comparator: Alternative psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.25, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Frequency of SH repetition at post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.71 [‐1.55, 0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Comparator: TAU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.92, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Comparator: Enhanced usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.02 [‐1.84, ‐0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.3 Comparator: alternative psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.99 [‐8.40, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Treatment adherence: Number of individual therapy sessions attended <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.95 [‐0.18, 12.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Comparator: TAU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.10 [12.16, 20.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Comparator: Enhanced usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.82 [‐0.63, 4.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.3 Comparator: Alternative psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>126</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.70 [1.71, 7.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Treatment adherence: Number of group therapy sessions attended <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.39 [‐0.20, 10.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Comparator: Enhanced usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.12 [‐3.09, 15.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Comparator: Alternative psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.80 [1.73, 5.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Treatment adherence: Number of family therapy sessions attended <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [‐3.85, 6.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Comparator: TAU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.90 [2.57, 7.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.2 Comparator: Enhanced usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.02 [‐5.43, 3.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Treatment adherence: Number of telephone therapy sessions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐1.23, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Comparator: Enhanced usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐1.23, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Depression scores at post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐0.81, ‐0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 Comparator: EUC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐0.81, ‐0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Hopelessness scores at post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.62 [‐1.07, ‐0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.1 Comparator: TAU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐1.07, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.2 Comparator: Enhanced usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐1.22, ‐0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 General functioning scores at post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.19 [‐5.31, 15.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.2 Comparator: Enhanced usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.19 [‐5.31, 15.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Suicidal ideation scores at post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.43 [‐0.68, ‐0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.1 Comparator: TAU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐1.07, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.2 Comparator: Enhanced usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.66 [‐1.05, ‐0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.3 Comparator: Alternative psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐0.62, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.11 Suicidal ideation scores by 12‐months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.78 [‐6.91, 5.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.1 Comparator: Enhanced usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.60 [‐10.91, 7.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.2 Comparator: Alternative psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐8.29, 7.99]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">DBT‐A versus TAU or another comparator</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013667-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">MBT‐A versus TAU or another comparator</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Repetition of SH by post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.06, 8.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Repetition of SH at post‐intervention (Risk‐Taking and Self‐Harm Inventory) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.10, 2.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Depression scores at post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.72 [‐2.86, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">MBT‐A versus TAU or another comparator</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013667-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Group‐based psychotherapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Repetition of SH by six months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [0.56, 5.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Repetition of SH by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.22, 2.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Depression scores at six months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [‐2.76, 3.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Depression scores at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>473</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.94 [‐4.04, 2.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 General functioning scores at six months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>402</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.25, 0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.6 General functioning scores at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>396</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.30, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.7 Suicidal ideation scores at six months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [‐7.75, 10.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.8 Suicidal ideation scores at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>471</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.51 [‐9.62, 6.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Group‐based psychotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013667-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Family therapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Repetition of SH at post‐intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.49, 2.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 Comparator: TAU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.41, 2.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.2 Comparator: Enhanced usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.29, 3.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Treatment adherence by six months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.99 [1.55, 2.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Family therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#CD013667-tbl-0010">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-1"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.1 Repetition of SH by post‐intervention</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Donaldson 2005</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"[Participants were r]andomized to one of two treatment conditions" (p.114). Correspondence with study authors confirmed that a random numbers table was used to generate the allocation sequence. However, no specific information on allocation concealment was reported. Additionally, "...analyses yielded no differences between...groups in age...gender...race...or socioeconomic status... The two groups were comparable on rates of previous suicide attempts and psychiatric diagnoses" (p.116). </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information on participant blinding was reported. However, both treatments were so similar that it is possible participants were unaware of which treatment they were receiving. However, for clinical personnel "[t]he same seven therapists provided treatment in both...conditions” (p.114). However, there were no apparent deviations from the intended intervention. Additionally, "[f]ollow‐up data from all 31 families who completed follow‐ups (regardless<br/>of number of treatment sessions attended) were included in data analyses consistent with an intent to‐treat model" (p.115). </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data were available for 100% of those randomised.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Structured adolescent and parent follow‐up interviews...assessed incidents of further suicidal behaviors" (p.115). However, previous work has demonstrated that self‐harm prevalence estimates derived from self‐report may be underestimated, and supplementing prevalence estimates with medical or clinical record information is advisable (Mars 2016). However, repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. Additionally, whilst no information on outcome assessor blinding was reported, information on SH was ascertained from participant self‐report. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information is available on whether the data that produced this result was analysed in accordance with a pre‐specified analysis plan that was finalised before unblinded outcome data were available for analysis. "Outcome measures were administered 3 months (end of active treatment) and 6 months (end of maintenance)..." (p.115). All eligible outcome measurements within the outcome domain were reported. Additionally, "...interviews...assessed incidents of further suicidal behaviors" (p.115). All eligible analyses of the data were reported. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at some concerns for risk of bias as no specific information on allocation concealment was reported. </p> </td> </tr> <tr class="study-data"> <td> <p>Sinyor 2020</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col10" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"A random number generator was used to create the treatment allocation sequence...A member of the principal investigator's lab who was otherwise not involved in the study generated the list and created individual electronic files with allocation by subject number, protected by unique passwords that were only sent to the PI following each subject's inclusion..." (p.688). Additionally, "[t]here was no difference in mean age, sex, baseline SSI, MADRS, CGI‐S or BDI scores [at baseline] between groups" (p.689). </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"This study is a single‐site, single‐blind...RCT" (p.687). As this was a single, (assessor) blinded trial, participants and clinical personnel were not blinded to treatment allocation. However, there were no apparent deviations from the intended intervention. Additionally, "[t]his study used an intent‐to‐treat approach including all 24 subjects randomized into the trial each of whom had at least a baseline visit" (p.689). </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data were available for 100% of those randomised.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"...repeated SH (i.e. any episode of self‐injury regardless of intent occurring between research visits) as well as suicide attempts (i.e. any episode of self‐injury with at least some intent to die between research visits) derived from the Columbia Suicide Severity Rating Scale..." (p.688). However, previous work has demonstrated that self‐harm prevalence estimates derived from self‐report may be underestimated, and supplementing prevalence estimates with medical or clinical record information is advisable (Mars 2016). However, repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. Additionally, whilst "a blinded research coordinator...obtained study measures" (p.688), information on SH was ascertained from participant self‐report. Self‐reported self‐harm represents an participant‐reported outcome. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information is available as to whether the data that produced this result was analysed in accordance with a pre‐specified analysis plan that was finalised before unblinded outcome data were available for analysis. However,  correspondence with trial authors revealed data on all outcomes were collected at the conclusion of the acute treatment phase (10 weeks), and at 12 months (i.e., following the conclusion of the booster phase), although data on repetition of self‐harm for both these time points had to be requested from trial authors. Additionally,  data for all eligible analyses of the data were obtained following correspondence. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at high risk of bias as, although outcome assessors were blinded, repetition of self‐harm was ascertained from self‐reported information and participants were likely not blind to treatment allocation. Additionally, insufficient information was reported in the trial protocol to determine whether the data that produced this result analysed in accordance with a pre‐specified analysis plan that was finalized before unblinded outcome data were available for analysis. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.1 Repetition of SH by post‐intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#riskOfBias2Table-1">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-2"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.1 Repetition of SH at post‐intervention</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 2.1.1 Comparator: TAU</b> </p> </td> </tr> <tr class="study-data"> <td> <p>Cooney 2010</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Participants were randomly assigned…via a computerised randomisation<br/>procedure…In this procedure, the treatment assignment series was generated by the fifth author...in conjunction with a research assistant who was otherwise entirely independent from the study. Each treatment assignment was placed in a sealed numbered envelope...by the assistant, and once the participant had completed all pre‐treatment screening and<br/>research assessments, he or she was given the next envelope in the series and opened it to discover what treatment he or she was to receive” (p.10). Additionally, there were no significant differences between the intervention and comparator arms for any of the demographic characteristics and clinical variables measured (Table 1, p.17). </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>As this was a single (assessor) blinded trial, participants and clinical personnel were not blinded to treatment allocation. Additionally, "[i]Initially, owing to funding restrictions, we had planned to limit the number of participants in group sessions to two [persons] per family (i.e. the young person and one parent or caregiver). Approximately 12 weeks into group sessions, we extended this to three family members per group session..." (pp.11‐13).  However, It is unlikely that the addition of a third family member would have significantly affected the outcome. Additionally, given that both the intervention and comparator arms comprised family therapy, it is likely these deviations could have been balanced between groups. However, although data for all 29 participants randomised to the intervention or comparator arms is reported at the mid‐treatment assessment, at longer follow‐up periods only data on those available for assessment were presented. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data were available for 93.3% of those randomised.  However, analysis method did not correct for bias, nor were sensitivity analyses undertaken to investigate the potential effect of missing data. Despite this, data were available for 92.8% of those randomised to the intervention arm, and 93.7% of those randomised to the comparator arm. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"The primary outcome variable was the occurrence and frequency of self‐harm (i.e. suicide attempts and non‐suicidal self‐injuries)... To measure this, we used the Suicide Attempt‐Self‐Injury Interview...which we adapted for use with adolescents" (p.12). However, previous work has demonstrated that self‐harm prevalence estimates derived from self‐report may be underestimated, and supplementing prevalence estimates with medical or clinical record information is advisable (Mars 2016). However, repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. However, whilst "[a]ll subsequent assessments were administered by an assessor...who was also blind to treatment condition" (p.10), information on SH was ascertained from participant self‐report. Self‐reported self‐harm represents an participant‐reported outcome. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information is available as to whether the data that produced this result were analysed in accordance with a pre‐specified analysis plan that was finalised before unblinded outcome data were available for analysis. However, "[o]utcome assessments were conducted before treatment assignment, and scheduled to occur at approximately 3 [i.e., mid treatment] and 6‐month [i.e., post‐intervention] intervals... (p.10), all eligible outcome measurements within the outcome domain were reported. "The primary outcome variable was the occurrence and frequency of self‐harm (i.e. suicide attempts and non‐suicidal self‐injuries)... To measure this, we used the Suicide Attempt‐Self‐Injury Interview...which we adapted for use with adolescents" (p.12), all eligible analyses of the data were reported. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at some concerns for risk of bias as, although outcome assessors were blinded, repetition of self‐harm was ascertained from self‐reported information and participants were likely not blind to treatment allocation. Additionally, there were some minor deviations from the intended intervention that may have arisen as a result of the trial context. </p> </td> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 2.1.2 Comparator: Enhanced usual care</b> </p> </td> </tr> <tr class="study-data"> <td> <p>Santamarina‐Pérez 2020</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"...participants were then randomly assigned...using a computer‐generated list of random numbers and following a simple randomization procedure in a 1:1 ratio" (p.7). Additionally, "an independent and off‐site statistician generated the random allocation sequence" (p.7). There were no significant differences between the intervention and comparator arms for most of the demographic characteristics and clinical variables measured (Table 1, p.6). However, those assigned to the intervention arm had lower depression scores (MD 7.10, 95% CI 1.46 to 12.74, p=0.019). This result may have been compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Given the characteristics of the treatment arms, therapists and patients were not blind to the type of treatment" (p.7). Additionally, there were no apparent deviations from the intended intervention. "An intention‐to‐treat analysis was performed and involved all patients who were randomly assigned" (p.7). </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data were available for 85.7% of those randomised. However, Analysis method did not correct for bias, nor were sensitivity analyses undertaken to investigate the potential effect of missing data. Despite this, data were available for 83.3% of those randomised to the intervention arm, and 88.2% of those randomised to the comparator arm. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Frequency of NSSIs and the number of SAs... were collected based on the information reported during individual sessions and using medical records. These variables were collected by the patient’s clinician  using a register..." (p.5). Repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. Additionally, "[c]linical assessments of the participants were performed by an independent psychologist...who was blind to treatment assignment at baseline and at the end of the treatment after 16 weeks" (p.3). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Referring back to the trial protocol (NCT02406625), no specific information was reported. However, "...variables were collected..at week 4, week 8, week 12, and week 16 of treatment" (p.5). All eligible outcome measurements within the outcome domain were reported. Additionally, "[f]requency of NSSIs and the number of SAs...were collected by the patient’s clinician using a register..." (p.5). All eligible analyses of the data were reported. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at some concerns for risk of bias as insufficient information was reported in the trial protocol to determine whether the data that produced this result analysed in accordance with a pre‐specified analysis plan that was finalized before unblinded outcome data were available for analysis. </p> </td> </tr> <tr class="study-data"> <td> <p>Mehlum 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Treatment allocation of participants...was based on a permuted block randomisation procedure with an undisclosed and variable blocking factor...management of the randomisation procedures was performed by an external group..." (p.1083). Additionally, there were "[n]o significant differences between the treatment groups were found on any baseline characteristics" (p.1087). </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>As this was a single (assessor) blinded trial, participants and clinical personnel were not blinded to treatment allocation. Additionally, there were no apparent deviations from the intended intervention. "Data analysis was by intention to treat" (p.1086). </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data were available for 100% of those randomised.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"The primary outcomes were as follows: the number of self‐reported self‐harm episodes (suicide attempts and non‐suicidal self‐harm episodes combined)..." (p.1085). However, previous work has demonstrated that self‐harm prevalence estimates derived from self‐report may be underestimated, and supplementing prevalence estimates with medical or clinical record information is advisable (Mars 2016). Additionally, repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. However, whilst "[t]en independent assessors, blind to treatment allocation and to results from baseline interviews, conducted interviews at trial completion…" (p.4), information on SH was ascertained from participant self‐report. Self‐reported self‐harm represents an participant‐reported outcome. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Referring back to the trial protocol (NCT00675129), no specific information was reported. However, "...self‐harm was measured at 9 weeks (covering the first 9 weeks) and 15 weeks (covering the next 6 weeks)" (p.1085). All eligible outcome measurements within the outcome domain were reported. Additionally, "[t]he primary outcomes were as follows: the number of self‐reported self‐harm episodes (suicide attempts and non‐suicidal self‐harm episodes combined)..." (p.1085). All eligible analyses of the data were reported. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at some concerns for risk of bias as insufficient information was reported in the trial protocol to determine whether the data that produced this result analysed in accordance with a pre‐specified analysis plan that was finalized before unblinded outcome data were available for analysis. </p> </td> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 2.1.3 Comparator: Alternative psychotherapy</b> </p> </td> </tr> <tr class="study-data"> <td> <p>McCauley 2018</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Participants were randomized to treatment condition groups using a computerized adaptive minimization randomization procedure that matched participants across conditions within sites on age, number of suicide attempts, number of previous self‐injuries, and psychotropic medication use..." (p.2‐3). Additionally, there were no significant differences between the intervention and comparator arms for any of the demographic characteristics and clinical variables measured (Table 1, p.4). </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Participants learned their treatment assignment at the first therapy session." (p.3). However, '[t]herapists provided treatment in only 1 study arm..." (p.3). Given the similarity in treatment intensity between the intervention and comparator arms in this trial, it is possible that clinical personnel could have remained blind to treatment allocation. However, there were no apparent deviations from the intended intervention. Additionally, "[t]reatment effects were evaluated using intention‐to‐treat analyses" (p.3). Furthermore, "[a]ll dropouts and missing data were replaced using multiple imputation based on averaging 10 iterative Markov‐Chain<br/>Monte Carlo imputations to complete the missing data, providing a full intention‐to‐treat analysis" (p.4). </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data were available for 100% of those randomised.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Suicide attempts, NSSI, and self‐harm were measured using the SASII [Suicide Attempt Self‐Injury Interview]" (p.3). However, previous work has demonstrated that self‐harm prevalence estimates derived from self‐report may be underestimated, and supplementing prevalence estimates with medical or clinical record information is advisable (Mars 2016). However, repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. Additionally, whilst "[a]ssessors naive to treatment group" (p.3), information on SH was ascertained from participant self‐report. Self‐reported self‐harm represents an participant‐reported outcome. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Referring back to the trial protocol (NCT01528020), no specific information was reported. "Assessments occurred at baseline (before treatment), 3 months (middle of treatment), 6 months (end of treatment), 9 months, and 12 months" (p.3). Data on repetition of SH at the 3 month (middle of treatment) and 9 months assessment were not reported, however. Whilst the 9 month assessment represents a post‐intervention assessment time point, the authors do report data for other post‐intervention assessment time points for which a favourable effect for the intervention was not apparent. It is therefore unlikely trial authors selectively reported results for favourability. All eligible analyses of the data were reported. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at some concerns for risk of bias as, although outcome assessors were blinded, repetition of self‐harm was ascertained from self‐reported information and participants were likely not blind to treatment allocation. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.1 Repetition of SH at post‐intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#riskOfBias2Table-2">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-3"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 3.1 Repetition of SH by post‐intervention</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Griffiths 2019</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Randomisation (at the individual level) was independent and concealed, using randomised‐permuted blocks adjusted to permit access to group treatment without undue delay. Group allocation remained concealed until completion of self‐report ratings" (p.3).  Whilst, "[a]t entry to the study, there were no significant between group differences on demographic or service usage variables..." (p.3), the trial authors also report that "[u]sing the recommended cut‐off [for the 11‐item Borderline Personality Features Scale for Children] 55% of participants in the treatment arm warranted further assessment for borderline personality disorder compared to only 15% of the control arm" (p.6) (OR 6.60, 95% CI 1.70 to 25.62). </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>As this was a single (assessor) blinded trial, participants and clinical personnel were not blind to treatment allocation. Referring back to the trial protocol (NCT02771691), little specific information was provided on the content of the intervention. However, there was no apparent deviation from the intended intervention. Additionally, "...we also carried out intention‐to‐treat analyses to determine indicative treatment effects on the primary and secondary outcome measures, adjusting for pre‐specified baseline covariates" (p.4). </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data were available for 100% of those randomised.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Our primary outcome was self‐harm post‐treatment as assessed by...[t]he self‐harm subscale of the Risk‐Taking and Self‐Harm Inventory for Adolescents (RTSHI)...[and s]elf‐harm related hospital use as reported by emergency department presentation in...electronic records" (p.4). Additionally, repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. "All measures were administered blind by the research assistants...For self‐harm related emergency department use, the research assistants reviewed...electronic records after the last face to face assessment had been conducted in order to maintain blinding" (p.4). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Referring back to the trial protocol (NCT02771691), no specific information was reported. "Our primary outcome was self‐harm post‐treatment as assessed by...[t]he self‐harm subscale of the Risk‐Taking and Self‐Harm Inventory for Adolescents (RTSHI)...[and s]elf‐harm related hospital use as reported by emergency department presentation in...electronic records…[all measures were administered…at baseline, 12, 24 and 36 weeks" (p.4). All eligible outcome measurements within the outcome domain were reported. "Our primary outcome was self‐harm post‐treatment as assessed by...[t]he self‐harm subscale of the Risk‐Taking and Self‐Harm Inventory for Adolescents (RTSHI)...[and s]elf‐harm related hospital use as reported by<br/>emergency department presentation in...electronic records" (p.4). All eligible analyses of the data were reported. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at some concerns for risk of bias as just over half of the participants assigned to the intervention arm warranted further assessment for borderline personality disorder at baseline compared to 15% of those assigned to the control arm, suggesting there may have been a problem with the randomisation process. </p> </td> </tr> <tr class="study-data"> <td> <p>Rossouw 2012</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Allocation was by minimization, controlling for past hospital admissions, gender, and age" (p.1305). Additionally, "...participants were randomized by an independent statistician working offsite..." (p.1306). Additionally,  there were no significant differences between the intervention and comparator arms for most of the demographic characteristics and clinical variables measured (Table 1, p.1308). However, whilst those assigned to the intervention arm were significantly younger (MD ‐0.60, 95% CI ‐1.15 to ‐0.05; p=0.04), this result may have been compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"...participants were...blinded to assignment" (p.1305). Given the difference in therapeutic intensity between the intervention and comparator arms, however, it is unlikely that clinical personnel blinding could have been convincingly achieved. Additionally, there were no apparent deviations from the intended intervention. "Data analysis was by intention to treat" (p.1306). </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data were available for 88.7% of those randomised. However, analysis method did not correct for bias, nor were sensitivity analyses undertaken to investigate the potential effect of missing data. Despite this, data were available for 90.0% of those randomised to the intervention arm, and 87.5% of those randomised to the comparator arm. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"The primary outcome was self‐harm assessed by self‐report...using the self‐harm scale of the Risk‐Taking and Self‐Harm Inventory (RTSHI)" (p.1306). However, this was based on fewer adolescents scoring above the cut‐point on the Risk Taking and Self‐Harm Inventory (RTSHI) and it is unclear how this scale may relate to actual SH behaviour. Additionally, previous work has demonstrated that self‐harm prevalence estimates derived from self‐report may be underestimated, and supplementing prevalence estimates with medical or clinical record information is advisable (Mars 2016). Additionally, repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. However, whilst "assessors…were…blinded to assignment" (p.1305), information on SH was ascertained from participant self‐report. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information is available as to whether the data that produced this result analysed in accordance with a pre‐specified analysis plan that was finalised before unblinded outcome data were available for analysis. However,  "[t]he primary outcome was self‐harm assessed by self‐report at baseline and every 3 months until 12 months after randomization" (p.1306). All eligible outcome measurements within the outcome domain were reported. Additionally, "[t]he primary outcome was self‐harm assessed by self‐report..." (p.1306). All eligible analyses of the data were reported. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at high risk of bias as, repetition of self‐harm assessed by self‐report using the self‐harm scale of the Risk‐Taking and Self‐Harm Inventory (RTSHI) and it is unclear how this scale may relate to actual SH behaviour. Additionally, although outcome assessors were blinded, repetition of self‐harm was ascertained from self‐reported information and participants were likely not blind to treatment allocation. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 3.1 Repetition of SH by post‐intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#riskOfBias2Table-3">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-4"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 3.2 Repetition of SH at post‐intervention (Risk‐Taking and Self‐Harm Inventory)</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Griffiths 2019</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Randomisation (at the individual level) was independent and concealed, using randomised‐permuted blocks adjusted to permit access to group treatment without undue delay. Group allocation remained concealed until completion of self‐report ratings" (p.3).  Whilst, "[a]t entry to the study, there were no significant between group differences on demographic or service usage variables..." (p.3), the trial authors also report that "[u]sing the recommended cut‐off [for the 11‐item Borderline Personality Features Scale for Children] 55% of participants in the treatment arm warranted further assessment for borderline personality disorder compared to only 15% of the control arm" (p.6) (OR 6.60, 95% CI 1.70 to 25.62). </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>As this was a single (assessor) blinded trial, participants and clinical personnel were not blind to treatment allocation. Referring back to the trial protocol (NCT02771691), little specific information was provided on the content of the intervention. However, there was no apparent deviation from the intended intervention. Additionally,  "...we also carried out intention‐to‐treat analyses to determine indicative treatment effects on the primary and secondary outcome measures, adjusting for pre‐specified baseline covariates" (p.4). </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data were available for 100% of those randomised.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Our primary outcome was self‐harm post‐treatment as assessed by...[t]he self‐harm subscale of the Risk‐Taking and Self‐Harm Inventory for Adolescents (RTSHI)...[and s]elf‐harm related hospital use as reported by emergency department presentation in...electronic records" (p.4). Additionally, repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. "All measures were administered blind by the research assistants...For self‐harm related emergency department use, the research assistants reviewed...electronic records after the last face to face assessment had been conducted in order to maintain blinding" (p.4). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Referring back to the trial protocol (NCT02771691), no specific information was reported. However, "[o]ur primary outcome was self‐harm post‐treatment as assessed by...[t]he self‐harm subscale of the Risk‐Taking and Self‐Harm Inventory for Adolescents (RTSHI)...[and s]elf‐harm related hospital use as reported by emergency department presentation in...electronic records…[all measures were administered…at baseline, 12, 24 and 36 weeks" (p.4). All eligible outcome measurements within the outcome domain were reported. Additionally, "[o]ur primary outcome was self‐harm post‐treatment as assessed by...[t]he self‐harm subscale of the Risk‐Taking and Self‐Harm Inventory for Adolescents (RTSHI)...[and s]elf‐harm related hospital use as reported by emergency department presentation in...electronic records" (p.4). All eligible analyses of the data were reported. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at some concerns for risk of bias as just over half of the participants assigned to the intervention arm warranted further assessment for borderline personality disorder at baseline compared to 15% of those assigned to the control arm, suggesting there may have been a problem with the randomisation process. </p> </td> </tr> <tr class="study-data"> <td> <p>Rossouw 2012</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Allocation was by minimization, controlling for past hospital admissions, gender, and age" (p.1305). Additionally, "...participants were randomized by an independent statistician working offsite..." (p.1306). Additionally,  there were no significant differences between the intervention and comparator arms for most of the demographic characteristics and clinical variables measured (Table 1, p.1308). However, whilst those assigned to the intervention arm were significantly younger (MD ‐0.60, 95% CI ‐1.15 to ‐0.05; p=0.04), this result may have been compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"...participants were...blinded to assignment" (p.1305). Given the difference in therapeutic intensity between the intervention and comparator arms, however, it is unlikely that clinical personnel blinding could have been convincingly achieved. However, there were no apparent deviations from the intended intervention. Additionally, "[d]ata analysis was by intention to treat" (p.1306). </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data were available for 88.7% of those randomised. However, analysis method did not correct for bias, nor were sensitivity analyses undertaken to investigate the potential effect of missing data. Despite this, data were available for 90.0% of those randomised to the intervention arm, and 87.5% of those randomised to the comparator arm. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"The primary outcome was self‐harm assessed by self‐report...using the self‐harm scale of the Risk‐Taking and Self‐Harm Inventory (RTSHI)" (p.1306). However, this was based on fewer adolescents scoring above the cut‐point on the Risk Taking and Self‐Harm Inventory (RTSHI) and it is unclear how this scale may relate to actual SH behaviour. Additionally, previous work has demonstrated that self‐harm prevalence estimates derived from self‐report may be underestimated, and supplementing prevalence estimates with medical or clinical record information is advisable (Mars 2016). However, repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. Although, whilst "assessors…were…blinded to assignment" (p.1305), information on SH was ascertained from participant self‐report. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information is available as to whether the data that produced this result analysed in accordance with a pre‐specified analysis plan that was finalised before unblinded outcome data were available for analysis. However, "[t]he primary outcome was self‐harm assessed by self‐report at baseline and every 3 months until 12 months after randomization" (p.1306). All eligible outcome measurements within the outcome domain were reported. Additionally, "[t]he primary outcome was self‐harm assessed by self‐report..." (p.1306). All eligible analyses of the data were reported. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at high risk of bias as, repetition of self‐harm assessed by self‐report using the self‐harm scale of the Risk‐Taking and Self‐Harm Inventory (RTSHI) and it is unclear how this scale may relate to actual SH behaviour. Additionally, although outcome assessors were blinded, repetition of self‐harm was ascertained from self‐reported information and participants were likely not blind to treatment allocation. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 3.2 Repetition of SH at post‐intervention (Risk‐Taking and Self‐Harm Inventory)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#riskOfBias2Table-4">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-5"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 5.1 Repetition of SH at post‐intervention</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 5.1.1 Comparator: TAU</b> </p> </td> </tr> <tr class="study-data"> <td> <p>Harrington 1998</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"...a series of opaque and sealed envelopes containing either a blank sheet or the letter F were prepared and randomly assorted by an assistant" (p.2).  Additionally, "[t]he groups were well matched on clinical characteristics" (p.514), including age, sex, history of SH, method of SH, family history of SH, and other clinical and functional characteristics (Table 1, p.514). </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Given the difference in therapeutic intensity between the intervention and comparator arms, it is unlikely that participant blinding could have been convincingly achieved. Furthermore, "[the envelopes] were opened by the social worker at the time of the assessment, who then assigned the case to the family intervention plus routine care or routine care alone" (p.513), suggesting that clinical personnel were not blind to treatment assignment. However, there were no apparent deviations from the intended intervention. Additionally, "[a]ll the analyses were conducted ‘intent to treat’"(p.514). </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data were available for 97.4% of those randomised.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Correspondence with trial authors revealed repetition of SH was ascertained from self‐report. However, previous work has demonstrated that self‐harm prevalence estimates derived from self‐report may be underestimated, and supplementing prevalence estimates with medical or clinical record information is advisable (Mars 2016). However, It is likely that repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. Additionally, whilst "[t]reatment assignment was entered on a register and concealed from the outcome assessors" (p.2), information on SH was ascertained from participant self‐report. Self‐reported self‐harm represents an participant‐reported outcome. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information is available as to whether the data that produced this result were analysed in accordance with a pre‐specified analysis plan that was finalised before unblinded outcome data were available for analysis. However, "[o]utcome assessments were conducted...2 months and...at 6 months" (p.514). All eligible outcome measurements within the outcome domain were reported. Additionally, correspondence with trial authors revealed repetition of SH was ascertained from self‐report. All eligible analyses of the data were reported. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at some concerns for risk of bias as, although outcome assessors were blinded, repetition of self‐harm was ascertained from self‐reported information and participants were likely not blind to treatment allocation. </p> </td> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 5.1.2 Comparator: Enhanced usual care</b> </p> </td> </tr> <tr class="study-data"> <td> <p>Asarnow 2017</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Eligible participants were randomly assigned in a 1:1 ratio to [intervention] or [comparator] using a computerized algorithm. To improve balance across conditions, the randomization procedure was stratified on gender and SA versus NSSI‐only status at presentation. Enrollment...staff were masked to randomization status." (p.507). Additionally, "[intervention] and [comparator] youths were similar in regard to demographic characteristics and clinical variables, with no statistically significant between group differences" (p.509; Table 1, p.511). </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Given the difference in therapeutic intensity between the intervention and comparator arms, it is unlikely that participant or clinical personnel blinding could have been convincingly achieved. However, there were no apparent deviations from the intended intervention. Additionally, "[p]rimary analyses were intent to treat, incorporating data from all<br/>participants regardless of degree of participation" (p.509). </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Although data were available for 100% of the sample using any report [i.e., youth self‐report supplemented by parental report, where necessary], youth‐report data were available for 55% of E‐TAU youths versus 100% of SAFETY youths" (p.510). However, "[s]ensitivity analyses using parent report when youth report was unavailable yielded similar results...Additional sensitivity analyses assuming that all E‐TAU youths who dropped out early reached the 3‐month time point SA‐free also yielded comparable results" (p.511). </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"...youth self‐report was used in primary analyses of SA and SH outcomes" (p.509). However, previous work has demonstrated that self‐harm prevalence estimates derived from self‐report may be underestimated, and supplementing prevalence estimates with medical or clinical record information is advisable (Mars 2016). However, repetition of self‐harm was ascertained in the same way for both the intervention and comparator arms. Although, whilst "[a]ssessment staff were naive to treatment condition" (p.508), information on SH was ascertained from participant self‐report. Self‐reported self‐harm represents an participant‐reported outcome. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Referring back to the trial protocol (NCT00692302), there were no apparent departures from the analysis plan. Referring back to the trial protocol (NCT00692302), all eligible outcome measurements within the outcome domain were reported. Additionally, referring back to the trial protocol (NCT00692302), all eligible analyses of the data were reported. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Overall, this trial was rated as at some concerns for risk of bias as, although outcome assessors were blinded, repetition of self‐harm was ascertained from self‐reported information and participants were likely not blind to treatment allocation. </p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 5.1 Repetition of SH at post‐intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013667.pub2/references#riskOfBias2Table-5">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013667.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013667-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013667-note-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013667-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD013667-note-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD013667-note-0018">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD013667-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013667-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013667-note-0020">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD013667-note-0010">Português</a> </li> <li class="section-language"> <a class="" href="ro#CD013667-note-0021">Română</a> </li> <li class="section-language"> <a class="" href="ru#CD013667-note-0008">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD013667-note-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013667-note-0015">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013667-note-0016">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013667\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013667\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013667\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013667\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013667\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=qy4lqFNF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013667.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013667.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013667.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013667.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013667.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728939654"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013667.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728939658"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013667.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ed0b87a3b9368',t:'MTc0MDcyODk0MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 